| 1 |
Mittal P, Quattrocchi G, Tohidi-Esfahani I, Sayar Z, Chandratheva A, Cohen H. Antiphospholipid syndrome, antiphospholipid antibodies, and stroke. Int J Stroke 2023;18:383-91. [PMID: 36571450 DOI: 10.1177/17474930221150349] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Kambhatla S, Vipparthy S, Manadan AM. Rheumatic diseases associated with alveolar hemorrhage: analysis of the national inpatient sample. Clin Rheumatol 2023;42:1177-83. [PMID: 36396790 DOI: 10.1007/s10067-022-06449-9] [Reference Citation Analysis]
|
| 3 |
Tincani A, Fontana G, Mackworth-Young C. The history of antiphospholipid syndrome. Reumatismo 2023;74. [PMID: 36942979 DOI: 10.4081/reumatismo.2022.1556] [Reference Citation Analysis]
|
| 4 |
Cincotta MC, Walker RH. Diagnostic Uncertainties: Chorea. Semin Neurol 2023. [PMID: 36882120 DOI: 10.1055/s-0043-1763506] [Reference Citation Analysis]
|
| 5 |
Nevras V, Milaras N, Katsioulis C, Sotiriou Z, Tsalamandris S, Gkounti G, Skevos S. Acute Coronary Syndromes in Antiphospholipid Syndrome-above Suspicion: A Systematic Review. Curr Probl Cardiol 2023;48:101503. [PMID: 36402221 DOI: 10.1016/j.cpcardiol.2022.101503] [Reference Citation Analysis]
|
| 6 |
Khayata M, Wang TKM, Chan N, Alkharabsheh S, Verma BR, Oliveira GH, Klein AL, Littlejohn E, Xu B. Multimodality Cardiac Imaging in Patients with Systemic Lupus Erythematosus. Curr Probl Cardiol 2023;48:101048. [PMID: 34774920 DOI: 10.1016/j.cpcardiol.2021.101048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 7 |
Knight JS, Branch DW, Ortel TL. Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management. BMJ 2023;380:e069717. [PMID: 36849186 DOI: 10.1136/bmj-2021-069717] [Reference Citation Analysis]
|
| 8 |
Stammler R, Nguyen Y, Yelnik C, Le Guern V, Lambert M, Paule R, Hachulla E, Mouthon L, Dupré A, Ackermann F, Dufrost V, Wahl D, Godeau B, Leroux G, Benhamou Y, Lazaro E, Daugas E, Bezanahary H, Mekinian A, Piette JC, Morel N, Costedoat-Chalumeau N. Precipitating factors of catastrophic antiphospholipid syndrome: the role of anticoagulant treatment in a series of 112 patients. J Thromb Haemost 2023:S1538-7836(23)00146-0. [PMID: 36792010 DOI: 10.1016/j.jtha.2023.02.007] [Reference Citation Analysis]
|
| 9 |
Petrovic G, Pasic S, Soldatovic I. Association of Antiphospholipid Antibodies with Clinical Manifestations in Children with Systemic Lupus Erythematosus. J Clin Med 2023;12. [PMID: 36835956 DOI: 10.3390/jcm12041424] [Reference Citation Analysis]
|
| 10 |
Hasan H, Surjancev I, Arnason JA, Garg S, Rose WN. Corticosteroids, Plasmapheresis, Argatroban, Rituximab, and Sirolimus Provided Clinical Benefit for Catastrophic Antiphospholipid Syndrome in a Patient with a History of Heparin-Induced Thrombocytopenia. Case Rep Rheumatol 2023;2023:3226278. [PMID: 36816449 DOI: 10.1155/2023/3226278] [Reference Citation Analysis]
|
| 11 |
D'Ippolito S, Barbaro G, Paciullo C, Tersigni C, Scambia G, Di Simone N. Antiphospholipid Syndrome in Pregnancy: New and Old Pathogenetic Mechanisms. Int J Mol Sci 2023;24. [PMID: 36834614 DOI: 10.3390/ijms24043195] [Reference Citation Analysis]
|
| 12 |
Maximiliano CL, Jaime GC, Erika MH. Rivaroxaban plus aspirin versus acenocoumarol to manage recurrent venous thromboembolic events despite systemic anticoagulation with rivaroxaban. Thromb Res 2023;222:43-8. [PMID: 36565679 DOI: 10.1016/j.thromres.2022.12.008] [Reference Citation Analysis]
|
| 13 |
Capozzi A, Manganelli V, Riitano G, Caissutti D, Longo A, Garofalo T, Sorice M, Misasi R. Advances in the Pathophysiology of Thrombosis in Antiphospholipid Syndrome: Molecular Mechanisms and Signaling through Lipid Rafts. J Clin Med 2023;12. [PMID: 36769539 DOI: 10.3390/jcm12030891] [Reference Citation Analysis]
|
| 14 |
Haga Y, Ohara A, Yakuwa T, Yamashita A, Udo M, Matsuoka M, Yasumoto A, Takahashi H. Persistently high platelet factor 4 levels in an adolescent with recurrent late thrombotic complications after SARS-CoV-2 mRNA vaccination: A case report.. [DOI: 10.21203/rs.3.rs-2441808/v1] [Reference Citation Analysis]
|
| 15 |
Płazak W, Drabik L. SARS-CoV-2 infection and SLE: endothelial dysfunction, atherosclerosis, and thrombosis. Clin Rheumatol 2023;:1-12. [PMID: 36622519 DOI: 10.1007/s10067-022-06497-1] [Reference Citation Analysis]
|
| 16 |
Santos-Moreno P, Arias-Aponte J, Rodríguez-Vargas GS, Nieto-Zambrano PD, Villarreal L, Ibatá L, Martinez S, Rubio-Rubio JA, Rodríguez P, Rojas-Villarraga A. Polyautoimmunity in systemic lupus erythematosus patients: New insights from a cross-sectional study. J Transl Autoimmun 2023;6:100187. [PMID: 36654852 DOI: 10.1016/j.jtauto.2022.100187] [Reference Citation Analysis]
|
| 17 |
Harsini S, Rezaei N. Autoimmune diseases. Clinical Immunology 2023. [DOI: 10.1016/b978-0-12-818006-8.00001-3] [Reference Citation Analysis]
|
| 18 |
Wu Y, Wong C, Fang L, Hung W. Acrocyanosis and retiform purpura as the first manifestation of catastrophic antiphospholipid syndrome in a child: A case report. Dermatol Sin 2023;0:0. [DOI: 10.4103/ds.ds-d-22-00086] [Reference Citation Analysis]
|
| 19 |
van den Hoogen LL, Bisoendial RJ. B-Cells and BAFF in Primary Antiphospholipid Syndrome, Targets for Therapy? J Clin Med 2022;12. [PMID: 36614819 DOI: 10.3390/jcm12010018] [Reference Citation Analysis]
|
| 20 |
Coss SL, Zhou D, Chua GT, Aziz RA, Hoffman RP, Wu YL, Ardoin SP, Atkinson JP, Yu CY. The complement system and human autoimmune diseases. J Autoimmun 2022;:102979. [PMID: 36535812 DOI: 10.1016/j.jaut.2022.102979] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 21 |
Peng Q, Chen X, Han Y, Tang G, Liu J, Liu Y, Zhou Q, Long L. Applicability of the Padua scale for Chinese rheumatic in-patients with venous thromboembolism. PLoS One 2022;17:e0278157. [PMID: 36525417 DOI: 10.1371/journal.pone.0278157] [Reference Citation Analysis]
|
| 22 |
Dupré A, Morel N, Yelnik C, Moguelet P, Le Guern V, Stammler R, Nguyen Y, Paule R, Dufrost V, Ackermann F, Benhamou Y, Godeau B, Lambert M, Duffau P, Mekinian A, Saadoun D, Mouthon L, Hachulla E, Maillard H, Levesque H, Morell-Dubois S, Leroux G, Piette JC, Chasset F, Costedoat-Chalumeau N. Cutaneous Involvement in Catastrophic Antiphospholipid Syndrome in a Multicenter Cohort of 65 Patients. JAMA Dermatol 2023;159:62-7. [PMID: 36477813 DOI: 10.1001/jamadermatol.2022.5221] [Reference Citation Analysis]
|
| 23 |
Suleiman M, Costedoat-chalumeau N, Le Guern V, Morel N, Amoura Z, Espitia O, Martis N, Jeandel P, Audia S, Cormarmond C, Sève P, Sene D, Gerfaud-valentin M, Goutte J, Lavigne C, Thomas G, Bourgarit A, Roblot P, Puyade M, Martin M. Syndrome des antiphospholipides et atteinte surrénalienne : étude cas-témoin nationale multicentrique. La Revue de Médecine Interne 2022;43:A358-A359. [DOI: 10.1016/j.revmed.2022.10.060] [Reference Citation Analysis]
|
| 24 |
Mohammed RHA, Mumtaz H, Sangah AB, Shaikh SS, Nasir N, Jabeen S. Pregnancy in lupus: an updated consensus to guide best practice strategies. Egypt Rheumatol Rehabil 2022;49:67. [DOI: 10.1186/s43166-022-00167-5] [Reference Citation Analysis]
|
| 25 |
Barilaro G, Coloma-Bazan E, Chacur A, Della Rocca C, Perez-Isidro A, Ruiz-Ortiz E, Viñas O, Tàssies Penella D, Reverter JC, Molina Andujar A, Cervera R, Espinosa G. Persistence of antiphospholipid antibodies over time and its association with recurrence of clinical manifestations: A longitudinal study from a single centre. Autoimmun Rev 2022;21:103208. [PMID: 36202304 DOI: 10.1016/j.autrev.2022.103208] [Reference Citation Analysis]
|
| 26 |
Azoulay LD, Pineton de Chambrun M, Larcher R, Pène F, Argaud L, Mayaux J, Jamme M, Coudroy R, Mathian A, Gibelin A, Azoulay E, Tandjaoui-Lambiotte Y, Dargent A, Beloncle F, Raphalen JH, Troger A, de Prost N, Devaquet J, Contou D, Gaugain S, Trouiller P, Grangé S, Ledochowski S, Lemarie J, Faguer S, Degos V, Moyon Q, Luyt CE, Kerneis M, Combes A, Amoura Z. Prevalence, characteristics and outcome of cardiac manifestations in critically-ill antiphospholipid syndrome patients. J Autoimmun 2022;133:102908. [PMID: 36126365 DOI: 10.1016/j.jaut.2022.102908] [Reference Citation Analysis]
|
| 27 |
Tan JW, Shukla A, Hu JR, Majumdar SK. Spontaneous Adrenal Hemorrhage with Mild Hypoadrenalism in a Patient Anticoagulated with Apixaban for Antiphospholipid Syndrome: A Case Report and Literature Review. Case Rep Endocrinol 2022;2022:6538800. [PMID: 36504598 DOI: 10.1155/2022/6538800] [Reference Citation Analysis]
|
| 28 |
Capecchi M, Abbattista M, Ciavarella A, Uhr M, Novembrino C, Martinelli I. Anticoagulant Therapy in Patients with Antiphospholipid Syndrome. J Clin Med 2022;11. [PMID: 36498557 DOI: 10.3390/jcm11236984] [Reference Citation Analysis]
|
| 29 |
Fernández-Buhigas I. Obstetric management of the most common autoimmune diseases: A narrative review. Front Glob Womens Health 2022;3:1031190. [PMID: 36505012 DOI: 10.3389/fgwh.2022.1031190] [Reference Citation Analysis]
|
| 30 |
Teng Wu, Wei Huang, Jiaping Qi, Yixuan Li, Yuan Zhang, Huan Jiang, Jing Wang, Ju Zhang, Zhaoyu Jiang, Lin Chen, Zhenhua Ying. Research trends and frontiers on antiphospholipid syndrome: A 10-year bibliometric analysis (2012–2021). Front Pharmacol 2022;13:1035229. [PMID: 36386238 DOI: 10.3389/fphar.2022.1035229] [Reference Citation Analysis]
|
| 31 |
Erton ZB, K Leaf R, de Andrade D, Clarke AE, Tektonidou MG, Pengo V, Sciascia S, Ugarte A, Belmont HM, Gerosa M, Fortin PR, Lopez-Pedrera C, Atsumi T, Zhang Z, Cohen H, Ramires de Jesús G, Branch DW, Wahl D, Andreoli L, Rodriguez-Almaraz E, Petri M, Barilaro G, Zuo Y, Artim-Esen B, Willis R, Quintana R, Vendramini MB, Barber MW, Bertolaccini ML, Roubey R, Erkan D. Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry"). Lupus 2022;:9612033221128742. [PMID: 36206383 DOI: 10.1177/09612033221128742] [Reference Citation Analysis]
|
| 32 |
Haga Y, Ohara A, Yakuwa T, Yamashita A, Udo M, Matsuoka M, Yasumoto A, Takahashi H. A case of an adolescent with antiphospholipid syndrome and persistently high PF4 levels with recurrent late thrombotic complications after mRNA SARS-CoV-2 vaccine.. [DOI: 10.21203/rs.3.rs-2110749/v1] [Reference Citation Analysis]
|
| 33 |
Mustafa R. Neurologic Manifestations of Catastrophic Antiphospholipid Syndrome. Curr Neurol Neurosci Rep 2022;22:589-600. [PMID: 36040563 DOI: 10.1007/s11910-022-01228-0] [Reference Citation Analysis]
|
| 34 |
Morad CS, Fayez D, Mahmoud M, Aboud FM. Primary and secondary antiphospholipid syndrome characteristics in an Egyptian cohort. The Egyptian Rheumatologist 2022;44:373-376. [DOI: 10.1016/j.ejr.2022.07.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 35 |
Djokovic A, Stojanovich L, Stanisavljevic N, Matic P, Colic D, Skrijelj D, Djokic S, Filipovic B. Analysis of Serbian Primary Antiphospholipid Syndrome Patients Confirmed a Strong Association Between Livedo Reticularis and Arterial Thrombosis: A National Cross-Sectional Cohort Study. J Clin Rheumatol 2022;28:362-6. [PMID: 35697016 DOI: 10.1097/RHU.0000000000001879] [Reference Citation Analysis]
|
| 36 |
Masson C, An Nguyen TT, Dufrost V, Audrain M, Hémont C, Agard C, Artifoni M, Connault J, Fouassier M, Hamidou M, Guedon AF, Wahl D, Zuily S, Espitia O. Antiphospholipid syndrome in patients over 65 years: A comparative study of clinical and biological features and thrombotic relapses. Lupus 2022;:9612033221130975. [PMID: 36177950 DOI: 10.1177/09612033221130975] [Reference Citation Analysis]
|
| 37 |
Loiseau P, Foret T, Defilippis EM, Risse J, Etienne AD, Dufrost V, Moulinet T, Erkan D, Devilliers H, Wahl D, Zuily S. Risk of livedo with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis. Lupus. [DOI: 10.1177/09612033221126852] [Reference Citation Analysis]
|
| 38 |
Naranjo L, Stojanovich L, Djokovic A, Andreoli L, Tincani A, Maślińska M, Sciascia S, Infantino M, Garcinuño S, Kostyra-grabczak K, Manfredi M, Regola F, Stanisavljevic N, Milanovic M, Saponjski J, Roccatello D, Cecchi I, Radin M, Benucci M, Pleguezuelo D, Serrano M, Shoenfeld Y, Serrano A. Circulating immune-complexes of IgG/IgM bound to B2-glycoprotein-I associated with complement consumption and thrombocytopenia in antiphospholipid syndrome. Front Immunol 2022;13:957201. [DOI: 10.3389/fimmu.2022.957201] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 39 |
Morel N, Le Guern V, Mouthon L, Piette JC, Costedoat-Chalumeau N. [Heart involvement in systemic lupus erythematosus and antiphospholipid syndrome]. Rev Med Interne 2022:S0248-8663(22)00607-5. [PMID: 36088204 DOI: 10.1016/j.revmed.2022.08.003] [Reference Citation Analysis]
|
| 40 |
Hashmath Z, Bose A, Thabet R, Mishra AK, Kranis M. Right Atrial Thrombus Mimicking a Myxoma: Synergism of Hormonal Contraceptives and Antiphospholipid Antibodies. Tex Heart Inst J 2022;49:e207455. [PMID: 35939276 DOI: 10.14503/THIJ-20-7455] [Reference Citation Analysis]
|
| 41 |
Yao WC, Leong KH, Chiu LT, Chou PY, Wu LC, Chou CY, Kuo CF, Tsai SY. The trends in the incidence and thrombosis-related comorbidities of antiphospholipid syndrome: a 14-year nationwide population-based study. Thromb J 2022;20:50. [PMID: 36050731 DOI: 10.1186/s12959-022-00409-8] [Reference Citation Analysis]
|
| 42 |
Schulz A, Herrmann E, Ott O, Lindhoff-Last E. Thromboembolic Antiphospholipid Syndrome (APS): Efficacy and Safety of Different Anticoagulants-Results of the APSantiCO Registry. J Clin Med 2022;11. [PMID: 36013082 DOI: 10.3390/jcm11164845] [Reference Citation Analysis]
|
| 43 |
Rousselin C, Amoura Z, Faguer S, Bataille P, Boffa JJ, Canaud G, Guerrot D, Jourde-Chiche For The Gclr N, Karras A, Auxenfants E, Chapelet A, Lambert M, Behal H, Nochy D, Jean-Paul DVH, Brocheriou For The Cfpr I, Gnemmi V, Quemeneur T. Renal and vascular outcomes in patients with isolated antiphospholipid syndrome nephropathy. J Autoimmun 2022;132:102889. [PMID: 35987174 DOI: 10.1016/j.jaut.2022.102889] [Reference Citation Analysis]
|
| 44 |
Jin J, Xu X, Hou L, Hou Y, Li J, Liang M, Li C. Thrombocytopenia in the first trimester predicts adverse pregnancy outcomes in obstetric antiphospholipid syndrome. Front Immunol 2022;13:971005. [DOI: 10.3389/fimmu.2022.971005] [Reference Citation Analysis]
|
| 45 |
Sloan EE, McCurdy D. The Antiphospholipid Syndrome in the Pediatric Population. Adv Pediatr 2022;69:107-21. [PMID: 35985703 DOI: 10.1016/j.yapd.2022.03.013] [Reference Citation Analysis]
|
| 46 |
Song X, Fan Y, Jia Y, Li G, Liu M, Xu Y, Zhang J, Li C. A novel aGAPSS-based nomogram for the prediction of ischemic stroke in patients with antiphospholipid syndrome. Front Immunol 2022;13:930087. [DOI: 10.3389/fimmu.2022.930087] [Reference Citation Analysis]
|
| 47 |
Ohya Y, Matsuo R, Sato N, Irie F, Nakamura K, Wakisaka Y, Ago T, Kamouchi M, Kitazono T, Investigators for Fukuoka Stroke Registry. Causes of ischemic stroke in young adults versus non-young adults: A multicenter hospital-based observational study. PLoS ONE 2022;17:e0268481. [DOI: 10.1371/journal.pone.0268481] [Reference Citation Analysis]
|
| 48 |
Shi M, Gao W, Jin Y, Zhu J, Liu Y, Wang T, Li C. Antiphospholipid Syndrome-Related Pulmonary Embolism: Clinical Characteristics and Early Recognition. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.872523] [Reference Citation Analysis]
|
| 49 |
Gan Y, Zhao Y, Li G, Ye H, Zhou Y, Hou C, Wang L, Guo J, Li C. Risk Factors and Outcomes of Acute Myocardial Infarction in a Cohort of Antiphospholipid Syndrome. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.871011] [Reference Citation Analysis]
|
| 50 |
Truglia S, Capozzi A, Mancuso S, Manganelli V, Rapino L, Riitano G, Recalchi S, Colafrancesco S, Ceccarelli F, Garofalo T, Alessandri C, Longo A, Misasi R, Conti F, Sorice M. Relationship Between Gender Differences and Clinical Outcome in Patients With the Antiphospholipid Syndrome. Front Immunol 2022;13:932181. [DOI: 10.3389/fimmu.2022.932181] [Reference Citation Analysis]
|
| 51 |
Huang Y, Liu H, Qi W, Du L, Li M, Zeng X, Guo X, Zhao J, Zhang S. Sex Differences in Clinical Characteristics and Prognosis in Primary Thrombotic Antiphospholipid Syndrome. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.895098] [Reference Citation Analysis]
|
| 52 |
André F, Böckle BC. Sjögren-Syndrom. J Dtsch Dermatol Ges 2022;20:980-1003. [PMID: 35881105 DOI: 10.1111/ddg.14823_g] [Reference Citation Analysis]
|
| 53 |
André F, Böckle BC. Sjögren's syndrome. J Dtsch Dermatol Ges 2022. [PMID: 35775593 DOI: 10.1111/ddg.14823] [Reference Citation Analysis]
|
| 54 |
Signorelli F, Balbi GGM, Aikawa NE, Silva CA, Kupa LVK, Medeiros-Ribeiro AC, Yuki EF, Pasoto SG, Saad CG, Borba EF, Seguro LPC, Pedrosa T, Oliveira VAA, Costa ALCS, Ribeiro CT, Santos REB, Andrade DCO, Bonfá E. Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome. Lupus 2022;31:974-84. [PMID: 35593174 DOI: 10.1177/09612033221102073] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 55 |
Pengo V, Denas G. Antiphospholipid Syndrome in Patients with Venous Thromboembolism. Semin Thromb Hemost 2022. [PMID: 35728601 DOI: 10.1055/s-0042-1749590] [Reference Citation Analysis]
|
| 56 |
Asif S, Bali A, Dang AK, Gonzalez DA, Kumar R. Neurological and Neuropsychiatric Manifestations of Antiphospholipid-Antibody Syndrome (APS). Cureus 2022. [DOI: 10.7759/cureus.26022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 57 |
Qi W, Zhao J, Huang C, Jiang N, Li J, Wu C, Zhang S, Hu C, Xu D, Wang Q, Li M, Tian X, Zhao Y, Zeng X. Clinical characteristics and prognosis of patients with antiphospholipid antibodies based on cluster analysis: an 8-year cohort study. Arthritis Res Ther 2022;24:140. [PMID: 35690831 DOI: 10.1186/s13075-022-02814-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 58 |
Erton ZB, Sevim E, de Jesús GR, Cervera R, Ji L, Pengo V, Ugarte A, Andrade D, Andreoli L, Atsumi T, Fortin PR, Gerosa M, Zuo Y, Petri M, Sciascia S, Tektonidou MG, Aguirre-Zamorano MA, Branch DW, Erkan D; APS ACTION. Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ('Registry'). Lupus Sci Med 2022;9:e000633. [PMID: 35701043 DOI: 10.1136/lupus-2021-000633] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 59 |
Rosa Dos Santos AP, de Oliveira Vaz C, Hounkpe BW, Jacintho BC, Oliveira JD, Tripiquia Vechiatto Mesquita GL, Pereira Dos Santos I, Annichino-Bizzacchi J, Appenzeller S, de Moraes Mazetto Fonseca B, Orsi FA. Association between interferon-I producing plasmacytoid dendritic cells and thrombotic antiphospholipid syndrome. Lupus 2022;:9612033221101731. [PMID: 35612283 DOI: 10.1177/09612033221101731] [Reference Citation Analysis]
|
| 60 |
Hoxha A, Simioni P. Obstetric Antiphospholipid Syndrome. Antiphospholipid Syndrome - Recent Advances in Clinical and Basic Aspects 2022. [DOI: 10.5772/intechopen.101804] [Reference Citation Analysis]
|
| 61 |
Grimes K, P. Klein A, Lalla R, Morawo A, Somani S, J. Woodward M, W. Cole J. Antiphospholipid Syndrome and Stroke. Antiphospholipid Syndrome - Recent Advances in Clinical and Basic Aspects 2022. [DOI: 10.5772/intechopen.101777] [Reference Citation Analysis]
|
| 62 |
Mittal N, Abohelwa M, Rahman MR, Shurmur S. Cardiovascular complications of catastrophic antiphospholipid syndrome: a case report and review of literature. European Heart Journal - Case Reports 2022;6. [DOI: 10.1093/ehjcr/ytac199] [Reference Citation Analysis]
|
| 63 |
Chandra A, Chakraborty U, Ghosh S, Dasgupta S. Anticoagulation in COVID-19: current concepts and controversies. Postgrad Med J 2022;98:395-402. [PMID: 33850011 DOI: 10.1136/postgradmedj-2021-139923] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 26.0] [Reference Citation Analysis]
|
| 64 |
de Moraes Mazetto B, Hounkpe BW, da Silva Saraiva S, Vieira-damiani G, dos Santos APR, Jacinto BC, de Oliveira Vaz C, Mesquita GTV, Annichino-bizzacchi JM, De Paula EV, Orsi FA. Association between neutrophil extracellular traps (NETs) and thrombosis in antiphospholipid syndrome. Thrombosis Research 2022. [DOI: 10.1016/j.thromres.2022.05.001] [Reference Citation Analysis]
|
| 65 |
Djokovic A, Stojanovich L, Stanisavljevic N, Djokic S, Filipovic B, Matic P, Milanovic M, Apostolovic S, Saponjski J. Cardiac manifestations in primary antiphospholipid syndrome and their association to antiphospholipid antibodies' types and titers-cross-sectional study of Serbian cohort. Clin Rheumatol 2022;41:1447-55. [PMID: 35018582 DOI: 10.1007/s10067-022-06056-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 66 |
Cornish EF, McDonnell T, Williams DJ. Chronic Inflammatory Placental Disorders Associated With Recurrent Adverse Pregnancy Outcome. Front Immunol 2022;13:825075. [PMID: 35529853 DOI: 10.3389/fimmu.2022.825075] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 67 |
Karan A, Adeyemo A, Omar M, Fahmi K, Sattiraju S. The Lupus Attack: A Case Report and Literature Review of Myocardial Infarction and Antiphospholipid Syndrome. Cureus. [DOI: 10.7759/cureus.24067] [Reference Citation Analysis]
|
| 68 |
Christiansen TK, Nilsson AC, Madsen GI, Voss A. Small intestine necrosis in catastrophic antiphospholipid syndrome: A rare and severe case. Lupus 2022;:9612033221093496. [PMID: 35393873 DOI: 10.1177/09612033221093496] [Reference Citation Analysis]
|
| 69 |
Wei M, Xu Y, Xia D, Li J, Dong S. Care and Treatment for an Antiphospholipid Syndrome-Related Lower Limb Skin Ulcer Unhealed for 7 Years: A Case Report. Int J Low Extrem Wounds 2022;:15347346221090079. [PMID: 35360964 DOI: 10.1177/15347346221090079] [Reference Citation Analysis]
|
| 70 |
Escoda T, George J, Jarrot PA, Jean R, Mazodier K, Sanderson F, Poullin P, Saby L, Jourde-Chiche N, Kaplanski G, Chiche L. Aortitis is an under-recognized manifestation of antiphospholipid syndrome: A case report and literature review. Lupus 2022;:9612033221091142. [PMID: 35341372 DOI: 10.1177/09612033221091142] [Reference Citation Analysis]
|
| 71 |
Bustamante-Arias A, Ruiz Lozano RE, Rodriguez-Garcia A. Dry eye disease, a prominent manifestation of systemic autoimmune disorders. Eur J Ophthalmol 2022;:11206721221088259. [PMID: 35300528 DOI: 10.1177/11206721221088259] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 72 |
Kyle K, Bordelon Y, Venna N, Linnoila J. Autoimmune and Paraneoplastic Chorea: A Review of the Literature. Front Neurol 2022;13:829076. [DOI: 10.3389/fneur.2022.829076] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 73 |
Gwynne PJ, Clendenen LH, Turk SP, Marques AR, Hu LT. Antiphospholipid autoantibodies in Lyme disease arise after scavenging of host phospholipids by Borrelia burgdorferi. J Clin Invest 2022;132:e152506. [PMID: 35289310 DOI: 10.1172/JCI152506] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 74 |
Kuo YN, Lai CS, Chen YH, Kuo-Lung L. Severe thoracic pyomyositis in a patient with systemic lupus erythematosus. BMJ Case Rep 2022;15:e246484. [PMID: 35260400 DOI: 10.1136/bcr-2021-246484] [Reference Citation Analysis]
|
| 75 |
Ammirati E, Bizzi E, Veronese G, Groh M, Van de Heyning CM, Lehtonen J, Pineton de Chambrun M, Cereda A, Picchi C, Trotta L, Moslehi JJ, Brucato A. Immunomodulating Therapies in Acute Myocarditis and Recurrent/Acute Pericarditis. Front Med 2022;9:838564. [DOI: 10.3389/fmed.2022.838564] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 76 |
Svenungsson E, Spaak J, Strandberg K, Wallén HN, Agewall S, Brolin EB, Collste O, Daniel M, Ekenbäck C, Frick M, Henareh L, Malmqvist K, Elvin K, Sörensson P, Y-Hassan S, Hofman-Bang C, Tornvall P. Antiphospholipid antibodies in patients with myocardial infarction with and without obstructive coronary arteries. J Intern Med 2022;291:327-37. [PMID: 34820922 DOI: 10.1111/joim.13409] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 77 |
Scheen M, Adedjouma A, Esteve E, Buob D, Abisror N, Planche V, Fain O, Boffa JJ, De Seigneux S, Mekinian A, Haidar F. Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management. Autoimmun Rev 2022;:103072. [PMID: 35217200 DOI: 10.1016/j.autrev.2022.103072] [Reference Citation Analysis]
|
| 78 |
Hassan F, Naffaa ME, Saab A, Putterman C. Cognitive Impairment in Anti-Phospholipid Syndrome and Anti-Phospholipid Antibody Carriers. Brain Sciences 2022;12:222. [DOI: 10.3390/brainsci12020222] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 79 |
Billet AC, Chevallier O, Samson M, Petit JM, Bonnotte B, Audia S. Adrenal Insufficiency Revealing a Bilateral Adrenal Hemorrhage-Adrenal Infarction Related to Antiphospholipid Syndrome. Am J Med 2022;135:194-5. [PMID: 34509446 DOI: 10.1016/j.amjmed.2021.08.011] [Reference Citation Analysis]
|
| 80 |
Abnormal Movements in Neurological Autoimmune Disorders. Autoimmune Encephalitis and Related Disorders of the Nervous System 2022. [DOI: 10.1017/9781108696722.022] [Reference Citation Analysis]
|
| 81 |
Tumian NR, Hunt BJ. Clinical Management of Thrombotic Antiphospholipid Syndrome. JCM 2022;11:735. [DOI: 10.3390/jcm11030735] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 82 |
Alijotas-Reig J, Esteve-Valverde E, Anunciación-Llunell A, Marques-Soares J, Pardos-Gea J, Miró-Mur F. Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: A Comprehensive Review. J Clin Med 2022;11:675. [PMID: 35160128 DOI: 10.3390/jcm11030675] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 83 |
Quintana-López G, Rodríguez-Pintó I, Maldonado-Cañón K, Gerard Espinosa, Diaz-Rojas J, Cervera R. Cost-effectiveness analysis of treatments for the first episode of catastrophic antiphospholipid syndrome: A study based on the catastrophic antiphospholipid syndrome registry. Lupus 2022;:9612033211070973. [PMID: 35037492 DOI: 10.1177/09612033211070973] [Reference Citation Analysis]
|
| 84 |
Tekgöl Uzuner G, Özdemir AÖ, Korkmaz C, Uzuner N. Anti-Phosholipid Syndrome Misdiagnosed As Multiple Sclerosis: A Case Report. OSMANGAZİ JOURNAL OF MEDICINE 2022. [DOI: 10.20515/otd.978880] [Reference Citation Analysis]
|
| 85 |
Man YL, Sanna G. Neuropsychiatric Manifestations of Antiphospholipid Syndrome—A Narrative Review. Brain Sciences 2022;12:91. [DOI: 10.3390/brainsci12010091] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 86 |
Kwak S, Green M. Rare yet catastrophic presentation of undiagnosed antiphospholipid syndrome. BMJ Case Rep 2022;15:e245838. [PMID: 35012938 DOI: 10.1136/bcr-2021-245838] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 87 |
Martin J, Petryayeva E, Khan WI. Autoantibodies in Common Connective Tissue Diseases: A Primer for Laboratory Professionals. The Journal of Applied Laboratory Medicine 2022;7:114-136. [DOI: 10.1093/jalm/jfab131] [Reference Citation Analysis]
|
| 88 |
Cheng CY, Baritussio A, Giordani AS, Iliceto S, Marcolongo R, Caforio ALP. Myocarditis in systemic immune-mediated diseases: Prevalence, characteristics and prognosis. A systematic review. Autoimmun Rev 2022;:103037. [PMID: 34995763 DOI: 10.1016/j.autrev.2022.103037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 89 |
Manca E. Autoantibodies in Neuropsychiatric Systemic Lupus Erythematosus (NPSLE): Can They Be Used as Biomarkers for the Differential Diagnosis of This Disease? Clin Rev Allergy Immunol 2022;63:194-209. [PMID: 34115263 DOI: 10.1007/s12016-021-08865-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 90 |
Larner AJ. Investigation of TGA (1): Neuropsychology, Neurophysiology and Other Investigations. Transient Global Amnesia 2022. [DOI: 10.1007/978-3-030-98939-2_4] [Reference Citation Analysis]
|
| 91 |
Le Joncour A, Saadoun D. Systemic Diseases Affecting Liver Vessels. Vascular Disorders of the Liver 2022. [DOI: 10.1007/978-3-030-82988-9_20] [Reference Citation Analysis]
|
| 92 |
Stankić D, Miljić P. Investigation of the relation between the type and titer of antiphospholipid antibodies and the clinical manifestations of antiphospholipid syndrome. Srpski medicinski časopis Lekarske komore 2022;3:35-44. [DOI: 10.5937/smclk3-32463] [Reference Citation Analysis]
|
| 93 |
Hedrich CM, Kallinich T. Antiphospholipid-Syndrom bei Kindern und Jugendlichen. Pädiatrische Rheumatologie 2022. [DOI: 10.1007/978-3-662-60410-6_39] [Reference Citation Analysis]
|
| 94 |
Santacruz JC, Mantilla MJ, Rueda I, Pulido S, Rodríguez G, Londono J. Obstetric Antiphospholipid Syndrome From the Perspective of a Rheumatologist. Cureus 2022;14:e21090. [PMID: 35165550 DOI: 10.7759/cureus.21090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 95 |
Larner AJ. Differential Diagnosis of TGA. Transient Global Amnesia 2022. [DOI: 10.1007/978-3-030-98939-2_3] [Reference Citation Analysis]
|
| 96 |
Bezerra AS, Moya FG, Filho ISF, Fioretti AC. Bilateral Carotid Aneurysms Secondary to Catastrophic Antiphospholipid Syndrome in a Patient with Differential Diagnosis of Polyarteritis Nodosa. WJCD 2022;12:30-37. [DOI: 10.4236/wjcd.2022.121004] [Reference Citation Analysis]
|
| 97 |
Zúñiga-garza E, Franco-lópez F. Isquemia mesentérica como presentación de síndrome antifosfolípidos primario en paciente masculino. Cirujano General 2022;44:93-96. [DOI: 10.35366/109719] [Reference Citation Analysis]
|
| 98 |
Chen JL, Yu X, Luo R, Liu M. Severe digital ischemia coexists with thrombocytopenia in malignancy-associated antiphospholipid syndrome: A case report and review of literature. World J Clin Cases 2021; 9(36): 11457-11466 [DOI: 10.12998/wjcc.v9.i36.11457] [Reference Citation Analysis]
|
| 99 |
Carré J, Jourdi G, Gendron N, Helley D, Gaussem P, Darnige L. Recent Advances in Anticoagulant Treatment of Immune Thrombosis: A Focus on Direct Oral Anticoagulants in Heparin-Induced Thrombocytopenia and Anti-Phospholipid Syndrome. Int J Mol Sci 2021;23:93. [PMID: 35008518 DOI: 10.3390/ijms23010093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 100 |
Méneret A, Garcin B, Frismand S, Lannuzel A, Mariani LL, Roze E. Treatable Hyperkinetic Movement Disorders Not to Be Missed. Front Neurol 2021;12:659805. [PMID: 34925200 DOI: 10.3389/fneur.2021.659805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 101 |
Takahashi W, Morita T, Tanaka K, Ide S, Hujimori K. Challenging endovascular treatment for the patient with chronic limb threatening ischemia due to antiphospholipid syndrome. J Cardiol Cases 2021;24:276-9. [PMID: 34917209 DOI: 10.1016/j.jccase.2021.04.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 102 |
De Carvalho JF, Fernanda Mendanha Sousa A. Antiphospholipid Syndrome Associated with Nonradiographic Axial Spondyloarthritis. Case Rep Rheumatol 2021;2021:4359488. [PMID: 34900358 DOI: 10.1155/2021/4359488] [Reference Citation Analysis]
|
| 103 |
Jerez-Lienas A, Mathian A, Aboab J, Crassard I, Hie M, Cohen-Aubart F, Haroche J, Wahl D, Cervera R, Amoura Z. Cerebral Vein Thrombosis in the Antiphospholipid Syndrome: Analysis of a Series of 27 Patients and Review of the Literature. Brain Sci 2021;11:1641. [PMID: 34942943 DOI: 10.3390/brainsci11121641] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 104 |
Thakur N. Antiphospholipid Syndrome – Early Pregnancy Loss. AJNER 2021. [DOI: 10.52711/2349-2996.2021.00136] [Reference Citation Analysis]
|
| 105 |
Han SH, Park KD, Kim SC. Antiphospholipid syndrome with mesenteric vein thrombosis and hepatic nodular regenerative hyperplasia in a child: A case report. Medicine (Baltimore) 2021;100:e28105. [PMID: 35049239 DOI: 10.1097/MD.0000000000028105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 106 |
Zhang J, Li C, Han X, Chen Z, Adhikari BK, Wang Y, Wang Y, Sun J. The digestive system involvement of antiphospholipid syndrome: pathophysiology, clinical characteristics, and treatment strategies. Ann Med 2021;53:1328-39. [PMID: 34409894 DOI: 10.1080/07853890.2021.1962964] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 107 |
Arora S, Nair S, Prabhu R, Avanthika C, Jhaveri S, Samayam S, Katta MR, Agarwal P. Role of Direct Oral Anticoagulation Agents as Thromboprophylaxis in Antiphospholipid Syndrome. Cureus 2021;13:e19009. [PMID: 34824926 DOI: 10.7759/cureus.19009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 108 |
Yang W, Kang MK, Ha SY, Kang DW, Bae J, Lee EJ, Jeong HY, Kim JM, Jung KH, Lee SH. Current status and role of antiphospholipid antibody testing in cryptogenic stroke. Eur J Neurol 2021. [PMID: 34800314 DOI: 10.1111/ene.15191] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 109 |
Leone P, Prete M, Malerba E, Bray A, Susca N, Ingravallo G, Racanelli V. Lupus Vasculitis: An Overview. Biomedicines 2021;9:1626. [PMID: 34829857 DOI: 10.3390/biomedicines9111626] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 110 |
Fierro JJ, Velásquez M, Cadavid AP, de Leeuw K. Effects of anti-beta 2-glycoprotein 1 antibodies and its association with pregnancy-related morbidity in antiphospholipid syndrome. Am J Reprod Immunol 2021;:e13509. [PMID: 34738282 DOI: 10.1111/aji.13509] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 111 |
Coletto LA, Gerosa M, Valentini M, Cimaz R, Caporali R, Meroni PL, Chighizola CB. Myocardial involvement in anti-phospholipid syndrome: Beyond acute myocardial infarction. Autoimmun Rev 2021;:102990. [PMID: 34740852 DOI: 10.1016/j.autrev.2021.102990] [Reference Citation Analysis]
|
| 112 |
Ocampo-piraquive V, Vecino MJ, Posso-osorio I, Cañas CA. Infarto adrenal unilateral no hemorrágico durante el puerperio en una paciente con síndrome antifosfolipídico. Revista Colombiana de Reumatología 2021. [DOI: 10.1016/j.rcreu.2021.09.007] [Reference Citation Analysis]
|
| 113 |
Barilaro G, Espinosa G, Cervera R. The antiphospholipid syndrome. Revista Colombiana de Reumatología 2021;28:166-176. [DOI: 10.1016/j.rcreu.2021.03.012] [Reference Citation Analysis]
|
| 114 |
Anunciación-Llunell A, Miró-Mur F, Esteve-Valverde E, Marques-Soares J, Pardos-Gea J, Alijotas-Reig J. Proteomics and enriched biological processes in Antiphospholipid syndrome: A systematic review. Autoimmun Rev 2021;:102982. [PMID: 34718168 DOI: 10.1016/j.autrev.2021.102982] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 115 |
Koubi M, Rossi P, Arcani R, Gomes De Pihno Q, Chau C, Blanc J, Grosdidier C, Guervilly C, Bretelle F, Bernard-Guervilly F. Relevance of systematic anti-nuclear antibodies testing after obstetrical complications. J Reprod Immunol 2021;148:103437. [PMID: 34700104 DOI: 10.1016/j.jri.2021.103437] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 116 |
Martins FF, Campos TML. Evaluation of Frequency, Clinical Correlation, and Antibodies Confirmation Profile in Patients with Suspected Antiphospholipid Syndrome. TH Open 2021;5:e470-8. [PMID: 34693196 DOI: 10.1055/s-0041-1736289] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 117 |
Casanegra AI, Shepherd RF. Raynaud Phenomenon and Other Vasospastic Disorders. Cardiol Clin 2021;39:583-99. [PMID: 34686269 DOI: 10.1016/j.ccl.2021.06.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 118 |
Ricard L, Laurent C, Papo M, Deriaz S, Catano J, Alamowitch S, Kayem G, Chasset F, De Moreuil C, Boffa JJ, Gerotziafas G, Elalamy I, Bornes M, Maillot F, Audemard-Verger A, Planche V, Ballot E, Fain O, Mekinian A. Clinical and prognostic significance of antinuclear antibodies in primary antiphospholipid syndrome: A multicenter retrospective study. Joint Bone Spine 2021;89:105297. [PMID: 34656751 DOI: 10.1016/j.jbspin.2021.105297] [Reference Citation Analysis]
|
| 119 |
Baleeiro C, Duran CS, Signorelli F, Balbi GG, Bonfá E, Andrade DC. Distinct features of youth-onset primary antiphospholipid syndrome. Lupus 2021;30:1888-95. [PMID: 34634966 DOI: 10.1177/09612033211038054] [Reference Citation Analysis]
|
| 120 |
Benkirane A, Devalet B, Montigny P, London F. Late-onset of primary antiphospholipid syndrome: a case report. Acta Neurol Belg 2021;121:1375-6. [PMID: 33242192 DOI: 10.1007/s13760-020-01555-4] [Reference Citation Analysis]
|
| 121 |
Minina YD, Kalinin VA. Development of multifocal ischemic stroke after cessation of anticoagulant therapy in a patient with antiphospholipid syndrome. Science and Innovations in Medicine 2021;6:42-45. [DOI: 10.35693/2500-1388-2021-6-3-42-45] [Reference Citation Analysis]
|
| 122 |
Carvalho JF, Shoenfeld Y. Uric acid levels in primary antiphospholipid syndrome. Lupus 2021;30:2176-8. [PMID: 34569385 DOI: 10.1177/09612033211045922] [Reference Citation Analysis]
|
| 123 |
Wan L, Liu T, Chen T, Chi H, Zhou Z, Tang Z, Hu Q, Teng J, Sun Y, Liu H, Cheng X, Ye J, Su Y, Lu Y, Yang C, Shi H. The high prevalence of abnormal MRI findings in non-neuropsychiatric patients with persistently positive antiphospholipid antibodies. Rheumatology (Oxford) 2021:keab649. [PMID: 34559215 DOI: 10.1093/rheumatology/keab649] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 124 |
Ramjas V, Jain A, Lee RDM, Fioni F, Tawfik N, Sandhu O, Hamid P. Unraveling the Association Between Myocardial Infarction of Nonobstructive Coronary Arteries and Antiphospholipid Syndrome. Cureus 2021;13:e17002. [PMID: 34540404 DOI: 10.7759/cureus.17002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 125 |
Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, Sáez-Comet L, Lefkou E, Mekinian A, Belizna C, Ruffatti A, Tincani A, Pardos-Gea J, Nalli C, Marozio L, Espinosa G, De Carolis S, Latino O, Sebastian U, LLurba E, Trespidi L, Chighizola C, Pengo V, Rovere-Querini P, Canti V, Mayer-Pickel K, Reshetnyak T, Tabacco S, Arnau A; EUROAPS Study Group. Bleeding and antithrombotic therapy during pregnancy in women with poor aPL-related obstetric outcomes: A survey of 1075 cases from EUROAPS registry∗. Eur J Anaesthesiol 2021;38:916-22. [PMID: 34397526 DOI: 10.1097/EJA.0000000000001484] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 126 |
Chandrasekar TS, Gokul BJ, Viveksandeep TC, Yogesh KR, Sathiamoorthy S, Prasad MS. Antiphospholipid Antibody Syndrome Presenting as Subacute Abdominal Pain Due to Portomesenteric Thrombosis. Journal of Digestive Endoscopy 2022;12:e1-e1. [DOI: 10.1055/s-0040-1701397] [Reference Citation Analysis]
|
| 127 |
Cheldieva FA, Reshetnyak TM, Lila AM. Assessment of the activity and organ damage in antiphospholipid syndrome. Sovremennaâ revmatologiâ 2021;15:101-106. [DOI: 10.14412/1996-7012-2021-4-101-106] [Reference Citation Analysis]
|
| 128 |
Grossi C, Artusi C, Meroni P, Borghi MO, Neglia L, Lonati PA, Oggioni M, Tedesco F, De Simoni MG, Fumagalli S. β2 glycoprotein I participates in phagocytosis of apoptotic neurons and in vascular injury in experimental brain stroke. J Cereb Blood Flow Metab 2021;41:2038-53. [PMID: 33444093 DOI: 10.1177/0271678X20984551] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 129 |
Barros VIPVL, Igai AMK, Oliveira ALML, Teruchkin MM, Orsi FA. Obstetric antiphospholipid syndrome. Rev Bras Ginecol Obstet 2021;43:495-501. [PMID: 34318477 DOI: 10.1055/s-0041-1732382] [Reference Citation Analysis]
|
| 130 |
Arantes FT, Mazetto BM, Saraiva SS, Tobaldini LQ, Dos Santos APR, Annichino-Bizzacchi J, Orsi FA. Inflammatory markers in thrombosis associated with primary antiphospholipid syndrome. J Thromb Thrombolysis 2020;50:772-81. [PMID: 32462539 DOI: 10.1007/s11239-020-02155-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 131 |
Cohen H, Cuadrado MJ, Erkan D, Duarte-Garcia A, Isenberg DA, Knight JS, Ortel TL, Rahman A, Salmon JE, Tektonidou MG, Williams DJ, Willis R, Woller SC, Andrade D. 16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends. Lupus 2020;29:1571-93. [PMID: 33100166 DOI: 10.1177/0961203320950461] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 17.5] [Reference Citation Analysis]
|
| 132 |
Matthia E, Altshuler E, Naik DK, Keeley EC. Acute coronary syndrome as the first presentation of antiphospholipid antibody syndrome. BMJ Case Rep 2021;14:e242872. [PMID: 34290014 DOI: 10.1136/bcr-2021-242872] [Reference Citation Analysis]
|
| 133 |
Samuelsson I, Parodis I, Gunnarsson I, Zickert A, Hofman-Bang C, Wallén H, Svenungsson E. Myocardial infarctions, subtypes and coronary atherosclerosis in SLE: a case-control study. Lupus Sci Med 2021;8:e000515. [PMID: 34290127 DOI: 10.1136/lupus-2021-000515] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 134 |
Walter IJ, Klein Haneveld MJ, Lely AT, Bloemenkamp KWM, Limper M, Kooiman J. Pregnancy outcome predictors in antiphospholipid syndrome: A systematic review and meta-analysis. Autoimmun Rev 2021;20:102901. [PMID: 34280554 DOI: 10.1016/j.autrev.2021.102901] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 135 |
He S, Wallén H, Thålin C, Svensson J, Blombäck M. Fibrin Network Porosity and Endo-/Exogenous Thrombin Cross-talk. Semin Thromb Hemost 2021. [PMID: 34255337 DOI: 10.1055/s-0041-1729963] [Reference Citation Analysis]
|
| 136 |
Freire de Carvalho J, Correia de Araujo RP, Skare TL. Osteonecrosis in Primary Antiphospholipid Syndrome is Associated with Previous Glucocorticoid Use and Thrombocytopenia. Rheumatol Ther 2021;8:1255-61. [PMID: 34228316 DOI: 10.1007/s40744-021-00333-9] [Reference Citation Analysis]
|
| 137 |
Vaz CO, Mazetto BM, Vasconcelos PENS, Bastos LB, Cursino MA, Quintanilha JCF, Mesquita GLTV, Santos APR, Jacintho BC, Oliveira JD, Annichino-Bizzachi J, Orsi FA. Association between plasmatic oxidative stress and thrombosis in primary antiphospholipid syndrome. J Thromb Thrombolysis 2021. [PMID: 34224066 DOI: 10.1007/s11239-021-02509-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 138 |
Kee TP, Venkatanarasimha N, Mohideen SMH, Chan LL, Gogna A, Schaefer PW, Chia GS, Choi YS, Chen RC. A Tale of Two Organ Systems: Imaging review of diseases affecting the thoracic and neurological systems. Part 1. Curr Probl Diagn Radiol 2021:S0363-0188(21)00107-9. [PMID: 34304949 DOI: 10.1067/j.cpradiol.2021.06.008] [Reference Citation Analysis]
|
| 139 |
Díaz-coronado JC, Herrera-uribe S, Hernández-parra D, Betancur-vásquez L, Lacouture-fierro J, González-hurtado D, González-arango J, Uribe-arango L, Saavedra-chacón MF, Monsalve-yepes S, Guerra-zarama S, Serna-giraldo JD, López-lópez JD, Barbosa-arana J, Soto-osorio MC, Durango Y, Pineda-tamayo RA. Síndrome antifosfolípido (SAF): diferencias clínicas e inmunoserológicas entre SAF primario y secundario en una cohorte colombiana. Revista Colombiana de Reumatología 2021;28:191-196. [DOI: 10.1016/j.rcreu.2020.10.002] [Reference Citation Analysis]
|
| 140 |
Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, Kamel H, Kernan WN, Kittner SJ, Leira EC, Lennon O, Meschia JF, Nguyen TN, Pollak PM, Santangeli P, Sharrief AZ, Smith SC Jr, Turan TN, Williams LS. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. Stroke 2021;52:e364-467. [PMID: 34024117 DOI: 10.1161/STR.0000000000000375] [Cited by in Crossref: 519] [Cited by in F6Publishing: 367] [Article Influence: 259.5] [Reference Citation Analysis]
|
| 141 |
Díaz-coronado JC, Herrera-uribe S, Hernández-parra D, Betancur-vásquez L, Lacouture-fierro J, González-hurtado D, González-arango J, Uribe-arango L, Saavedra-chacón MF, Monsalve-yepes S, Guerra-zarama S, Serna-giraldo JD, López-lópez JD, Barbosa-arana J, Soto-osorio MC, Durango Y, Pineda-tamayo RA. Antiphospholipid syndrome (APS): Clinical and immunoserological differences between primary and secondary APS in a Colombian cohort. Revista Colombiana de Reumatología (English Edition) 2021;28:191-196. [DOI: 10.1016/j.rcreue.2021.06.003] [Reference Citation Analysis]
|
| 142 |
Mauracher LM, Krall M, Roiß J, Hell L, Koder S, Hofbauer TM, Gebhart J, Hayden H, Brostjan C, Ay C, Pabinger I. Neutrophil subpopulations and their activation potential in patients with antiphospholipid syndrome and healthy individuals. Rheumatology (Oxford) 2021;60:1687-99. [PMID: 33026085 DOI: 10.1093/rheumatology/keaa532] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 143 |
Khoury S, Soleman M, Margolis G, Barashi R, Rozenbaum Z, Keren G, Shacham Y. Incidence, characteristics and outcomes in very young patients with ST segment elevation myocardial infarction. Coron Artery Dis 2020;31:103-8. [PMID: 31524668 DOI: 10.1097/MCA.0000000000000779] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 144 |
Sciascia S, Radin M, Cecchi I, Bertolaccini ML, Bertero MT, Rubini E, Vaccarino A, Bazzan M, Giachino O, Baldovino S, Rossi D, Mengozzi G, Roccatello D. Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients. Rheumatology (Oxford) 2021;60:1106-13. [PMID: 31840749 DOI: 10.1093/rheumatology/kez596] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 145 |
Lee HA, Kim SE, Jung DW, Byeon JR, Choe AR, Tae CH, Moon CM, Jung HK, Shim KN, Jung SA. Small Bowel Necrosis Associated with Catastrophic Antiphospholipid Syndrome: A Case Report. Korean J Gastroenterol 2021;77:294-9. [PMID: 34158449 DOI: 10.4166/kjg.2021.014] [Reference Citation Analysis]
|
| 146 |
Croles FN, Te Boekhorst PAW, Leebeek FWG, Jansen AJG. Therapeutic plasma exchange for anticoagulant-refractory antiphospholipid syndrome with severe ischemic and necrotic skin lesions: A case series. Transfus Apher Sci 2021;:103192. [PMID: 34226147 DOI: 10.1016/j.transci.2021.103192] [Reference Citation Analysis]
|
| 147 |
Leal Rato M, Bandeira M, Romão VC, Aguiar de Sousa D. Neurologic Manifestations of the Antiphospholipid Syndrome - an Update. Curr Neurol Neurosci Rep 2021;21:41. [PMID: 34125304 DOI: 10.1007/s11910-021-01124-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 148 |
Menozzi E, Mulroy E, Akbarian-Tefaghi L, Bhatia KP, Balint B. Movement disorders in systemic autoimmune diseases: Clinical spectrum, ancillary investigations, pathophysiological considerations. Parkinsonism Relat Disord 2021;88:116-28. [PMID: 34092506 DOI: 10.1016/j.parkreldis.2021.05.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 149 |
Abdelmahmuod EA, Hamad A, Almaghraby A, Mohamed S, Alkuwari M. Development of intracardiac thrombus in a young patient with antiphospholipid syndrome while she was on rivaroxaban: Case report and literature review. Clin Case Rep 2021;9:e04137. [PMID: 34026171 DOI: 10.1002/ccr3.4137] [Reference Citation Analysis]
|
| 150 |
Yazdi F, Shakibi MR, Mirkamali H, Baniasad A. Addison's disease in antiphospholipid syndrome: A rare complication. Clin Case Rep 2021;9:e04107. [PMID: 34026149 DOI: 10.1002/ccr3.4107] [Reference Citation Analysis]
|
| 151 |
Afifi N, El Bakry SA, Mohannad N, Bassyouni IH, Elezz NFA, El-Shazly R, Hussein SA. Clinical Features and Disease Damage Risk Factors in an Egyptian SLE Cohort: A Multicenter Study. Curr Rheumatol Rev 2021;17:222-31. [PMID: 33243127 DOI: 10.2174/1573397116666201126161244] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 152 |
Gelman R, Kharouf F, Ishay Y, Gural A. Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia in Association with Antiphospholipid Syndrome. Acta Haematol 2021;144:693-7. [PMID: 34000726 DOI: 10.1159/000516295] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 153 |
Abdel-Wahab N, Tayar JH, Fa'ak F, Sharma G, Lopez-Olivo MA, Yousif A, Shagroni T, Al-Hawamdeh S, Rojas-Hernandez CM, Suarez-Almazor ME. Systematic review of observational studies reporting antiphospholipid antibodies in patients with solid tumors. Blood Adv 2020;4:1746-55. [PMID: 32337583 DOI: 10.1182/bloodadvances.2020001557] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 154 |
Cohen H, Isenberg DA. How I treat anticoagulant-refractory thrombotic antiphospholipid syndrome. Blood 2021;137:299-309. [PMID: 32898856 DOI: 10.1182/blood.2020004942] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 155 |
Aibar J, Schulman S. Arterial Thrombosis in Patients with Antiphospholipid Syndrome: A Review and Meta-Analysis. Semin Thromb Hemost 2021;47:709-23. [PMID: 33971678 DOI: 10.1055/s-0041-1725057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 156 |
Wind M, Hendriks M, van Brussel BTJ, Eikenboom J, Allaart CF, Lamb HJ, Siebelink HJ, Ninaber MK, van Geloven N, van Lith JMM, Huizinga TWJ, Rabelink TJ, Sueters M, Teng YKO. Effectiveness of a multidisciplinary clinical pathway for women with systemic lupus erythematosus and/or antiphospholipid syndrome. Lupus Sci Med 2021;8:e000472. [PMID: 33952625 DOI: 10.1136/lupus-2020-000472] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 157 |
Inoue H, Yamamura R, Yamada K, Hamasaki T, Inoue N, Mukasa A. Hemichorea induced by a sphenoid ridge meningioma. Surg Neurol Int 2021;12:201. [PMID: 34084628 DOI: 10.25259/SNI_171_2021] [Reference Citation Analysis]
|
| 158 |
Naranjo L, Ostos F, Gil-Etayo FJ, Hernández-Gallego J, Cabrera-Marante Ó, Pleguezuelo DE, Díaz-Simón R, Cerro M, Lora D, Martínez-Salio A, Serrano A. Presence of Extra-Criteria Antiphospholipid Antibodies Is an Independent Risk Factor for Ischemic Stroke. Front Cardiovasc Med 2021;8:665741. [PMID: 34012984 DOI: 10.3389/fcvm.2021.665741] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 159 |
Williamson KA, Sanchez-Alvarez C, Duarte-García A. 28-Year-Old Man With Recurrent Vertigo, Syncope, and Progressive Memory Impairment. Mayo Clin Proc 2021;96:1309-14. [PMID: 33958060 DOI: 10.1016/j.mayocp.2020.08.052] [Reference Citation Analysis]
|
| 160 |
Alijotas-reig J. Does incomplete obstetric antiphospholipid syndrome really exist? Medicina Clínica (English Edition) 2021;156:515-519. [DOI: 10.1016/j.medcle.2020.12.018] [Reference Citation Analysis]
|
| 161 |
Kungwankiattichai S, Nakkinkun Y, Owattanapanich W, Ruchutrakool T. High Incidence of Antiphospholipid Antibodies in Newly Diagnosed Patients With Lymphoma and a Proposed aPL Predictive Score. Clin Appl Thromb Hemost 2020;26:1076029620928392. [PMID: 32633133 DOI: 10.1177/1076029620928392] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 162 |
Berkman SA, Song SS. Ischemic Stroke in the Young. Clin Appl Thromb Hemost 2021;27:10760296211002274. [PMID: 33870763 DOI: 10.1177/10760296211002274] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 163 |
Shibuya M, Kimura Y, Takuma S, Kamekura N, Fujisawa T. Cardiovascular Considerations in Anesthetic Management for a Patient With Antiphospholipid Syndrome and Decreased Cardiac Function: A Case Study. Anesth Prog 2021;68:33-7. [PMID: 33827125 DOI: 10.2344/anpr-67-03-07] [Reference Citation Analysis]
|
| 164 |
Llorente-Chávez A, Martín-Nares E, Núñez-Álvarez C, Hernández-Molina G. Thrombosis and thrombocytopenia in antiphospholipid syndrome: their association with mean platelet volume and hematological ratios. Thromb Res 2021;203:12-7. [PMID: 33895567 DOI: 10.1016/j.thromres.2021.04.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 165 |
Antovic A, Bruzelius M. Impaired Fibrinolysis in the Antiphospholipid Syndrome. Semin Thromb Hemost 2021;47:506-11. [PMID: 33878780 DOI: 10.1055/s-0041-1725098] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 166 |
Shen H, Huang X, Fan C. Clinical Characteristics and Management of Cerebral Venous Sinus Thrombosis in Patients With Antiphospholipid Syndrome: A Single-Center Retrospective Study. Clin Appl Thromb Hemost 2021;27:1076029621999104. [PMID: 33872100 DOI: 10.1177/1076029621999104] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 167 |
Tannous T, Rosso C, Iannuccilli J, Tannous K, Keating M. Primary Refractory Catastrophic Antiphospholipid Syndrome Masquerading as Buerger's Disease. Cureus 2021;13:e14350. [PMID: 33972907 DOI: 10.7759/cureus.14350] [Reference Citation Analysis]
|
| 168 |
Swan D, Newland A, Rodegheiro F, Thachil J. Thrombosis in immune thrombocytopenia - current status and future perspectives. Br J Haematol 2021;194:822-34. [PMID: 33822358 DOI: 10.1111/bjh.17390] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 169 |
Heras CB, Gómez AP, Hajkhan AM, Rubio ER. Síndrome antifosfolípido. Medicine - Programa de Formación Médica Continuada Acreditado 2021;13:1760-1768. [DOI: 10.1016/j.med.2021.04.003] [Reference Citation Analysis]
|
| 170 |
Yang J, Liang M. Risk factors for pregnancy morbidity in women with antiphospholipid syndrome. J Reprod Immunol 2021;145:103315. [PMID: 33845396 DOI: 10.1016/j.jri.2021.103315] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 171 |
Radin M, Foddai S, Cecchi I, Rubini E, Barinotti A, Mahler M, Seaman A, Ramirez C, Casas S, Roccatello D, Sciascia S. Improving the clinical accuracy in patients with antiphospholipid antibodies using anti-phosphatidylserine/prothrombin and anti-beta2 glycoprotein I domain and particle-based multi-analyte technology. Thromb Res 2021;202:100-3. [PMID: 33798802 DOI: 10.1016/j.thromres.2021.03.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 172 |
Benhamou Y, Delluc A, Mauge L, Fischer AM, Sanchez O; pour le groupe de travail Recommandations de bonne pratique pour la prise en charge de la MVTE. [Which aetiological investigations to undertake during the progress of PE/DVT?]. Rev Mal Respir 2021;38 Suppl 1:e90-8. [PMID: 33744073 DOI: 10.1016/j.rmr.2019.05.008] [Reference Citation Analysis]
|
| 173 |
El Hasbani G, Taher AT, Sciascia S, Uthman I. Antiphospholipid syndrome: the need for new international classification criteria. Expert Rev Clin Immunol 2021;17:385-94. [PMID: 33682558 DOI: 10.1080/1744666X.2021.1900733] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 174 |
Miyamae T, Kawabe T. Non-Criteria Manifestations of Juvenile Antiphospholipid Syndrome. J Clin Med 2021;10:1240. [PMID: 33802787 DOI: 10.3390/jcm10061240] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 175 |
Dieudonné Y, Guffroy A, Poindron V, Sprauel PS, Martin T, Korganow AS, Gies V. B cells in primary antiphospholipid syndrome: Review and remaining challenges. Autoimmun Rev 2021;20:102798. [PMID: 33722752 DOI: 10.1016/j.autrev.2021.102798] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 176 |
Daoud F, Rachdi I, Frikha O, Ben Salah M, Charaa S, Zoubeidi H, Somai M, Hadhri K, Kooli M, Chammakhi C, Boussema F. Salmonella osteomyelitis complicating aseptic osteonecrosis: Don't forget about the antiphospholipid syndrome. Clin Case Rep 2021;9:2205-9. [PMID: 33936665 DOI: 10.1002/ccr3.3984] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 177 |
Li S, Lan XL, Cai HC, Zhu TN, Wang SJ, Zhao YQ. [The clinical manifestations and risk factors in primary antiphospholipid syndrome with thrombocytopenia]. Zhonghua Xue Ye Xue Za Zhi 2021;42:33-8. [PMID: 33677866 DOI: 10.3760/cma.j.issn.0253-2727.2021.01.007] [Reference Citation Analysis]
|
| 178 |
Eremeeva DR, Zainulina MS, Dolgova YS, Shakhaliev RA, Silvanovich OA, Pavlova LA. Use of plasmapheresis in treatment of patients with unfavorable anamnestic pregnancy outcomes coupled to antiphospholipid antibodies. Akušerstvo, ginekologiâ i reprodukciâ 2021;15:22-31. [DOI: 10.17749/2313-7347/ob.gyn.rep.2021.105] [Reference Citation Analysis]
|
| 179 |
Chae HJ, Kim JW, Lee YL, Park JH, Lee SY. Mononeuropathy multiplex associated with systemic vasculitis: A case report. World J Clin Cases 2021; 9(7): 1741-1747 [PMID: 33728320 DOI: 10.12998/wjcc.v9.i7.1741] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 180 |
Gandhi AA, Estes SK, Rysenga CE, Knight JS. Understanding the Pathophysiology of Thrombotic APS through Animal Models. Int J Mol Sci 2021;22:2588. [PMID: 33806694 DOI: 10.3390/ijms22052588] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 181 |
Spinillo A, Bellingeri C, De Maggio I, Riceputi G, Pandolfi MP, Spada C, Alpini C, Montecucco C, Beneventi F. The impact of various entities of antiphospholipid antibodies positivity on adverse pregnancy outcome. An epidemiological perspective. J Reprod Immunol 2021;145:103304. [PMID: 33677238 DOI: 10.1016/j.jri.2021.103304] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 182 |
Alijotas-Reig J. Does incomplete obstetric antiphospholipid syndrome really exist? Med Clin (Barc) 2021;156:515-9. [PMID: 33632509 DOI: 10.1016/j.medcli.2020.12.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 183 |
Cohen H, Efthymiou M, Devreese KMJ. Monitoring of anticoagulation in thrombotic antiphospholipid syndrome. J Thromb Haemost 2021;19:892-908. [PMID: 33325604 DOI: 10.1111/jth.15217] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 184 |
Gomez-Flores M, Herrera-Argaez G, Vazquez-Martinez O, Herz-Ruelas M, Ocampo-Candiani J, Villarreal-Martinez A, Galarza-Delgado DA, Hernandez-Galarza I, Chavez-Alvarez S. Cutaneous manifestations of antiphospholipid syndrome. Lupus 2021;30:541-8. [PMID: 33583236 DOI: 10.1177/0961203321990100] [Reference Citation Analysis]
|
| 185 |
Choi E, Henkin S. Raynaud's phenomenon and related vasospastic disorders. Vasc Med 2021;26:56-70. [PMID: 33566754 DOI: 10.1177/1358863X20983455] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 186 |
Bachhuber A. [Inflammatory spinal cord diseases and transverse myelitis]. Radiologe 2021;61:251-7. [PMID: 33570678 DOI: 10.1007/s00117-021-00816-4] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 187 |
Singh T, Chapman AR, Dweck MR, Mills NL, Newby DE. MINOCA: a heterogenous group of conditions associated with myocardial damage. Heart 2021;107:1458-64. [PMID: 33568434 DOI: 10.1136/heartjnl-2020-318269] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 188 |
Patel RA, Hall DA, Eichenseer S, Bailey M. Movement Disorders and Hematologic Diseases. Mov Disord Clin Pract 2021;8:193-207. [PMID: 33553488 DOI: 10.1002/mdc3.13129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 189 |
Ali RA, Gandhi AA, Dai L, Weiner J, Estes SK, Yalavarthi S, Gockman K, Sun D, Knight JS. Antineutrophil properties of natural gingerols in models of lupus. JCI Insight 2021;6:138385. [PMID: 33373329 DOI: 10.1172/jci.insight.138385] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 190 |
Weiss R, Bushi D, Mindel E, Bitton A, Diesendruck Y, Gera O, Drori T, Zmira O, Aharoni SA, Agmon-Levin N, Kashi O, Benhar I, Golderman V, Orion D, Chapman J, Shavit-Stein E. Autoantibodies to Annexin A2 and cerebral thrombosis: Insights from a mouse model. Lupus 2021;30:775-84. [PMID: 33554716 DOI: 10.1177/0961203321992117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 191 |
Yoo JS, Kim YS, Kim HY, Kwon HS, Koh SH, Heo SH, Kim BJ, Bushnell CD, Chang DI. Comparison of patients with transient and sustained increments of antiphospholipid antibodies after acute ischemic stroke. J Neurol 2021;268:2541-9. [PMID: 33547954 DOI: 10.1007/s00415-021-10432-w] [Reference Citation Analysis]
|
| 192 |
Muthu S, Chellamuthu G, Gopalsamy TP, Kandasamy V. Secondary Erosive Arthritis in a Young Lady - A Rare Manifestation of Primary Antiphospholipid Antibody Syndrome. J Orthop Case Rep 2021;11:15-8. [PMID: 34141662 DOI: 10.13107/jocr.2021.v11.i02.2006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 193 |
Mormile I, Granata F, Punziano A, de Paulis A, Rossi FW. Immunosuppressive Treatment in Antiphospholipid Syndrome: Is It Worth It? Biomedicines 2021;9:132. [PMID: 33535377 DOI: 10.3390/biomedicines9020132] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 194 |
de Oliveira Vaz C, de Moraes Mazetto Fonseca B, Nascimento Silva Vasconcelos PE, Brito Bastos L, Cursino MA, Coelho França Quintanilha J, Tripiquia Vechiatto Mesquita GL, Rosa Dos Santos AP, Cardoso Jacintho B, Oliveira JD, Annichino-Bizzachi J, Andrade Orsi F. Self-perceived quality of life of primary antiphospholipid syndrome patients using vitamin K antagonist. Lupus 2021;30:707-14. [PMID: 33509064 DOI: 10.1177/0961203321990079] [Reference Citation Analysis]
|
| 195 |
Goulenok T, Vasco C, Faille D, Ajzenberg N, De Raucourt E, Dupont A, Frere C, James C, Rabut E, Rugeri L, Schleinitz N, Sacré K, Papo T; RAVI study group. Acquired factor V inhibitor: a nation-wide study of 38 patients. Br J Haematol 2021;192:892-9. [PMID: 33471937 DOI: 10.1111/bjh.17308] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 196 |
Araújo DM, Rodrigues CEM, Gonçalves NGG, Rabelo-Júnior CN, Lobo MDP, Moreira RA, Monteiro-Moreira ACO. Proteins Involved in the Induction of Procoagulant Activity and Autoimmune Response in Patients With Primary Antiphospholipid Syndrome. Clin Appl Thromb Hemost 2020;26:1076029620905338. [PMID: 32299226 DOI: 10.1177/1076029620905338] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 197 |
Song SY, Rajah G, Ding YC, Ji XM, Meng R. The antiphospholipid syndrome may induce non-thrombotic internal jugular vein stenosis: two cases report. BMC Neurol 2021;21:9. [PMID: 33413173 DOI: 10.1186/s12883-020-02035-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 198 |
Malviya SA, Deng Y, Nikolaidis M. Hereditary Coagulation Disorders. Essentials of Blood Product Management in Anesthesia Practice 2021. [DOI: 10.1007/978-3-030-59295-0_27] [Reference Citation Analysis]
|
| 199 |
Hedrich CM, Kallinich T. Antiphospholipid-Syndrom bei Kindern und Jugendlichen. Pädiatrische Rheumatologie 2021. [DOI: 10.1007/978-3-662-60411-3_39-1] [Reference Citation Analysis]
|
| 200 |
Khamashta MA, Ugarte A, Ruiz-irastorza G. Clinical presentation of antiphospholipid syndrome. Lahita's Systemic Lupus Erythematosus 2021. [DOI: 10.1016/b978-0-12-820583-9.00026-9] [Reference Citation Analysis]
|
| 201 |
Qureshi F, Viswanathan V, Sane S. Tuberculosis in Catastrophic Antiphospholipid Antibody Syndrome. Indian Pediatr 2021;58:82-83. [DOI: 10.1007/s13312-021-2104-y] [Reference Citation Analysis]
|
| 202 |
Handa R. Antiphospholipid Syndrome. Clinical Rheumatology 2021. [DOI: 10.1007/978-981-33-4885-1_18] [Reference Citation Analysis]
|
| 203 |
Dillane D, Keeling S. Systemic Lupus Erythematosus. Preoperative Assessment 2021. [DOI: 10.1007/978-3-030-58842-7_30] [Reference Citation Analysis]
|
| 204 |
Chighizola CB, Borghi MO, Meroni PL. Antibodies and diagnostic tests in antiphosholipid syndrome. Systemic Lupus Erythematosus 2021. [DOI: 10.1016/b978-0-12-814551-7.00059-3] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 205 |
D'Mello RJ, Hsu CD, Chaiworapongsa P, Chaiworapongsa T. Update on the Use of Intravenous Immunoglobulin in Pregnancy. Neoreviews 2021;22:e7-e24. [PMID: 33386311 DOI: 10.1542/neo.22-1-e7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 206 |
Bangar MS, Ahmed J. Antiphospholipid Syndrome (APS) With Chronic Thrombosis of Portovenous System and Extra Hepatic Portal Hypertension - Role of Anticoagulation. Pediatric Oncall 2021;18. [DOI: 10.7199/ped.oncall.2021.40] [Reference Citation Analysis]
|
| 207 |
Cheng C, Cheng GY, Denas G, Pengo V. Arterial thrombosis in antiphospholipid syndrome (APS): Clinical approach and treatment. A systematic review. Blood Rev 2021;48:100788. [PMID: 33341301 DOI: 10.1016/j.blre.2020.100788] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 208 |
Billoir P, Michon A, Darnige L. Central serous chorioretinopathy and antiphospholipid syndrome: Three cases report. Lupus 2021;30:514-7. [PMID: 33307985 DOI: 10.1177/0961203320979736] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 209 |
Fujieda Y, Amengual O. New insights into the pathogenic mechanisms and treatment of arterial thrombosis in antiphospholipid syndrome. Eur J Rheumatol 2020. [PMID: 33226327 DOI: 10.5152/eurjrheum.2020.20058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 210 |
Joshi A, Sood V, Mendonca S, Dogra M, Batta G, Tiwari R, Yanamandra U. Catastrophic Antiphospholipid Syndrome in Immune Thrombocytopenic Purpura - Beyond Tenuous Concomitance! Indian J Nephrol 2020;30:424-6. [PMID: 33840964 DOI: 10.4103/ijn.IJN_188_19] [Reference Citation Analysis]
|
| 211 |
Shil RSK, Al Dhuhoori AA, Thomachan VM, Teir JA, Radhakrishnan R. Atypical Presentation of Anti-Phospholipid Antibody Syndrome with Seizure and Atrial Mass. Case Reports in Medicine 2020;2020:1-5. [DOI: 10.1155/2020/8877445] [Reference Citation Analysis]
|
| 212 |
Markousis-Mavrogenis G, Sfikakis PP, Mavrogeni SI, Tektonidou MG. Combined brain/heart magnetic resonance imaging in antiphospholipid syndrome-two sides of the same coin. Clin Rheumatol 2021;40:2559-68. [PMID: 33196982 DOI: 10.1007/s10067-020-05498-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 213 |
Fujino Y, Kawasaki T, Kawamata H, Tamura A, Shiga K, Oyamada H. Cerebral Infarction with Pulmonary Thromboembolism Due to Immobilization. Intern Med 2020;59:2955-9. [PMID: 32713906 DOI: 10.2169/internalmedicine.3285-19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 214 |
Misasi R, Longo A, Recalchi S, Caissutti D, Riitano G, Manganelli V, Garofalo T, Sorice M, Capozzi A. Molecular Mechanisms of "Antiphospholipid Antibodies" and Their Paradoxical Role in the Pathogenesis of "Seronegative APS". Int J Mol Sci 2020;21:E8411. [PMID: 33182499 DOI: 10.3390/ijms21218411] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 215 |
Mintjens-Jager EMW, Vos ME, Kats-Ugurlu G, Hospers GAP, Rutgers A, van Meurs M. Severe mesenteric ischemia with multiple organ failure in a patient previously treated with a humanized monoclonal antibody against programmed death receptor-1 (pembrolizumab), a case of pembrolizumab associated catastrophic antiphospholipid syndrome? SAGE Open Med Case Rep 2020;8:2050313X20972225. [PMID: 33224503 DOI: 10.1177/2050313X20972225] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 216 |
Sayar Z, Moll R, Isenberg D, Cohen H. Thrombotic antiphospholipid syndrome: A practical guide to diagnosis and management. Thromb Res 2021;198:213-21. [PMID: 33485122 DOI: 10.1016/j.thromres.2020.10.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 217 |
Slivka AP, Agriesti JE, Orsinelli DA. Natural history of nonbacterial thrombotic endocarditis treated with warfarin. Int J Stroke 2021;16:519-25. [PMID: 33040698 DOI: 10.1177/1747493020961744] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 218 |
Bala MM, Celinska-Lowenhoff M, Szot W, Padjas A, Kaczmarczyk M, Swierz MJ, Undas A. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome. Cochrane Database Syst Rev 2020;10:CD012169. [PMID: 33045766 DOI: 10.1002/14651858.CD012169.pub3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 219 |
Gaspar P, Cohen H, Isenberg DA. The assessment of patients with the antiphospholipid antibody syndrome: where are we now? Rheumatology (Oxford) 2020;59:1489-94. [PMID: 32359070 DOI: 10.1093/rheumatology/keaa172] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 220 |
Iseki T, Yamashita Y, Ueno Y, Hira K, Miyamoto N, Yamashiro K, Tsunemi T, Teranishi K, Yatomi K, Nakajima S, Kijima C, Oishi H, Hattori N. Cerebral artery dissection secondary to antiphospholipid syndrome: A report of two cases and a literature review. Lupus 2021;30:118-24. [PMID: 33016197 DOI: 10.1177/0961203320960821] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 221 |
Ferrannini G, Svenungsson E, Kjellström B, Elvin K, Grosso G, Näsman P, Rydén L, Norhammar A. Antiphospholipid antibodies in patients with dysglycaemia: A neglected cardiovascular risk factor? Diab Vasc Dis Res 2020;17:1479164120922123. [PMID: 32506943 DOI: 10.1177/1479164120922123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 222 |
Chatterjee S, Pauling JD. Anti-phospholipid syndrome leading to digital ischaemia and rare organ complications in systemic sclerosis and related disorders. Clin Rheumatol 2021;40:2457-65. [PMID: 32959188 DOI: 10.1007/s10067-020-05399-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 223 |
Tarango C, Palumbo JS. Antiphospholipid syndrome in pediatric patients. Curr Opin Hematol 2019;26:366-71. [PMID: 31348049 DOI: 10.1097/MOH.0000000000000523] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 224 |
Polytarchou K, Varvarousis D, Manolis AS. Cardiovascular Disease in Antiphospholipid Syndrome. CVP 2020;18:538-48. [DOI: 10.2174/1570161117666190830101341] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 225 |
Zen M, Loredo Martinez M, Benvenuti F, Gatto M, Saccon F, Larosa M, Iaccarino L, Doria A. Prevalence, outcome and management of patients with SLE and secondary antiphospholipid antibody syndrome after aPL seroconversion. Rheumatology 2021;60:1313-20. [DOI: 10.1093/rheumatology/keaa463] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 226 |
Harne P, Sampat PJ, Bisen M, Bengabr J, Neupane H. Therapeutic Challenges with Catastrophic Antiphospholipid Antibody Syndrome: A Case Report. Cureus 2020. [DOI: 10.7759/cureus.10482] [Reference Citation Analysis]
|
| 227 |
Lettau M, Schrezenmeier EV, Specker C, Dörner T. [Lupus and thrombophilia : Antiphospholipid syndrome]. Z Rheumatol 2020;79:332-41. [PMID: 32300863 DOI: 10.1007/s00393-020-00786-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 228 |
de Jesús GR, Benson AE, Chighizola CB, Sciascia S, Branch DW. 16th International Congress on Antiphospholipid Antibodies Task Force Report on Obstetric Antiphospholipid Syndrome. Lupus 2020;29:1601-15. [PMID: 32883160 DOI: 10.1177/0961203320954520] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 229 |
Zuily S, Cohen H, Isenberg D, Woller SC, Crowther M, Dufrost V, Wahl D, Doré CJ, Cuker A, Carrier M, Pengo V, Devreese KM. Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2020;18:2126-37. [DOI: 10.1111/jth.14935] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 230 |
Sugiyama K, Suzuki S, Koizumi N, Ogino H. Antiphospholipid syndrome with chronic thromboembolic pulmonary hypertension and coronary artery disease: a case report. J Cardiothorac Surg 2020;15:225. [PMID: 32838812 DOI: 10.1186/s13019-020-01254-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 231 |
Tong M, Tsai BW, Chamley LW. Antiphospholipid antibodies and extracellular vesicles in pregnancy. Am J Reprod Immunol 2021;85:e13312. [PMID: 32715546 DOI: 10.1111/aji.13312] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 232 |
Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, Sáez-Comet L, Lefkou E, Mekinian A, Belizna C, Ruffatti A, Hoxha A, Tincani A, Nalli C, Marozio L, Maina A, Espinosa G, Ríos-Garcés R, Cervera R, Carolis S, Monteleone G, Latino O, Udry S, LLurba E, Garrido-Gimenez C, Trespidi L, Gerosa M, Chighizola CB, Rovere-Querini P, Canti V, Mayer-Pickel K, Tabacco S, Arnau A, Trapé J, Ruiz-Hidalgo D, Sos L, Farran-Codina I; EUROAPS Study Group. Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry. Rheumatology (Oxford) 2020;59:1306-14. [PMID: 31580459 DOI: 10.1093/rheumatology/kez419] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 10.3] [Reference Citation Analysis]
|
| 233 |
Cohen H, Sayar Z, Efthymiou M, Gaspar P, Richards T, Isenberg D. Management of anticoagulant-refractory thrombotic antiphospholipid syndrome. Lancet Haematol 2020;7:e613-23. [PMID: 32735839 DOI: 10.1016/S2352-3026(20)30116-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 234 |
Branch DW. What's new in obstetric antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program 2019;2019:421-5. [PMID: 31808896 DOI: 10.1182/hematology.2019000043] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 235 |
Nour-Eldine W, Noureldine HA, Haydar BA, Eldine MN, Noureldine MHA, Uthman I. A glimpse into the history of description of the antiphospholipid syndrome. Lupus 2020;29:1493-502. [PMID: 32741306 DOI: 10.1177/0961203320947152] [Reference Citation Analysis]
|
| 236 |
Saito M, Makino Y, Inoue K, Watanabe Y, Hoshi O, Kubota T. Anti-DNA antibodies cross-reactive with β2-glycoprotein I induce monocyte tissue factor through the TLR9 pathway. Immunol Med 2021;44:124-35. [PMID: 32701417 DOI: 10.1080/25785826.2020.1796285] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 237 |
Xourgia E, Tektonidou MG. Management of Non-criteria Manifestations in Antiphospholipid Syndrome. Curr Rheumatol Rep 2020;22:51. [PMID: 32699944 DOI: 10.1007/s11926-020-00935-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 238 |
Ortel TL, Meleth S, Catellier D, Crowther M, Erkan D, Fortin PR, Garcia D, Haywood N, Kosinski AS, Levine SR, Phillips MJ, Whitehead N. Recurrent thrombosis in patients with antiphospholipid antibodies and an initial venous or arterial thromboembolic event: A systematic review and meta-analysis. J Thromb Haemost 2020;18:2274-86. [PMID: 32484606 DOI: 10.1111/jth.14936] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 239 |
Marziale A, Bettacchioli E, Picart G, Nafai S, Galinat H, Meroni PL, Frostegard J, Alarcon-Riquelme ME, Renaudineau Y; PRECISESADS Clinical Consortium. Antiphospholipid autoantibody detection is important in all patients with systemic autoimmune diseases. J Autoimmun 2020;115:102524. [PMID: 32693965 DOI: 10.1016/j.jaut.2020.102524] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 240 |
Bianchi L, Sensini C, Hansel K, Tramontana M, Romita P, Giuffrida R, Stingeni L. Cutaneous necrosis in patient with antiphospholipid syndrome successfully treated with topical pimecrolimus and warfarin. Dermatologic Therapy 2020;33. [DOI: 10.1111/dth.13655] [Reference Citation Analysis]
|
| 241 |
Mlekuš Kozamernik K, Jensterle M, Ambrožič A, Pfeifer M. Adrenal failure and antiphospholipid syndrome. J Int Med Res 2020;48:030006052090365. [DOI: 10.1177/0300060520903659] [Reference Citation Analysis]
|
| 242 |
Carvalho JF, Viana VS, Leon EP, Bonfa E, Pasoto SG, Martins VR. RETRACTED: Antibodies to cellular prion protein and its cognate ligand stress-inducible protein 1 in systemic lupus erythematosus. Lupus 2020;29:NP1-7. [PMID: 32588733 DOI: 10.1177/0961203320935987] [Reference Citation Analysis]
|
| 243 |
He H, Wu N. A 75-year-old woman with primary antiphospholipid syndrome presenting with livedoid vasculopathy. Dermatol Ther 2020;33:e13480. [PMID: 32359084 DOI: 10.1111/dth.13480] [Reference Citation Analysis]
|
| 244 |
Serrano R, Pons-Estel GJ, Espinosa G, Quintana RM, Reverter JC, Tassies D, Monteagudo J, Cervera R. Long-term follow-up of antiphospholipid syndrome: real-life experience from a single center. Lupus 2020;29:1050-9. [PMID: 32536318 DOI: 10.1177/0961203320933009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 245 |
Chrabaszcz M, Małyszko J, Sikora M, Alda-Malicka R, Stochmal A, Matuszkiewicz-Rowinska J, Rudnicka L. Renal Involvement in Systemic Sclerosis: An Update. Kidney Blood Press Res 2020;45:532-48. [PMID: 32521536 DOI: 10.1159/000507886] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 246 |
Li X, Deng X, Duan H, Zeng L, Zhou J, Liu C, Guo X, Liu X. Clinical features associated with pregnancy outcomes in women with positive antiphospholipid antibodies and previous adverse pregnancy outcomes: a real-world prospective study. Clin Rheumatol 2021;40:193-204. [PMID: 32514680 DOI: 10.1007/s10067-020-05203-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 247 |
Nasonov EL, Reshetnyak TM, Alekberova ZS. [Thrombotic microangiopathy in rheumatology: a link between thrombosis and autoimmunity]. Ter Arkh 2020;92:4-14. [PMID: 32598770 DOI: 10.26442/00403660.2020.05.000697] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 248 |
Borisova AB, Lisitsyna TA, Veltishchev DY, Reshetnyak TM, Seravina OF, Kovalevskaya OB, Krasnov VN, Nasonov EL. [Mental disorders and cognitive impairment in patients with antiphospholipid syndrome]. Ter Arkh 2020;92:92-103. [PMID: 32598781 DOI: 10.26442/00403660.2020.05.000625] [Reference Citation Analysis]
|
| 249 |
Algahtani FH, AlQahtany FS, ElGohary G, Alsharidi A, Sayeeda A, AlArfaj H, Gamal AY. The clinical and laboratory manifestations profile of antiphospholipid syndrome among Saudi Arabia population: Examining the applicability of Sapporo criteria. Saudi J Biol Sci 2020;27:2425-30. [PMID: 32884425 DOI: 10.1016/j.sjbs.2020.05.037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 250 |
Sarecka-Hujar B, Kopyta I. Antiphospholipid syndrome and its role in pediatric cerebrovascular diseases: A literature review. World J Clin Cases 2020; 8(10): 1806-1817 [PMID: 32518771 DOI: 10.12998/wjcc.v8.i10.1806] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 251 |
Aringer M, Wiefel K, Leuchten N. Neue Klassifikationskriterien des SLE: was helfen sie für die klinische Diagnose des SLE? Aktuelle Rheumatologie 2020;45:299-306. [DOI: 10.1055/a-1165-1725] [Reference Citation Analysis]
|
| 252 |
Teisseyre M, Perrochia H, Reboul P, Cariou S, Renaud S, Aglae C, Moranne O. Primary antiphospholipid syndrome associated with anti-phospholipase A2 receptor antibody-positive membranous nephropathy. BMC Nephrol 2020;21:196. [PMID: 32448215 DOI: 10.1186/s12882-020-01856-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 253 |
Elmogy AA, Gergis M, Hassan A, Hanna IS, Yacoub M. Thromboendarterectomy in a patient with Systemic Lupus and antiphospholipid Syndrome, lessons learned from a complex disease interaction. Glob Cardiol Sci Pract 2020;2020:e202015. [PMID: 33150159 DOI: 10.21542/gcsp.2020.15] [Reference Citation Analysis]
|
| 254 |
Cheldieva FA, Reshetnyak TM, Radenska-lopovok SG, Korsakova YO, Lila AM. ANTIPHOSPHOLIPID SYNDROME AND SYSTEMIC LUPUS ERYTHEMATOSUS: WHAT DISEASE IS A CAUSE OF ORGAN DAMAGES? Naučno-praktičeskaâ revmatologiâ 2020;58:225-231. [DOI: 10.14412/1995-4484-2020-225-231] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 255 |
Lenz CJ, Mankad R, Klarich K, Kurmann R, McBane RD. Antiphospholipid syndrome and the relationship between laboratory assay positivity and prevalence of non-bacterial thrombotic endocarditis: A retrospective cohort study. J Thromb Haemost 2020;18:1408-14. [PMID: 32180317 DOI: 10.1111/jth.14798] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 256 |
Nascimento IS, Radin M, Gândara APR, Sciascia S, de Andrade DCO. Global antiphospholipid syndrome score and anti-ß2-glycoprotein I domain I for thrombotic risk stratification in antiphospholipid syndrome: A four-year prospective study. Lupus 2020;29:676-85. [DOI: 10.1177/0961203320916527] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 257 |
Mazzoccoli C, Comitangelo D, D'Introno A, Mastropierro V, Sabbà C, Perrone A. Antiphospholipid syndrome: a case report with an unusual wide spectrum of clinical manifestations. Auto Immun Highlights 2019;10:9. [PMID: 32257065 DOI: 10.1186/s13317-019-0119-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 258 |
Vreede AP, Bockenstedt PL, McCune WJ, Knight JS. Cryptic conspirators: a conversation about thrombocytopenia and antiphospholipid syndrome. Curr Opin Rheumatol 2019;31:231-40. [PMID: 30747734 DOI: 10.1097/BOR.0000000000000595] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 259 |
Skoczynska M, Crowther MA, Chowaniec M, Ponikowska M, Chaturvedi S, Legault K. Thrombotic microangiopathy in the course of catastrophic antiphospholipid syndrome successfully treated with eculizumab: case report and systematic review of the literature. Lupus 2020;29:631-9. [DOI: 10.1177/0961203320917460] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 260 |
Miranda S, Park J, Le Gal G, Piran S, Kherani S, Rodger MA, Delluc A. Prevalence of confirmed antiphospholipid syndrome in 18‐50 years unselected patients with first unprovoked venous thromboembolism. J Thromb Haemost 2020;18:926-30. [DOI: 10.1111/jth.14720] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 261 |
Svenungsson E, Antovic A. The antiphospholipid syndrome - often overlooked cause of vascular occlusions? J Intern Med 2020;287:349-72. [PMID: 31957081 DOI: 10.1111/joim.13022] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 262 |
Restrepo Ocampo C, Arango Gutiérrez L, Rodríguez Padilla LM, Mesa Navas MA, Velásquez Franco CJ, Gutiérrez Marín JH, Campo Campo MN. Clinical manifestations and maternal and perinatal outcomes in pregnant women with obstetric antiphospholipid syndrome at a high complexity institution: Descriptive study. Revista Colombiana de Reumatología (English Edition) 2020;27:73-79. [DOI: 10.1016/j.rcreue.2020.06.003] [Reference Citation Analysis]
|
| 263 |
Tsukamoto E, Tanei T, Senda J, Kato T, Naito T, Ishii K, Okada K, Hasegawa T. Subarachnoid Hemorrhage After Ischemic Stroke Associated with Systemic Lupus Erythematosus and Antiphospholipid Syndrome. World Neurosurgery 2020;136:248-252. [DOI: 10.1016/j.wneu.2020.01.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 264 |
Restrepo Ocampo C, Arango Gutiérrez L, Rodríguez Padilla LM, Mesa Navas MA, Velásquez Franco CJ, Gutiérrez Marín JH, Campo Campo MN. Manifestaciones clínicas y desenlaces maternos y perinatales en gestantes con síndrome antifosfolípido obstétrico de una institución de alta complejidad: estudio descriptivo. Revista Colombiana de Reumatología 2020;27:73-79. [DOI: 10.1016/j.rcreu.2020.01.002] [Reference Citation Analysis]
|
| 265 |
Stammler R, Legendre P, Cacoub P, Blanche P, Piette J-, Costedoat -Chalumeau N. Catastrophic antiphospholipid syndrome following the introduction of rivaroxaban. Lupus 2020;29:787-90. [DOI: 10.1177/0961203320914363] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 266 |
Dziamski K, Sharmeen S, Banki K, Perl A. Nine-test panel has superior sensitivity to detect antiphospholipid antibody syndrome in patients with or without SLE. Clin Immunol 2020;214:108388. [PMID: 32200114 DOI: 10.1016/j.clim.2020.108388] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 267 |
Specker C, Fischer-betz R, Dörner T. Antiphospholipidsyndrom: Update zu Diagnostik und Therapie. Z Rheumatol 2020;79:255-66. [DOI: 10.1007/s00393-020-00759-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 268 |
Schreiber K, Hunt BJ. Managing antiphospholipid syndrome in pregnancy. Thromb Res 2019;181 Suppl 1:S41-6. [PMID: 31477227 DOI: 10.1016/S0049-3848(19)30366-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 269 |
Soybilgic A, Avcin T. Pediatric APS: State of the Art. Curr Rheumatol Rep 2020;22:9. [PMID: 32124078 DOI: 10.1007/s11926-020-0887-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 270 |
Désage S, Dargaud Y. Diagnostic biologique du syndrome des antiphospholipides. Revue Francophone des Laboratoires 2020;2020:34-41. [DOI: 10.1016/s1773-035x(20)30096-4] [Reference Citation Analysis]
|
| 271 |
Warriach SA, Mustafa M, O'keeffe D, Watts M. Unusual case of antiphospholipid syndrome presenting as adrenal insufficiency. BMJ Case Rep 2020;13:e233631. [DOI: 10.1136/bcr-2019-233631] [Reference Citation Analysis]
|
| 272 |
Bansal R, Nath PV, Hoang TD, Shakir MK. Adrenal Insufficiency Secondary to Bilateral Adrenal Hemorrhage Associated with Antiphospholipid Syndrome. AACE Clinical Case Reports 2020;6:e65-e69. [DOI: 10.4158/accr-2019-0376] [Reference Citation Analysis]
|
| 273 |
Semczuk-Kaczmarek K, Platek AE, Ryś-Czaporowska A, Szymanski FM, Filipiak KJ. Acute Myocardial Infarction Due to Antiphospholipid Syndrome - Case Report and Review of the Literature. Curr Probl Cardiol 2021;46:100552. [PMID: 32216971 DOI: 10.1016/j.cpcardiol.2020.100552] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 274 |
Hwang JJ, Shin SH, Kim YJ, Oh YM, Lee SD, Kim YH, Choi CW, Lee JS. Epidemiology of Antiphospholipid Syndrome in Korea: a Nationwide Population-based Study. J Korean Med Sci 2020;35:e35. [PMID: 32030922 DOI: 10.3346/jkms.2020.35.e35] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 275 |
Fujimoto M, Asai J, Asano Y, Ishii T, Iwata Y, Kawakami T, Kodera M, Abe M, Amano M, Ikegami R, Isei T, Isogai Z, Ito T, Inoue Y, Irisawa R, Ohtsuka M, Omoto Y, Kato H, Kadono T, Kaneko S, Kanoh H, Kawaguchi M, Kukino R, Kono T, Koga M, Sakai K, Sakurai E, Sarayama Y, Shintani Y, Tanioka M, Tanizaki H, Tsujita J, Doi N, Nakanishi T, Hashimoto A, Hasegawa M, Hayashi M, Hirosaki K, Fujita H, Fujiwara H, Maekawa T, Matsuo K, Madokoro N, Motegi SI, Yatsushiro H, Yamasaki O, Yoshino Y, Pavoux AJL, Tachibana T, Ihn H; Japanese Dermatological Association Guidelines. Wound, pressure ulcer and burn guidelines - 4: Guidelines for the management of connective tissue disease/vasculitis-associated skin ulcers. J Dermatol 2020;47:1071-109. [PMID: 31960490 DOI: 10.1111/1346-8138.15186] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 276 |
Arachchillage DRJ, Gomez K, Alikhan R, Anderson JAM, Lester W, Laffan M; British Society for Haematology Haemostasis and Thrombosis Taskforce. Addendum to British Society for Haematology Guidelines on Investigation and Management of Antiphospholipid syndrome, 2012 ( Br. J.Haematol. 2012; 157: 47–58): use of direct acting oral anticoagulants. Br J Haematol 2020;189:212-5. [DOI: 10.1111/bjh.16308] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 277 |
Ambrus JL. Sjogren’s Syndrome. The Autoimmune Diseases 2020. [DOI: 10.1016/b978-0-12-812102-3.00033-6] [Reference Citation Analysis]
|
| 278 |
Kello N, Lee J, Jackson D, Marder G, Narain S. Renal Manifestations in Lupus Pregnancy. Obstetric and Gynecologic Nephrology 2020. [DOI: 10.1007/978-3-030-25324-0_5] [Reference Citation Analysis]
|
| 279 |
Wehler M. Immunologische Notfälle. Klinische Notfallmedizin Band 1 Wissen 2020. [DOI: 10.1016/b978-3-437-23248-0.00016-x] [Reference Citation Analysis]
|
| 280 |
Savino S, Massimo R. Budd–Chiari Syndrome in Patients with Antiphospholipid Antibodies. Budd-Chiari Syndrome 2020. [DOI: 10.1007/978-981-32-9232-1_8] [Reference Citation Analysis]
|
| 281 |
Bhasin N, Knoll C, Skeith LM. Antiphospholipid Syndrome. Hematology in the Adolescent Female 2020. [DOI: 10.1007/978-3-030-48446-0_24] [Reference Citation Analysis]
|
| 282 |
Tanaka A, Mima Y, Abe Y, Isoda K, Imura J, Ohara M, Ueda N, Ikeda M, Shoda T, Morikawa M, Otsubo R. A case of catastrophic antiphospholipid syndrome with cerebral venous thrombosis. Jpn J Stroke 2020;42:429-434. [DOI: 10.3995/jstroke.10729] [Reference Citation Analysis]
|
| 283 |
Shovman O, Shoenfeld Y. Antiphospholipid Syndrome. The Autoimmune Diseases 2020. [DOI: 10.1016/b978-0-12-812102-3.00032-4] [Reference Citation Analysis]
|
| 284 |
Wildner P, Stasiołek M, Matysiak M. Differential diagnosis of multiple sclerosis and other inflammatory CNS diseases. Multiple Sclerosis and Related Disorders 2020;37:101452. [DOI: 10.1016/j.msard.2019.101452] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 285 |
Jami-carrera J, Cevallos-espinel J, Cruz-castillo Y, López I. Nódulos eritematosos en miembros inferiores de una mujer. Diagnóstico y comentario. Piel 2020;35:50-51. [DOI: 10.1016/j.piel.2019.03.001] [Reference Citation Analysis]
|
| 286 |
Fritzler MJ. Autoantibody Assays: Performance, Interpretation, and Standardization. The Autoimmune Diseases 2020. [DOI: 10.1016/b978-0-12-812102-3.00069-5] [Reference Citation Analysis]
|
| 287 |
Tolentino Júnior DS, de Oliveira CM, de Assis EM. Population-based Study of 24 Autoimmune Diseases Carried Out in a Brazilian Microregion. J Epidemiol Glob Health 2019;9:243-51. [PMID: 31854165 DOI: 10.2991/jegh.k.190920.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 288 |
Loza G, Hallo C, Chiliquinga B, Hallo A. Alveolar Hemorrhage, a Rare and Life-Threatening Complication of Catastrophic Antiphospholipid Syndrome. Case Rep Rheumatol 2019;2019:3284258. [PMID: 31815030 DOI: 10.1155/2019/3284258] [Reference Citation Analysis]
|
| 289 |
Madison JA, Zuo Y, Knight JS. Pediatric antiphospholipid syndrome. Eur J Rheumatol. 2019;1-10. [PMID: 31804173 DOI: 10.5152/eurjrheum.2019.19160] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 290 |
Barratt SL, Pauling JD, Chaudhuri N. Pulmonary involvement in antiphospholipid syndrome. Pulmonary Manifestations of Systemic Diseases 2019. [DOI: 10.1183/2312508x.10014419] [Reference Citation Analysis]
|
| 291 |
Bevill BT, Argula RG, Gilkeson GC, Kim NH. A Man with Severe Pulmonary Hypertension and Right Ventricular Failure. Ann Am Thorac Soc 2018;15:1472-6. [PMID: 30499723 DOI: 10.1513/AnnalsATS.201802-092CC] [Reference Citation Analysis]
|
| 292 |
Pontara E, Cheng C, Cattini MG, Bison E, Pelloso M, Denas G, Pengo V. An in vitro model to mimic the thrombotic occlusion of small vessels in catastrophic antiphospholipid syndrome (CAPS). Lupus 2019;28:1663-8. [PMID: 31701800 DOI: 10.1177/0961203319886915] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 293 |
Roit Z, Weil J, Llovera I. More Than Skin Deep: A Case of Catastrophic Antiphospholipid Syndrome. J Emerg Med 2019;57:880-2. [PMID: 31677977 DOI: 10.1016/j.jemermed.2019.08.030] [Reference Citation Analysis]
|
| 294 |
Unlu O, Erkan D, Barbhaiya M, Andrade D, Nascimento I, Rosa R, Banzato A, Pengo V, Ugarte A, Gerosa M, Ji L, Efthymiou M, Branch DW, de Jesus GR, Tincani A, Belmont HM, Fortin PR, Petri M, Rodriguez E, Pons-Estel GJ, Knight JS, Atsumi T, Willis R, Zuily S, Tektonidou MG; AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Investigators. The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository. Arthritis Care Res (Hoboken) 2019;71:134-41. [PMID: 29669399 DOI: 10.1002/acr.23584] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 295 |
Smiyan S, Komorovsky R, Tomashchuk N. Acute coronary syndrome leading to revision of a co-morbid condition in a young man with arthritis. Reumatologia 2019;57:243-8. [PMID: 31548752 DOI: 10.5114/reum.2019.87621] [Reference Citation Analysis]
|
| 296 |
Urbanski G, Yelnik CM, Maillard H, Launay D, Dubucquoi S, Hachulla E, Hatron PY, Lambert M. Antiphospholipid Syndrome With Isolated Isotype M Anticardiolipin and/or Anti-B2GPI Antibody Is Associated With Stroke. Stroke 2018;49:2770-2. [PMID: 30355196 DOI: 10.1161/STROKEAHA.118.023021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 297 |
Mayer-Pickel K, Stern C, Eberhard K, Lang U, Cervar-Zivkovic M. Changes of platelet count throughout pregnancy in women with antiphospholipid syndrome. J Reprod Immunol 2019;136:102612. [PMID: 31542513 DOI: 10.1016/j.jri.2019.102612] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 298 |
Collict M, Sciberras Buhagiar W, Mercieca C, Thake J. Catastrophic antiphospholipid syndrome in pregnancy: a life-threatening condition. BMJ Case Rep 2019;12:e230863. [PMID: 31527209 DOI: 10.1136/bcr-2019-230863] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 299 |
Prouvot J, Aglaé C, Daniel L, Moranne O. A catastrophic antiphospholipid syndrome complicated with heparin-induced thrombocytopaenia, successfully managed with double filtration plasmapheresis, steroids and a direct thrombin inhibitor. BMJ Case Rep 2019;12:e231161. [PMID: 31527216 DOI: 10.1136/bcr-2019-231161] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 300 |
Angelillo-Scherrer A, Mansouri Taleghani B, Förger F, Baerlocher GM, Pabst T, Pöllinger A, Banz Y, Geiser T, Kremer Hovinga JA, Rovó A. Immunoadsorption and autologous transplantation for life-threatening primary antiphospholipid syndrome. Blood Adv 2019;3:2664-7. [PMID: 31506284 DOI: 10.1182/bloodadvances.2019000465] [Reference Citation Analysis]
|
| 301 |
Stoots SA, Lief L, Erkan D. Clinical Insights into Diffuse Alveolar Hemorrhage in Antiphospholipid Syndrome. Curr Rheumatol Rep 2019;21:56. [PMID: 31493005 DOI: 10.1007/s11926-019-0852-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 302 |
Kokosi M, Lams B, Agarwal S. Systemic Lupus Erythematosus and Antiphospholipid Antibody Syndrome. Clinics in Chest Medicine 2019;40:519-29. [DOI: 10.1016/j.ccm.2019.06.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 303 |
Chirra M, Marsili L, Gallerini S, Keeling EG, Marconi R, Colosimo C. Paraneoplastic movement disorders: phenomenology, diagnosis, and treatment. European Journal of Internal Medicine 2019;67:14-23. [DOI: 10.1016/j.ejim.2019.05.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 304 |
McDonnell T, Wincup C, Buchholz I, Pericleous C, Giles I, Ripoll V, Cohen H, Delcea M, Rahman A. The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS. Blood Rev 2020;39:100610. [PMID: 31471128 DOI: 10.1016/j.blre.2019.100610] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 305 |
Jang SK, Sitek A, Said S, Shields RC. Catastrophic Antiphospholipid Syndrome as a Cause of Severe Gastrointestinal Bleeding. Am J Med 2019;132:e661-2. [PMID: 30904512 DOI: 10.1016/j.amjmed.2019.02.043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 306 |
Riva N, Gatt A. Update on the Diagnosis and Anticoagulant Treatment of the Antiphospholipid Syndrome. EMJ Rheumatol 2019. [DOI: 10.33590/emjrheumatol/10314116] [Reference Citation Analysis]
|
| 307 |
Mezhov V, Segan JD, Tran H, Cicuttini FM. Antiphospholipid syndrome: a clinical review. Med J Aust 2019;211:184-8. [PMID: 31271468 DOI: 10.5694/mja2.50262] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 308 |
Vásquez JF, Carreño Jaimes M, Amador JR, Uscátegui Ruiz AC, Real Chavarro AP. Dermal necrosis as the first manifestation of anti-phospholipid antibody syndrome. Revista Colombiana de Reumatología (English Edition) 2019;26:204-208. [DOI: 10.1016/j.rcreue.2018.05.005] [Reference Citation Analysis]
|
| 309 |
Vásquez JF, Carreño Jaimes M, Amador JR, Uscátegui Ruiz AC, Real Chavarro AP. Necrosis dérmica como primera manifestación del síndrome de anticuerpos antifosfolípido. Revista Colombiana de Reumatología 2019;26:204-208. [DOI: 10.1016/j.rcreu.2018.05.001] [Reference Citation Analysis]
|
| 310 |
Vavilova TV, Isaeva LA, Grinchenko KY, Bogatenkova JD, Sorokoumov VA. DIAGNOSIS OF ANTIPHOSPHOLIPID SYNDROME IN PEOPLE WITH CLINICAL CRITERIA OF THE DISEASE. EXPERIENCE OF A SEPARATE OUTPATIENT CENTER. Aterotromboz 2019. [DOI: 10.21518/2307-1109-2019-1-92-98] [Reference Citation Analysis]
|
| 311 |
Tinti MG, Carnevale V, Inglese M, Molinaro F, Bernal M, Migliore A, De Cata A. Eculizumab in refractory catastrophic antiphospholipid syndrome: a case report and systematic review of the literature. Clin Exp Med 2019;19:281-8. [PMID: 31214910 DOI: 10.1007/s10238-019-00565-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 312 |
Denham C, Tissier G, Golding A. Antiphospholipid antibody syndrome with thrombotic splenic infarcts associated with acute cytomegalovirus infection. Access Microbiol 2019;1:e000032. [PMID: 32974541 DOI: 10.1099/acmi.0.000032] [Reference Citation Analysis]
|
| 313 |
Kazzaz NM, Wilson AM, Kado R, Barnes GD, Knight JS. A 37-Year-Old Man With Primary Antiphospholipid Syndrome Presenting With Respiratory Distress and Worsening Toe Ischemia. Arthritis Care Res (Hoboken) 2017;69:1253-9. [PMID: 27992694 DOI: 10.1002/acr.23168] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 314 |
Karvunidis T, Matějovič M. Sepsis mimics. Vnitr Lek 2019;65:440-448. [DOI: 10.36290/vnl.2019.078] [Reference Citation Analysis]
|
| 315 |
Costedoat-chalumeau N, Morel N. Síndrome antifosfolipídico. EMC - Aparato Locomotor 2019;52:1-16. [DOI: 10.1016/s1286-935x(19)42133-3] [Reference Citation Analysis]
|
| 316 |
Головач ІЮ, Єгудіна ЄД. Management of Patients with Systemic Lupus Erythematosus at the Stage of Primary Care: Answers to Frequently Asked Questions. СМ 2019;0:31-42. [DOI: 10.30841/2307-5112.2.2019.174634] [Reference Citation Analysis]
|
| 317 |
Gómez-Puerta JA, Cervera R, Alarcón GS. Overrepresentation of Elderly Subjects in a Population-Based Study of Antiphospholipid Syndrome: Comment on the Article by Duarte-García et al. Arthritis Rheumatol 2019;71:1768-9. [PMID: 31131989 DOI: 10.1002/art.41002] [Reference Citation Analysis]
|
| 318 |
Bucci T, Menichelli D, Pignatelli P, Triggiani M, Violi F, Pastori D. Relationship of Antiphospholipid Antibodies to Risk of Dementia: A Systematic Review. JAD 2019;69:561-76. [DOI: 10.3233/jad-181294] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 319 |
Goldhar HA, O'Meara P, Castellucci LA. A case of antiphospholipid syndrome presenting cryptogenically as Budd-Chiari syndrome, then fulminantly as Libman-Sacks endocarditis. BMJ Case Rep 2019;12:e227450. [PMID: 31092489 DOI: 10.1136/bcr-2018-227450] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 320 |
Benagiano G, Benagiano M, Bianchi P, D'Elios MM, Brosens I. Contraception in autoimmune diseases. Best Pract Res Clin Obstet Gynaecol 2019;60:111-23. [PMID: 31160225 DOI: 10.1016/j.bpobgyn.2019.05.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 321 |
Kolitz T, Shiber S, Sharabi I, Winder A, Zandman-Goddard G. Cardiac Manifestations of Antiphospholipid Syndrome With Focus on Its Primary Form. Front Immunol 2019;10:941. [PMID: 31134062 DOI: 10.3389/fimmu.2019.00941] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 8.8] [Reference Citation Analysis]
|
| 322 |
Choi H, Ahn SS, Song JJ, Park YB, Song J, Lee SW. Anti-phospholipid antibody syndrome occurrence in patients with persistent anti-phospholipid antibodies. Rheumatol Int 2019;39:1359-67. [PMID: 31076830 DOI: 10.1007/s00296-019-04318-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 323 |
Savelli SL, Roubey RAS, Kitzmiller KJ, Zhou D, Nagaraja HN, Mulvihill E, Barbar-Smiley F, Ardoin SP, Wu YL, Yu CY. Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL). Front Immunol. 2019;10:885. [PMID: 31134052 DOI: 10.3389/fimmu.2019.00885] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 324 |
Serrano M, Martinez-Flores JA, Norman GL, Naranjo L, Morales JM, Serrano A. The IgA Isotype of Anti-β2 Glycoprotein I Antibodies Recognizes Epitopes in Domains 3, 4, and 5 That Are Located in a Lateral Zone of the Molecule (L-Shaped). Front Immunol 2019;10:1031. [PMID: 31134087 DOI: 10.3389/fimmu.2019.01031] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 325 |
Anghel L, Prisacariu C, Sascău R, Macovei L, Cristea E, Prisacariu G, Stătescu C. Particularities of Acute Myocardial Infarction in Young Adults. Journal Of Cardiovascular Emergencies 2019;5:25-31. [DOI: 10.2478/jce-2019-0005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 326 |
Ali RA, Gandhi AA, Meng H, Yalavarthi S, Vreede AP, Estes SK, Palmer OR, Bockenstedt PL, Pinsky DJ, Greve JM, Diaz JA, Kanthi Y, Knight JS. Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome. Nat Commun 2019;10:1916. [PMID: 31015489 DOI: 10.1038/s41467-019-09801-x] [Cited by in Crossref: 103] [Cited by in F6Publishing: 110] [Article Influence: 25.8] [Reference Citation Analysis]
|
| 327 |
Alijotas-reig J, Esteve-valverde E, Ferrer-oliveras R, Sáez-comet L, Lefkou E, Mekinian A, Belizna C, Ruffatti A, Tincani A, Marozio L, Espinosa G, Cervera R, Ríos-garcés R, De Carolis S, Latino O, Llurba E, Chighizola CB, Gerosa M, Pengo V, Lundelin K, Rovere-querini P, Canti V, Mayer-pickel K, Reshetnyak T, Hoxha A, Tabacco S, Stojanovich L, Gogou V, Varoudis A, Arnau A, Ruiz-hidalgo D, Trapé J, Sos L, Stoppani C, Martí-cañamares A, Farran-codina I. The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases. Autoimmunity Reviews 2019;18:406-14. [DOI: 10.1016/j.autrev.2018.12.006] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 328 |
Arias EJ, Bruck B, Vellimana AK, Eby C, Reynolds MR, Blinder MA, Zipfel GJ. Plasmapheresis for Management of Antiphospholipid Syndrome in the Neurosurgical Patient. Oper Neurosurg (Hagerstown) 2019;16:E124-9. [PMID: 29800263 DOI: 10.1093/ons/opy135] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 329 |
Melenotte C, Gay L, Mezouar S, Bardin N, Raoult D, Mège JL. The sexual dimorphism of anticardiolipin autoantibodies in acute Q fever patients. Clin Microbiol Infect 2019;25:763.e1-3. [PMID: 30898724 DOI: 10.1016/j.cmi.2019.02.030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 330 |
Nagura S, Sakata K, Sakai M, Fukahara K. Aortic Valve Replacement in a Patient with Primary Antiphospholipid Syndrome and Recurrent Cerebral Infarction. J J C V S 2019;48:119-124. [DOI: 10.4326/jjcvs.48.119] [Reference Citation Analysis]
|
| 331 |
Shemer A, Willis R, Gonzalez EB, Romay-Penabad Z, Shovman O, Shoenfeld Y, Blank M, Amital H. Oral administration of Domain-I of beta-2glycoprotein-I induces immunological tolerance in experimental murine antiphospholipid syndrome. J Autoimmun 2019;99:98-103. [PMID: 30797663 DOI: 10.1016/j.jaut.2019.02.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 332 |
Ricarte IF, Dutra LA, Barsottini OGP, Souza AWS, Andrade DCO, Mangueira C, Silva GS. Transcranial Doppler findings in antiphospholipid syndrome. Lupus 2019;28:483-91. [PMID: 30755144 DOI: 10.1177/0961203319828833] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 333 |
Wendebourg MJ, Nagy S, Derfuss T, Parmar K, Schlaeger R. Magnetic resonance imaging in immune-mediated myelopathies. J Neurol 2020;267:1233-44. [PMID: 30694379 DOI: 10.1007/s00415-019-09206-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 334 |
Edel Y, Kliminski V, Pokroy-Shapira E, Oren S, Dortort Lazar A, Pri-Paz Basson Y, Egbaria M, Molad Y. Elevated plasma level of soluble triggering receptor expressed on myeloid cells-1 is associated with inflammation activity and is a potential biomarker of thrombosis in primary antiphospholipid syndrome. Arthritis Res Ther 2019;21:10. [PMID: 30616644 DOI: 10.1186/s13075-018-1779-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 335 |
Grimaud F, Yelnik C, Pineton de Chambrun M, Amoura Z, Arnaud L, Costedoat Chalumeau N, Hachulla E, Lambert M, Roriz M, Sibilia J, Papo T, Sacre K. Clinical and immunological features of antiphospholipid syndrome in the elderly: a retrospective national multicentre study. Rheumatology 2019;58:1006-10. [DOI: 10.1093/rheumatology/key437] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 336 |
Ayan M, Alshebani Y, Tantoush H, Salih M, Abusnina W, Khaddr M, Smer A. Acute myocardial infarction in a young man with large left ventricular thrombus and the antiphospholipid syndrome. Baylor University Medical Center Proceedings 2019;32:110-112. [DOI: 10.1080/08998280.2018.1503479] [Reference Citation Analysis]
|
| 337 |
Cervera R, Rodríguez-pintó I, Espinosa G. Catastrophic Antiphospholipid Syndrome. Mosaic of Autoimmunity 2019. [DOI: 10.1016/b978-0-12-814307-0.00045-1] [Reference Citation Analysis]
|
| 338 |
Schranz M, Lucà MG, D’antiga L, Fagiuoli S. The Liver in Systemic Illness. Pediatric Hepatology and Liver Transplantation 2019. [DOI: 10.1007/978-3-319-96400-3_22] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 339 |
Stöcker W, Schlumberger W. Autoantikörper gegen Phospholipide. Springer Reference Medizin 2019. [DOI: 10.1007/978-3-662-48986-4_434] [Reference Citation Analysis]
|
| 340 |
Chaigne B, Guillevin L. Differential Diagnosis: Vasculitis, Rheumatoid Arthritis, Behçet’s Disease, and Thromboembolism. Atlas of Ulcers in Systemic Sclerosis 2019. [DOI: 10.1007/978-3-319-98477-3_17] [Reference Citation Analysis]
|
| 341 |
Stöcker W, Schlumberger W. Autoantikörper gegen Cardiolipin. Springer Reference Medizin 2019. [DOI: 10.1007/978-3-662-48986-4_360] [Reference Citation Analysis]
|
| 342 |
Freed J, Bauer KA. Thrombophilia. Consultative Hemostasis and Thrombosis. Elsevier; 2019. pp. 242-65. [DOI: 10.1016/b978-0-323-46202-0.00014-5] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 343 |
Purohit A, Kumar M. Antiphospholipid Syndrome. Hematopathology 2019. [DOI: 10.1007/978-981-13-7713-6_20] [Reference Citation Analysis]
|
| 344 |
Anvari E, Ferreira Provenzano L, Nevares A, Herlitz LC, Smith H. Lupus Nephritis (Including Antiphospholipid Antibody Syndrome), Adult. Glomerulonephritis 2019. [DOI: 10.1007/978-3-319-49379-4_14] [Reference Citation Analysis]
|
| 345 |
Na YS, Jang S, Hong S, Oh YM, Lee SD, Lee JS. Clinical Phenotype of a First Unprovoked Acute Pulmonary Embolism Associated with Antiphospholipid Antibody Syndrome. Tuberc Respir Dis (Seoul) 2019;82:53-61. [PMID: 30574689 DOI: 10.4046/trd.2018.0045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 346 |
Bhattacharyya S, Cho TA. Antiphospholipid Syndrome. Neurorheumatology 2019. [DOI: 10.1007/978-3-030-16928-2_5] [Reference Citation Analysis]
|
| 347 |
抗リン脂質抗体症候群の診断. Nihon Kessen Shiketsu Gakkaishi 2019;30:23-27. [DOI: 10.2491/jjsth.30.23] [Reference Citation Analysis]
|
| 348 |
Fujieda Y. Efficacy of dual antiplatelet therapy for preventing recurrence of arterial thrombosis in patients with antiphospholipid syndrome. Nihon Kessen Shiketsu Gakkaishi 2019;30:669-675. [DOI: 10.2491/jjsth.30.669] [Reference Citation Analysis]
|
| 349 |
Ueyama K, Ide Y, Sakamoto K, Kanemitsu H, Yamazaki K, Ikeda T, Minatoya K. Off Pump Coronary Artery Bypass Grafting for a Young Adult Patient with Antiphospholipid Syndrome. Journal of Coronary Artery Disease 2019;25:48-51. [DOI: 10.7793/jcad.25.19-00004] [Reference Citation Analysis]
|
| 350 |
Navarra SV, Torralba TP. The Musculoskeletal System and Bone Metabolism. Dubois' Lupus Erythematosus and Related Syndromes 2019. [DOI: 10.1016/b978-0-323-47927-1.00034-7] [Reference Citation Analysis]
|
| 351 |
El-darouti MA, Al-ali FM. Livedo Reticularis Associated with Ulceration. Challenging Cases in Dermatology Volume 2 2019. [DOI: 10.1007/978-3-030-21855-3_9] [Reference Citation Analysis]
|
| 352 |
Pandey A, Ali M, Jain S. A rare case of mitral valve replacement in antiphospholipid antibody syndrome. Apollo Med 2019;16:199. [DOI: 10.4103/am.am_6_19] [Reference Citation Analysis]
|
| 353 |
Domingues V, Moreira Balbi GG, Ramires de Jesús G, Signorelli F, Levy RA. Antiphospholipid Syndrome. Mosaic of Autoimmunity 2019. [DOI: 10.1016/b978-0-12-814307-0.00044-x] [Reference Citation Analysis]
|
| 354 |
Scheres LJ, Bistervels IM, Middeldorp S. Everything the clinician needs to know about evidence-based anticoagulation in pregnancy. Blood Reviews 2019;33:82-97. [DOI: 10.1016/j.blre.2018.08.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 355 |
Durcan L, Petri M. Clinical Aspects of Antiphospholipid Syndrome. Dubois' Lupus Erythematosus and Related Syndromes 2019. [DOI: 10.1016/b978-0-323-47927-1.00042-6] [Reference Citation Analysis]
|
| 356 |
Wysokinska E, Ortel TL. Antiphospholipid Syndrome. Consultative Hemostasis and Thrombosis 2019. [DOI: 10.1016/b978-0-323-46202-0.00020-0] [Reference Citation Analysis]
|
| 357 |
Heuser C, Branch W. Diagnosis and management of antiphospholipid syndrome. Evidence-based Obstetrics and Gynecology 2018. [DOI: 10.1002/9781119072980.ch31] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 358 |
Litvinova E, Darnige L, Kirilovsky A, Burnel Y, de Luna G, Dragon-Durey MA. Prevalence and Significance of Non-conventional Antiphospholipid Antibodies in Patients With Clinical APS Criteria. Front Immunol 2018;9:2971. [PMID: 30619328 DOI: 10.3389/fimmu.2018.02971] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 8.8] [Reference Citation Analysis]
|
| 359 |
Zhong C, Zhu Z, Wang A, Xu T, Bu X, Peng H, Yang J, Han L, Chen J, Xu T, Peng Y, Wang J, Li Q, Ju Z, Geng D, He J, Zhang Y. Multiple biomarkers covering distinct pathways for predicting outcomes after ischemic stroke. Neurology 2019;92:e295-304. [PMID: 30552300 DOI: 10.1212/WNL.0000000000006717] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 360 |
Ohnishi N, Fujieda Y, Hisada R, Nakamura H, Kato M, Oku K, Bohgaki T, Amengual O, Yasuda S, Atsumi T. Efficacy of dual antiplatelet therapy for preventing recurrence of arterial thrombosis in patients with antiphospholipid syndrome. Rheumatology 2019;58:969-74. [DOI: 10.1093/rheumatology/key340] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 361 |
Fleetwood T, Cantello R, Comi C. Antiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy. Front Neurol 2018;9:1001. [PMID: 30534110 DOI: 10.3389/fneur.2018.01001] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 362 |
Weeding E, Coit P, Yalavarthi S, Kaplan MJ, Knight JS, Sawalha AH. Genome-wide DNA methylation analysis in primary antiphospholipid syndrome neutrophils. Clin Immunol 2018;196:110-6. [PMID: 30471352 DOI: 10.1016/j.clim.2018.11.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 363 |
Sciascia S, Radin M. Thrombotic antiphospholipid syndrome. Lupus 2018;27:21-7. [PMID: 30452325 DOI: 10.1177/0961203318801686] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 364 |
Li C, Zhao J, Liu S, Song W, Zhu J, Hua L, Wang Q, Li M, Zeng X, Zhao Y. Pulmonary thromboendarterectomy is a curative resolution for chronic thromboembolic pulmonary hypertension associated with antiphospholipid syndrome: a retrospective cohort study. Lupus 2018;27:2206-14. [DOI: 10.1177/0961203318810427] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 365 |
Kato M, Hisada R, Atsumi T. Clinical profiles and risk assessment in patients with antiphospholipid antibodies. Expert Rev Clin Immunol 2019;15:73-81. [PMID: 30381978 DOI: 10.1080/1744666X.2019.1543025] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 366 |
Belhocine M, Coutte L, Martin Silva N, Morel N, Guettrot-Imbert G, Paule R, Le Jeunne C, Fredi M, Dreyfus M, Piette JC, Souchaud-Debouverie O, Deneux-Tharaux C, Tsatsaris V, Pannier E, Le Guern V, Costedoat-Chalumeau N. Intrauterine fetal deaths related to antiphospholipid syndrome: a descriptive study of 65 women. Arthritis Res Ther 2018;20:249. [PMID: 30400982 DOI: 10.1186/s13075-018-1745-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 367 |
Lee KH, Lee H, Lee CH, Kim JY, Kim JM, Kim SS, Jeong S, Hwang IS, Kim N, Kim NE, Shin S, Shin D, Song JS, Shin DH, Kim JD, Kim J, Lee YS, Kang H, Kim DH, Moon SH, Rho WS, Lee JY, Kronbichler A, Shin JI. Adrenal insufficiency in systematic lupus erythematosus (SLE) and antiphospholipid syndrome (APS): A systematic review. Autoimmun Rev 2019;18:1-8. [PMID: 30408580 DOI: 10.1016/j.autrev.2018.06.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 368 |
Shukla A, Bhatt P, Gupta DK, Modi T, Patel J, Gupte A, Meshram M, Bhatia S. Budd-Chiari syndrome has different presentations and disease severity during adolescence. Hepatol Int 2018;12:560-6. [PMID: 29971683 DOI: 10.1007/s12072-018-9880-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 369 |
Teng YKO, Bredewold EOW, Rabelink TJ, Huizinga TWJ, Eikenboom HCJ, Limper M, Fritsch-Stork RDE, Bloemenkamp KWM, Sueters M. An evidence-based approach to pre-pregnancy counselling for patients with systemic lupus erythematosus. Rheumatology (Oxford) 2018;57:1707-20. [PMID: 29165607 DOI: 10.1093/rheumatology/kex374] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 370 |
Fujita Y, Fukui S, Ishida M, Endo Y, Tsuji S, Takatani A, Igawa T, Shimizu T, Umeda M, Sumiyoshi R, Nishino A, Koga T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kawakami A. Reversible Cognitive Dysfunction in Elderly-onset Systemic Lupus Erythematosus, Successfully Treated with Aggressive Immunosuppressive Therapy. Intern Med 2018;57:3025-8. [PMID: 29780145 DOI: 10.2169/internalmedicine.0934-18] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 371 |
Scholz P, Auler M, Ruthard J, Brachvogel B, Klatt AR, Streichert T. Detection of annexin A8 antibodies in serum of patients with antiphospholipid syndrome. Biochem Med (Zagreb) 2018;28:030703. [PMID: 30429671 DOI: 10.11613/BM.2018.030703] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 372 |
Zahid H, Hassan S, Gul S, Rizwan K, Khan SU, Maghazi MA. Co-existing Bilateral Pulmonary Embolism and Intra-cardiac Mass: A Case of Catastrophic Antiphospholipid Syndrome-like Disease. Cureus 2018;10:e3438. [PMID: 30546985 DOI: 10.7759/cureus.3438] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 373 |
Uthman I, Noureldine MHA, Ruiz-Irastorza G, Khamashta M. Management of antiphospholipid syndrome. Ann Rheum Dis 2019;78:155-61. [PMID: 30282668 DOI: 10.1136/annrheumdis-2018-213846] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 374 |
Li C, Zhao J, He K, Wu Y, Liu S, Wang Q, Zhao Y. Curative resolution of chronic thromboembolic pulmonary hypertension with pulmonary thromboendarterectomy in primary antiphospholipid syndrome: A case report. Medicine (Baltimore) 2018;97:e12710. [PMID: 30290671 DOI: 10.1097/MD.0000000000012710] [Reference Citation Analysis]
|
| 375 |
Rovere-Querini P, Canti V, Erra R, Bianchi E, Slaviero G, D'Angelo A, Rosa S, Candiani M, Castiglioni MT. Eculizumab in a pregnant patient with laboratory onset of catastrophic antiphospholipid syndrome: A case report. Medicine (Baltimore) 2018;97:e12584. [PMID: 30290624 DOI: 10.1097/MD.0000000000012584] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 376 |
Dufrost V, Risse J, Reshetnyak T, Satybaldyeva M, Du Y, Yan X, Salta S, Gerotziafas G, Jing Z, Elalamy I, Wahl D, Zuily S. Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis. Autoimmunity Reviews 2018;17:1011-21. [DOI: 10.1016/j.autrev.2018.04.009] [Cited by in Crossref: 86] [Cited by in F6Publishing: 88] [Article Influence: 17.2] [Reference Citation Analysis]
|
| 377 |
Linnemann B. Antiphospholipid syndrome – an update. Vasa 2018;47:451-64. [DOI: 10.1024/0301-1526/a000723] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 9.2] [Reference Citation Analysis]
|
| 378 |
Ganapati A, Goel R, Kabeerdoss J, Gowri M, Mathew J, Danda D. Study of clinical utility of antibodies to phosphatidylserine/prothrombin complex in Asian-Indian patients with suspected APS. Clin Rheumatol 2019;38:545-53. [DOI: 10.1007/s10067-018-4301-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 379 |
Tobaldini LQ, Arantes FT, Saraiva SDS, Mazetto BM, Colella MP, de Paula EV, Annichino-Bizzachi J, Orsi FA. Circulating levels of tissue factor and the risk of thrombosis associated with antiphospholipid syndrome. Thromb Res 2018;171:114-20. [PMID: 30278301 DOI: 10.1016/j.thromres.2018.09.058] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 380 |
Antovic A, Sennström M, Bremme K, Svenungsson E. Obstetric antiphospholipid syndrome. Lupus Sci Med 2018;5:e000197. [PMID: 30364418 DOI: 10.1136/lupus-2016-000197] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 381 |
Di Minno MND, Scalera A, Tufano A, Ambrosino P, Bettiol A, Silvestri E, Emmi G, Prisco D. The association of adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) with cardiovascular disease in subjects with antiphospholipid antibodies. Atherosclerosis 2018;278:60-5. [PMID: 30253290 DOI: 10.1016/j.atherosclerosis.2018.09.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 382 |
Baig S, Bert J, Gertner E. Safety of retrievable inferior vena cava filters in patients with the antiphospholipid syndrome. Eur J Rheumatol 2018;5:100-3. [PMID: 30185357 DOI: 10.5152/eurjrheum.2018.17091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 383 |
Babar F, Cohen SD. Thrombotic Microangiopathies with Rheumatologic Involvement. Rheum Dis Clin North Am 2018;44:635-49. [PMID: 30274628 DOI: 10.1016/j.rdc.2018.06.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 384 |
Tanıgör G, Karabulut G, Çelebisoy N, Eraslan C, Zihni FY. Stroke presenting with an isolated foot drop in a patient with antiphospholipid syndrome: an uncommon clinical entity. Neurol Sci 2019;40:193-4. [PMID: 30171369 DOI: 10.1007/s10072-018-3552-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 385 |
Wang C, Guan X. Laboratory diagnosis of antiphospholipid syndrome. Frontiers in Laboratory Medicine 2018;2:97-101. [DOI: 10.1016/j.flm.2018.08.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 386 |
Bertlich I, Enk A, Toberer F. Schmerzhafte rezidivierende Ulzerationen am Bein. Hautarzt 2018;69:773-775. [DOI: 10.1007/s00105-018-4138-1] [Reference Citation Analysis]
|
| 387 |
Paule R, Morel N, Le Guern V, Fredi M, Coutte L, Belhocine M, Mouthon L, le Jeunne C, Chauvin A, Piette J, Costedoat-chalumeau N. Classification of primary antiphospholipid syndrome as systemic lupus erythematosus: Analysis of a cohort of 214 patients. Autoimmunity Reviews 2018;17:866-72. [DOI: 10.1016/j.autrev.2018.03.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 388 |
Ruffatti A, De Silvestro G, Marson P, Tonello M, Calligaro A, Favaro M, Del Ross T, Hoxha A, Mattia E, Pengo V. Catastrophic antiphospholipid syndrome: Lessons from 14 cases successfully treated in a single center. A narrative report. Journal of Autoimmunity 2018;93:124-30. [DOI: 10.1016/j.jaut.2018.07.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 389 |
Noureldine MHA, Nour-Eldine W, Khamashta MA, Uthman I. Insights into the diagnosis and pathogenesis of the antiphospholipid syndrome. Semin Arthritis Rheum 2019;48:860-6. [PMID: 30217394 DOI: 10.1016/j.semarthrit.2018.08.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 390 |
Mendoza-Pinto C, García-Carrasco M, Cervera R. Role of Infectious Diseases in the Antiphospholipid Syndrome (Including Its Catastrophic Variant). Curr Rheumatol Rep 2018;20:62. [PMID: 30123926 DOI: 10.1007/s11926-018-0773-x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 10.2] [Reference Citation Analysis]
|
| 391 |
Gerardi MC, Fernandes MA, Tincani A, Andreoli L. Obstetric Anti-phospholipid Syndrome: State of the Art. Curr Rheumatol Rep 2018;20:59. [PMID: 30105597 DOI: 10.1007/s11926-018-0772-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 392 |
Kadoya Y, Zen K, Oda Y, Matoba S. Successful Endovascular Treatment for Aortic Thrombosis Due to Primary Antiphospholipid Syndrome: A Case Report and Literature Review. Vasc Endovascular Surg 2019;53:51-7. [PMID: 30092725 DOI: 10.1177/1538574418791355] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 393 |
Cervera R, Rodríguez-pintó I, Espinosa G. The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: A comprehensive review. Journal of Autoimmunity 2018;92:1-11. [DOI: 10.1016/j.jaut.2018.05.007] [Cited by in Crossref: 101] [Cited by in F6Publishing: 102] [Article Influence: 20.2] [Reference Citation Analysis]
|
| 394 |
Yoo J, Villanueva H, Kaliamurthy M, Kang J, Lwin L. Is It Coincidence or Consequence for a Case with Antiphospholipid Antibody Syndrome Overlapping SLE to Develop an Immune Complex Nephropathy Followed by a Nonimmune Complex Podocytopathy? Case Rep Nephrol 2018;2018:6746473. [PMID: 30140476 DOI: 10.1155/2018/6746473] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 395 |
Soe MH, Agarwal KA, Akough-Weir A. The Wolf Hidden behind the Clots: Catastrophic Antiphospholipid Antibody Syndrome. Case Rep Med 2018;2018:4693037. [PMID: 30123280 DOI: 10.1155/2018/4693037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 396 |
Billoir P, Miranda S, Damian L, Richard V, Benhamou Y, Le Cam Duchez V. Development of a thrombin generation test in cultured endothelial cells: Evaluation of the prothrombotic effects of antiphospholipid antibodies. Thromb Res 2018;169:87-92. [PMID: 30031291 DOI: 10.1016/j.thromres.2018.07.021] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 397 |
Yelnik CM, Lambert M, Drumez E, Le Guern V, Bacri JL, Guerra MM, Laskin CA, Branch DW, Sammaritano LR, Morel N, Guettrot-Imbert G, Launay D, Hachulla E, Hatron PY, Salmon JE, Costedoat-Chalumeau N. Bleeding complications and antithrombotic treatment in 264 pregnancies in antiphospholipid syndrome. Lupus 2018;27:1679-86. [PMID: 30016929 DOI: 10.1177/0961203318787032] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 398 |
Taylor A, Alakbarzade V, Chandratheva A, Simister R, Scully M. The Importance of the Full Blood Count in Cerebral Ischemia: A Review of 609 Consecutive Young Patients with Stroke and Transient Ischemic Attacks. J Stroke Cerebrovasc Dis 2018;27:2500-4. [PMID: 29983229 DOI: 10.1016/j.jstrokecerebrovasdis.2018.05.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 399 |
Xu J, Zhou Q, Jiang N, Liu Z, Gao H, Sui Y, Liu R, Liu P, Cui Y. Bilateral adrenal hemorrhage revealed antiphospholipid syndrome in a male patient: benefit from comprehensive treatment. Curr Med Res Opin 2018;34:2165-8. [PMID: 29985065 DOI: 10.1080/03007995.2018.1498778] [Reference Citation Analysis]
|
| 400 |
Mohammed MA, Rady SA, El-mokadem MO, Fadda SM. Echocardiographic findings in systemic lupus erythematosus and its relation to disease activity and damage index. The Egyptian Rheumatologist 2018;40:173-8. [DOI: 10.1016/j.ejr.2017.10.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 401 |
Ricarte IF, Dutra LA. Manifestações neurológicas da síndrome do anticorpo antifosfolipídio. Rev Paul Reumatol 2018. [DOI: 10.46833/reumatologiasp.2018.17.2.12-17] [Reference Citation Analysis]
|
| 402 |
Ugolini-lopes MR, Caleiro MTC. Manifestações critério e não critério na síndrome antifosfolípide. Rev Paul Reumatol 2018. [DOI: 10.46833/reumatologiasp.2018.17.2.7-11] [Reference Citation Analysis]
|
| 403 |
Tektonidou MG, Sfikakis PP, Kolovou G, Mavrogeni S. Stress perfusion Cardiac Magnetic Resonance in Patients with Antiphospholipid Syndrome. Mediterr J Rheumatol 2018;29:99-102. [PMID: 32185309 DOI: 10.31138/mjr.29.2.99] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 404 |
Schreiber K, Radin M, Sciascia S. Current insights in obstetric antiphospholipid syndrome. Curr Opin Obstet Gynecol 2017;29:397-403. [PMID: 28915160 DOI: 10.1097/GCO.0000000000000406] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 405 |
Sirinvaravong N, Rodriguez Ziccardi MC, Patnaik S, Shah M, Fernandez G, Aliling JN, Rubin A. Nonbacterial thrombotic endocarditis in a patient with primary antiphospholipid syndrome. Oxf Med Case Reports 2018;2018:omy024. [PMID: 29977578 DOI: 10.1093/omcr/omy024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 406 |
Belizna C, Stojanovich L, Cohen-Tervaert JW, Fassot C, Henrion D, Loufrani L, Nagy G, Muchardt C, Hasan M, Ungeheuer MN, Arnaud L, Alijotas-Reig J, Esteve-Valverde E, Nicoletti F, Saulnier P, Godon A, Reynier P, Chrétien JM, Damian L, Omarjee L, Mahé G, Pistorius MA, Meroni PL, Devreese K. Primary antiphospholipid syndrome and antiphospholipid syndrome associated to systemic lupus: Are they different entities? Autoimmun Rev 2018;17:739-45. [PMID: 29885541 DOI: 10.1016/j.autrev.2018.01.027] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 407 |
Di Minno MND, Emmi G, Ambrosino P, Scalera A, Tufano A, Cafaro G, Peluso R, Bettiol A, Di Scala G, Silvestri E, Prisco D. Subclinical atherosclerosis in asymptomatic carriers of persistent antiphospholipid antibodies positivity: A cross-sectional study. Int J Cardiol 2019;274:1-6. [PMID: 30454720 DOI: 10.1016/j.ijcard.2018.06.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 408 |
Turetz M, Sideris AT, Friedman OA, Triphathi N, Horowitz JM. Epidemiology, Pathophysiology, and Natural History of Pulmonary Embolism. Semin Intervent Radiol 2018;35:92-8. [PMID: 29872243 DOI: 10.1055/s-0038-1642036] [Cited by in Crossref: 57] [Cited by in F6Publishing: 42] [Article Influence: 11.4] [Reference Citation Analysis]
|
| 409 |
Francès C, Chasset F. Síndrome de anticuerpos antifosfolípidos. EMC - Dermatología 2018;52:1-12. [DOI: 10.1016/s1761-2896(18)92423-4] [Reference Citation Analysis]
|
| 410 |
Chighizola CB, Meroni PL. Thrombosis and Anti-phospholipid Syndrome: a 5-Year Update on Treatment. Curr Rheumatol Rep 2018;20:44. [PMID: 29850957 DOI: 10.1007/s11926-018-0741-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 411 |
Morris CA, Patel MJ, Fenves AZ, Masia R. Case 17-2018: A 40-Year-Old Woman with Leg Swelling and Abdominal Distention and Pain. N Engl J Med 2018;378:2124-32. [PMID: 29847754 DOI: 10.1056/NEJMcpc1712228] [Reference Citation Analysis]
|
| 412 |
Gergianaki I, Bertsias G. Systemic Lupus Erythematosus in Primary Care: An Update and Practical Messages for the General Practitioner. Front Med (Lausanne) 2018;5:161. [PMID: 29896474 DOI: 10.3389/fmed.2018.00161] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 413 |
Ricarte IF, Dutra LA, Abrantes FF, Toso FF, Barsottini OGP, Silva GS, de Souza AWS, Andrade D. Neurologic manifestations of antiphospholipid syndrome. Lupus 2018;27:1404-14. [DOI: 10.1177/0961203318776110] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 414 |
Sahebari M, Rastin M, Boostani R, Forughipour M, Hashemzadeh K, Sadeghi SH. Subtypes of Antiphospholipid Antibodies in Neurologic Disorders: An Observational Study. Curr Rheumatol Rev 2019;15:59-66. [PMID: 29756580 DOI: 10.2174/1573397114666180514125412] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 415 |
Rottenstreich A, Arad A, Terespolsky H, Elchalal U, Amsalm H, Roth B, Kalish Y. Antiphospholipid antibody profile-based outcome of purely vascular and purely obstetric antiphospholipid syndrome. J Thromb Thrombolysis 2018;46:166-73. [DOI: 10.1007/s11239-018-1672-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 416 |
Chaturvedi S, McCrae KR. Clinical Risk Assessment in the Antiphospholipid Syndrome: Current Landscape and Emerging Biomarkers. Curr Rheumatol Rep 2017;19:43. [PMID: 28711993 DOI: 10.1007/s11926-017-0668-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 417 |
Flores-silva FD, Longoria-lozano O, Aguirre-villarreal D, Sentíes-madrid H, Vega-boada F, Díaz de León-sánchez E, Murra-antón S, Morales-moreno S, Quintanilla-gonzález L, Fragoso-loyo H, Guraieb-chaín P, Higuera-calleja J, Ceballos-ceballos J, Treviño-frenk I, González-duarte A, Dávila-maldonado L, Cantú-brito C, Valdés-ferrer SI. Natural history of longitudinally extensive transverse myelitis in 35 Hispanic patients with systemic lupus erythematosus: good short-term functional outcome and paradoxical increase in long-term mortality. Lupus 2018;27:1279-86. [DOI: 10.1177/0961203318770015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 418 |
Stredny CM, Waugh JL. Autoimmune Movement Disorders in Children. Semin Pediatr Neurol 2018;25:92-112. [PMID: 29735121 DOI: 10.1016/j.spen.2017.12.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 419 |
Ruffatti A, Hoxha A, Favaro M, Tonello M, Colpo A, Cucchini U, Banzato A, Pengo V. Additional Treatments for High-Risk Obstetric Antiphospholipid Syndrome: a Comprehensive Review. Clin Rev Allergy Immunol 2017;53:28-39. [PMID: 27342460 DOI: 10.1007/s12016-016-8571-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 420 |
Mayer-Pickel K, Eberhard K, Lang U, Cervar-Zivkovic M. Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome-A Retrospective Analysis and a Review of Additional Treatment in Pregnancy. Clin Rev Allergy Immunol 2017;53:54-67. [PMID: 27395067 DOI: 10.1007/s12016-016-8569-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 421 |
Stefanski AL, Specker C, Fischer-Betz R, Henrich W, Schleussner E, Dörner T. Maternal Thrombophilia and Recurrent Miscarriage - Is There Evidence That Heparin is Indicated as Prophylaxis against Recurrence? Geburtshilfe Frauenheilkd 2018;78:274-82. [PMID: 29576632 DOI: 10.1055/s-0044-100919] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 422 |
Go EJL, O'Neil KM. The catastrophic antiphospholipid syndrome in children. Curr Opin Rheumatol 2017;29:516-22. [PMID: 28632503 DOI: 10.1097/BOR.0000000000000426] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 423 |
Sadick V, Lane S, Fischer E, Seppelt I, Shetty A, McLean A. Post-partum catastrophic antiphospholipid syndrome presenting with shock and digital ischaemia - A diagnostic and management challenge. J Intensive Care Soc 2018;19:357-64. [PMID: 30515245 DOI: 10.1177/1751143718762343] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 424 |
Martinelli I, Abbattista M, Bucciarelli P, Tripodi A, Artoni A, Gianniello F, Novembrino C, Peyvandi F. Recurrent thrombosis in patients with antiphospholipid antibodies treated with vitamin K antagonists or rivaroxaban. Haematologica 2018;103:e315-7. [PMID: 29519861 DOI: 10.3324/haematol.2017.185132] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 425 |
Yang HK, Moon KW, Ji MJ, Han SB, Hwang JM. Primary antiphospholipid syndrome presenting with homonymous quadrantanopsia. Am J Ophthalmol Case Rep 2018;10:208-10. [PMID: 29552669 DOI: 10.1016/j.ajoc.2018.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 426 |
Gadó K, Domján G. Antiphospholipid Syndrome and Thrombocytopenia. Thrombocytopenia 2018. [DOI: 10.5772/intechopen.72509] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 427 |
Rekvig OP. Systemic Lupus Erythematosus: Definitions, Contexts, Conflicts, Enigmas. Front Immunol 2018;9:387. [PMID: 29545801 DOI: 10.3389/fimmu.2018.00387] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 428 |
Carmel-Neiderman NN, Tanne D, Goren I, Rotman-Pikielny P, Levy Y. Classical and additional antiphospholipid antibodies in blood samples of ischemic stroke patients and healthy controls. Immunol Res 2017;65:470-6. [PMID: 28116653 DOI: 10.1007/s12026-017-8897-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 429 |
Amengual O, Atsumi T. Antiphospholipid syndrome, "the best prophet of the future". Mod Rheumatol 2018;28:409-16. [PMID: 29385876 DOI: 10.1080/14397595.2018.1435988] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 430 |
Chighizola CB, Andreoli L, Gerosa M, Tincani A, Ruffatti A, Meroni PL. The treatment of anti-phospholipid syndrome: A comprehensive clinical approach. J Autoimmun 2018;90:1-27. [PMID: 29449131 DOI: 10.1016/j.jaut.2018.02.003] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 9.6] [Reference Citation Analysis]
|
| 431 |
El Hadidi KT, Medhat BM, Abdel Baki NM, Abdel Kafy H, Abdelrahaman W, Yousri AY, Attia DH, Eissa M, El Dessouki D, Elgazzar I, Elgengehy FT, El Ghobashy N, El Hadary H, El Mardenly G, El Naggar H, El Nahas AM, El Refai RM, El Rwiny HA, Elsman RM, Galal M, Ghoniem S, Maged LA, Sally SM, Naji H, Saad S, Shaaban M, Sharaf M, Sobhy N, Soliman RM, El Hadidi TS. Characteristics of systemic lupus erythematosus in a sample of the Egyptian population: a retrospective cohort of 1109 patients from a single center. Lupus 2018;27:1030-8. [DOI: 10.1177/0961203317751856] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 432 |
Savey L, Piette J, Bellanger J, Palazzo L, Amoura Z, Sauvanet A, Pouget-abadie J, Sogni P, Emmerich J, Costedoat-chalumeau N. Catastrophic antiphospholipid syndrome (CAPS)-induced ischemic pancreatic ducts injury mimicking intraductal papillary mucinous neoplasm (IPMN). Seminars in Arthritis and Rheumatism 2018;47:565-8. [DOI: 10.1016/j.semarthrit.2017.07.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 433 |
Silver RM. Catastrophic antiphospholipid syndrome and pregnancy. Semin Perinatol 2018;42:26-32. [PMID: 29179957 DOI: 10.1053/j.semperi.2017.11.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 434 |
Nazir S, Tachamo N, Lohani S, Hingorani R, Poudel DR, Donato A. Acute myocardial infarction and antiphospholipid antibody syndrome: a systematic review. Coron Artery Dis 2017;28:332-5. [PMID: 28225386 DOI: 10.1097/MCA.0000000000000476] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 435 |
Pontara E, Banzato A, Bison E, Cattini MG, Baroni G, Denas G, Calligaro A, Marson P, Tison T, Ruffatti A, Pengo V. Thrombocytopenia in high-risk patients with antiphospholipid syndrome. J Thromb Haemost 2018;16:529-32. [DOI: 10.1111/jth.13947] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 436 |
Schreiber K, Sciascia S, de Groot PG, Devreese K, Jacobsen S, Ruiz-Irastorza G, Salmon JE, Shoenfeld Y, Shovman O, Hunt BJ. Antiphospholipid syndrome. Nat Rev Dis Primers 2018;4:17103. [PMID: 29321641 DOI: 10.1038/nrdp.2017.103] [Cited by in Crossref: 164] [Cited by in F6Publishing: 174] [Article Influence: 32.8] [Reference Citation Analysis]
|
| 437 |
Sadetski M, Tourinho Moretto ML, Correia de Araujo RP, de Carvalho JF. Frequency of psychological alterations in primary antiphospholipid syndrome: preliminary study. Lupus 2018;27:837-40. [PMID: 29301475 DOI: 10.1177/0961203317751063] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 438 |
Radin M, Ugolini-Lopes MR, Sciascia S, Andrade D. Extra-criteria manifestations of antiphospholipid syndrome: Risk assessment and management. Semin Arthritis Rheum 2018;48:117-20. [PMID: 29395258 DOI: 10.1016/j.semarthrit.2017.12.006] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 439 |
. High-Risk Pregnancy. 2018. [DOI: 10.1017/9781108349185] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 440 |
Stojanovich L, Djokovic A, Stanisavljevic N, Zdravkovic M. The cutaneous manifestations are significantly related to cerebrovascular in a Serbian cohort of patients with Hughes syndrome. Lupus 2017;27:858-63. [DOI: 10.1177/0961203317751065] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 441 |
Liew J, Friedman M, Desai S, Taute L, Neishaboori N, Stenzel P, Wanchu A. Catastrophic antiphospholipid syndrome in a patient with systemic sclerosis and hereditary angioedema: case report and literature review. Modern Rheumatology Case Reports 2018;2:33-38. [DOI: 10.1080/24725625.2017.1351049] [Reference Citation Analysis]
|
| 442 |
Mohamed-hussein A, Makhlouf H, Hashem S. Catastrophic antiphospholipid lung syndrome in young female with repeated abortions. Lung India 2018;35:85. [DOI: 10.4103/lungindia.lungindia_254_17] [Reference Citation Analysis]
|
| 443 |
Yasuda S. Prognosis of Neuropsychiatric Systemic Lupus Erythematosus. Neuropsychiatric Systemic Lupus Erythematosus 2018. [DOI: 10.1007/978-3-319-76496-2_12] [Reference Citation Analysis]
|
| 444 |
Ragab G, Ruff W, Pearson D, Goubran H, Kriegel M. Antiphospholipid Syndrome. The Microbiome in Rheumatic Diseases and Infection 2018. [DOI: 10.1007/978-3-319-79026-8_22] [Reference Citation Analysis]
|
| 445 |
May JE, Marques MB. Therapeutic Apheresis for Hematologic Emergencies. Hematologic Challenges in the Critically Ill 2018. [DOI: 10.1007/978-3-319-93572-0_18] [Reference Citation Analysis]
|
| 446 |
Abe N, Atsumi T. Antiphospholipid syndrome. Nihon Kessen Shiketsu Gakkaishi 2018;29:294-306. [DOI: 10.2491/jjsth.29.294] [Reference Citation Analysis]
|
| 447 |
Joste V, Dragon-durey M, Darnige L. Diagnostic biologique du syndrome des antiphospholipides : des critères à la pratique. La Revue de Médecine Interne 2018;39:34-41. [DOI: 10.1016/j.revmed.2017.02.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 448 |
Nagalla S, Shen Y. Thrombophilia. Cardiovascular Thrombus 2018. [DOI: 10.1016/b978-0-12-812615-8.00037-5] [Reference Citation Analysis]
|
| 449 |
Stöcker W, Schlumberger W. Autoantikörper gegen Cardiolipin. Lexikon der Medizinischen Laboratoriumsdiagnostik 2018. [DOI: 10.1007/978-3-662-49054-9_360-1] [Reference Citation Analysis]
|
| 450 |
Stöcker W, Schlumberger W. Autoantikörper gegen Phospholipide. Lexikon der Medizinischen Laboratoriumsdiagnostik 2018. [DOI: 10.1007/978-3-662-49054-9_434-1] [Reference Citation Analysis]
|
| 451 |
Adoue D. Lupus érythémateux disséminé et syndrome des anticorps anti-phospholipides. Rhumatologie pour le Praticien 2018. [DOI: 10.1016/b978-2-294-74832-5.00040-3] [Reference Citation Analysis]
|
| 452 |
Wincup C, Ioannou Y. The Differences Between Childhood and Adult Onset Antiphospholipid Syndrome. Front Pediatr 2018;6:362. [PMID: 30542645 DOI: 10.3389/fped.2018.00362] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 453 |
Makarenko EV. ANTIPHOSPHOLIPID SYNDROME. jour 2017. [DOI: 10.51523/2708-6011.2017-14-4-1] [Reference Citation Analysis]
|
| 454 |
Galli M. Phospholipid inhibitors: State of the Art. Hamostaseologie 2017;31:243-50. [DOI: 10.5482/ha-1165] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 455 |
Mora-Ramirez M, Gonzalez-Pacheco H, Amezcua-Guerra LM. The Impact of Primary Antiphospholipid Syndrome on Long-term Cardiovascular Outcomes After Percutaneous Coronary Intervention and Stenting in Patients With Myocardial Infarction. J Clin Rheumatol 2018;24:169-73. [PMID: 29239935 DOI: 10.1097/RHU.0000000000000651] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 456 |
Radin M, Schreiber K, Cecchi I, Roccatello D, Cuadrado MJ, Sciascia S. The risk of ischaemic stroke in primary antiphospholipid syndrome patients: a prospective study. Eur J Neurol 2018;25:320-5. [PMID: 29082583 DOI: 10.1111/ene.13499] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 457 |
Breen K. The Antiphospholipid Syndrome. Handbook of Venous Thromboembolism 2017. [DOI: 10.1002/9781119095606.ch8] [Reference Citation Analysis]
|
| 458 |
Engel B, Müller G, Roch B, Schröder HE, Aringer M, Bornstein SR, Morawietz H. Serum of patients with antiphospholipid syndrome induces adhesion molecules in endothelial cells. Atheroscler Suppl 2017;30:141-8. [PMID: 29096830 DOI: 10.1016/j.atherosclerosissup.2017.05.039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 459 |
Graf J. Central Nervous System Manifestations of Antiphospholipid Syndrome. Rheumatic Disease Clinics of North America 2017;43:547-60. [DOI: 10.1016/j.rdc.2017.06.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 460 |
da Silva Saraiva S, de Moraes Mazetto B, Quinteiro Tobaldine L, Pereira Colella M, Vinícius De Paula E, Annichinno-Bizzachi J, Andrade Orsi F. The impact of antibody profile in thrombosis associated with primary antiphospholipid syndrome. Am J Hematol 2017;92:1163-9. [PMID: 28762539 DOI: 10.1002/ajh.24875] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 461 |
İlgen U, Yayla ME, Ateş A, Okatan İE, Yurteri EU, Torgutalp M, Keleşoğlu ABD, Turgay TM, Kınıklı G. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus. Lupus 2018;27:665-9. [PMID: 29050535 DOI: 10.1177/0961203317734924] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 462 |
Bala MM, Celinska-Lowenhoff M, Szot W, Padjas A, Kaczmarczyk M, Swierz MJ, Undas A. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome. Cochrane Database Syst Rev 2017;10:CD012169. [PMID: 28968483 DOI: 10.1002/14651858.CD012169.pub2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 463 |
Grosso G, Vikerfors A, Woodhams B, Adam M, Bremme K, Holmström M, Ågren A, Eelde A, Bruzelius M, Svenungsson E, Antovic A. Thrombin activatable fibrinolysis inhibitor (TAFI) — A possible link between coagulation and complement activation in the antiphospholipid syndrome (APS). Thrombosis Research 2017;158:168-73. [DOI: 10.1016/j.thromres.2017.06.028] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 464 |
Abdel-Wahab N, Talathi S, Lopez-Olivo MA, Suarez-Almazor ME. Risk of developing antiphospholipid antibodies following viral infection: a systematic review and meta-analysis. Lupus 2018;27:572-83. [PMID: 28945149 DOI: 10.1177/0961203317731532] [Cited by in Crossref: 78] [Cited by in F6Publishing: 86] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 465 |
Krasselt M, Baerwald C. Sex, Symptom Severity, and Quality of Life in Rheumatology. Clinic Rev Allerg Immunol 2019;56:346-61. [DOI: 10.1007/s12016-017-8631-6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 466 |
Riolo M, Giussani G, Scaccabarozzi C, Lunghi A, Salmaggi A. A case of recurrent stroke due to late onset antiphospholipid syndrome. Neurol Sci 2017;38:2221-2. [PMID: 28780708 DOI: 10.1007/s10072-017-3070-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 467 |
Chaturvedi S, McCrae KR. Diagnosis and management of the antiphospholipid syndrome. Blood Rev 2017;31:406-17. [PMID: 28784423 DOI: 10.1016/j.blre.2017.07.006] [Cited by in Crossref: 75] [Cited by in F6Publishing: 76] [Article Influence: 12.5] [Reference Citation Analysis]
|
| 468 |
Ma J, Song H, Wei M, He Y. Clinical characteristics and thrombosis outcomes of paediatric antiphospholipid syndrome: analysis of 58 patients. Clin Rheumatol. 2018;37:1295-1303. [PMID: 28748509 DOI: 10.1007/s10067-017-3776-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 469 |
Noureldine MHA, Uthman I. Antiphospholipid (Hughes) syndrome: insights for orthopedics. Lupus 2018;27:3-5. [PMID: 28728512 DOI: 10.1177/0961203317722850] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 470 |
Yelnik CM, Urbanski G, Drumez E, Caron C, Maillard H, Morell-dubois S, Dubucquoi S, Launay D, Hachulla E, Hatron PY, Duhamel A, Lambert M. Anticoagulation withdrawal in antiphospholipid syndrome: a retrospective matched-control study. Lupus 2018;27:357-64. [DOI: 10.1177/0961203317721751] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 471 |
Abrahams VM, Chamley LW, Salmon JE. Emerging Treatment Models in Rheumatology: Antiphospholipid Syndrome and Pregnancy: Pathogenesis to Translation. Arthritis Rheumatol 2017;69:1710-21. [PMID: 28445926 DOI: 10.1002/art.40136] [Cited by in Crossref: 62] [Cited by in F6Publishing: 62] [Article Influence: 10.3] [Reference Citation Analysis]
|
| 472 |
Shusterman M, Golub E, Mowrey WB, Broder A. The association between ABO blood types and venous thromboembolism in individuals with a positive antiphospholipid profile is varied by sex. Lupus 2017;27:319-26. [DOI: 10.1177/0961203317721352] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 473 |
Meng H, Yalavarthi S, Kanthi Y, Mazza LF, Elfline MA, Luke CE, Pinsky DJ, Henke PK, Knight JS. In Vivo Role of Neutrophil Extracellular Traps in Antiphospholipid Antibody-Mediated Venous Thrombosis. Arthritis Rheumatol 2017;69:655-67. [PMID: 27696751 DOI: 10.1002/art.39938] [Cited by in Crossref: 124] [Cited by in F6Publishing: 131] [Article Influence: 20.7] [Reference Citation Analysis]
|
| 474 |
Million M, Bardin N, Bessis S, Nouiakh N, Douliery C, Edouard S, Angelakis E, Bosseray A, Epaulard O, Branger S, Chaudier B, Blanc-Laserre K, Ferreira-Maldent N, Demonchy E, Roblot F, Reynes J, Djossou F, Protopopescu C, Carrieri P, Camoin-Jau L, Mege JL, Raoult D. Thrombosis and antiphospholipid antibody syndrome during acute Q fever: A cross-sectional study. Medicine (Baltimore) 2017;96:e7578. [PMID: 28723794 DOI: 10.1097/MD.0000000000007578] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 475 |
Stockinger T, Richter L, Kanzler M, Melichart-Kotik M, Pas H, Derfler K, Schmidt E, Rappersberger K. [Systemic lupus erythematosus : Unusual cutaneous manifestations]. Hautarzt 2016;67:970-81. [PMID: 27878308 DOI: 10.1007/s00105-016-3893-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 476 |
Kalatha T. Multiple Spinal Cord Infarction due to Primary Antiphospholipid Syndrome. JNSK 2017;7. [DOI: 10.15406/jnsk.2017.07.00226] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 477 |
Ibrahim U, Kedia S, Garcia G, Atallah JP. Antiphospholipid Syndrome: Multiple Manifestations in a Single Patient-A High Suspicion Is Still Needed. Case Rep Med 2017;2017:5797041. [PMID: 28620416 DOI: 10.1155/2017/5797041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 478 |
Salmon JE, Mineo C, Giles I, Chamley LW, Meroni PL, Abrahams VM. Mechanisms of Antiphospholipid Antibody-Mediated Pregnancy Morbidity. In: Erkan D, Lockshin MD, editors. Antiphospholipid Syndrome. Cham: Springer International Publishing; 2017. pp. 117-43. [DOI: 10.1007/978-3-319-55442-6_6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 479 |
Funke A, Danowski A, de Andrade DCO, Rêgo J, Levy RA. A importância de reconhecer a síndrome antifosfolípide na medicina vascular. J Vasc Bras 2017;16:140-9. [PMID: 29930638 DOI: 10.1590/1677-5449.011416] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 480 |
Taraborelli M, Reggia R, Dall'Ara F, Fredi M, Andreoli L, Gerosa M, Hoxha A, Massaro L, Tonello M, Costedoat-Chalumeau N, Cacoub P, Franceschini F, Meroni PL, Piette JC, Ruffatti A, Valesini G, Harris EN, Tincani A. Longterm Outcome of Patients with Primary Antiphospholipid Syndrome: A Retrospective Multicenter Study. J Rheumatol 2017;44:1165-72. [PMID: 28572466 DOI: 10.3899/jrheum.161364] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 481 |
Jabrane M, Ez-zahraoui MR, Hajji I, Fadili W, Moutaouakil A, Laouad I. Central retinal vein occlusion in a patient on hemodialysis secondary to antiphospholipid syndrome: Case report. Néphrologie & Thérapeutique 2017;13:245-7. [DOI: 10.1016/j.nephro.2016.07.455] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 482 |
Argobi Y, Smith GP. Cutaneous Manifestations of Connective Tissue Disease in the Inpatient Setting. Curr Derm Rep 2017;6:77-84. [DOI: 10.1007/s13671-017-0180-y] [Reference Citation Analysis]
|
| 483 |
Ito S, Hasuo T. Intravascular Images of Coronary Stenosis with Multiple Channels in a Patient with Antiphospholipid Syndrome: The Optical Coherence Tomography Findings. Intern Med 2017;56:1351-6. [PMID: 28566597 DOI: 10.2169/internalmedicine.56.7804] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 484 |
Meroni PL, Argolini LM, Pontikaki I. What is known about pediatric antiphospholipid syndrome? Expert Rev Hematol. 2016;9:977-985. [PMID: 27615277 DOI: 10.1080/17474086.2016.1235969] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 485 |
Oka S, Ono K, Nohgawa M. Successful Treatment of Catastrophic Antiphospholipid Antibody Syndrome Associated with MALT Lymphoma by Autologous Hematopoietic Stem Cell Transplantation. Intern Med 2017;56:1207-12. [PMID: 28502938 DOI: 10.2169/internalmedicine.56.7806] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 486 |
Lim W. Prevention of thrombosis in antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program 2016;2016:707-13. [PMID: 27913550 DOI: 10.1182/asheducation-2016.1.707] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 487 |
Mahale RR, Mehta A, Rangasetty S. Simultaneous Occurrence of Deep Vein Thrombosis and Carotid Artery Thrombosis in Antiphospholipid Antibody Syndrome. J Neurosci Rural Pract 2017;8:320-1. [PMID: 28479827 DOI: 10.4103/0976-3147.203827] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 488 |
Padricelli A, Giribono AM, Ferrara D, Spalla F, Bracale U, Del Guercio L, Servillo G, Ruotolo C, Bracale UM. Severe Mesenteric Ischemia in a Pregnant Woman with Antiphospholipid Syndrome. Ann Vasc Surg 2017;44:415.e11-6. [PMID: 28483615 DOI: 10.1016/j.avsg.2017.04.035] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 489 |
Cervera R. Antiphospholipid syndrome. Thromb Res 2017;151 Suppl 1:S43-7. [PMID: 28262233 DOI: 10.1016/S0049-3848(17)30066-X] [Cited by in Crossref: 134] [Cited by in F6Publishing: 99] [Article Influence: 22.3] [Reference Citation Analysis]
|
| 490 |
Demetrio Pablo R, Muñoz P, López-hoyos M, Calvo V, Riancho L, Martínez-taboada VM. Thrombocytopenia as a thrombotic risk factor in patients with antiphospholipid antibodies without disease criteria. Medicina Clínica (English Edition) 2017;148:394-400. [DOI: 10.1016/j.medcle.2017.04.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 491 |
Nageswara Rao AA, Elwood K, Kaur D, Warad DM, Rodriguez V. A retrospective review of pediatric antiphospholipid syndrome and thrombosis outcomes. Blood Coagul Fibrinolysis. 2017;28:205-210. [PMID: 27428014 DOI: 10.1097/mbc.0000000000000576] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 492 |
Tatapudi VS, Montgomery RA. Pharmacologic Complement Inhibition in Clinical Transplantation. Curr Transplant Rep 2017;4:91-100. [PMID: 29214126 DOI: 10.1007/s40472-017-0148-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 493 |
Kim BY, Chae JW, Kim H. Primary Antiphospholipid Syndrome Presenting as Bell Palsy without Cerebral Arterial Thrombosis. Korean J Med 2017;92:219-223. [DOI: 10.3904/kjm.2017.92.2.219] [Reference Citation Analysis]
|
| 494 |
Moroni L, Selmi C, Angelini C, Meroni PL. Evaluation of Endothelial Function by Flow-Mediated Dilation: a Comprehensive Review in Rheumatic Disease. Arch Immunol Ther Exp 2017;65:463-75. [DOI: 10.1007/s00005-017-0465-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 495 |
Pan S, O'Donnell J, Lemech LD, Roncolato F, Bonar F. Common femoral artery disease in antiphospholipid syndrome: histopathology. ANZ J Surg 2018;88:1203-4. [PMID: 28345183 DOI: 10.1111/ans.13793] [Reference Citation Analysis]
|
| 496 |
Song Y, Wang HY, Qiao J, Liu P, Chi HB. Antiphospholipid Antibody Titers and Clinical Outcomes in Patients with Recurrent Miscarriage and Antiphospholipid Antibody Syndrome: A Prospective Study. Chin Med J (Engl) 2017;130:267-72. [PMID: 28139508 DOI: 10.4103/0366-6999.198934] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 497 |
Khwaja J. Bilateral adrenal hemorrhage in the background of Escherichia coli sepsis: a case report. J Med Case Rep 2017;11:72. [PMID: 28302165 DOI: 10.1186/s13256-017-1236-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 498 |
Baroni G, Banzato A, Bison E, Denas G, Zoppellaro G, Pengo V. The role of platelets in antiphospholipid syndrome. Platelets 2017;28:762-6. [PMID: 28267395 DOI: 10.1080/09537104.2017.1280150] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 499 |
Yılmaz S, Yılmaz Z. Antiphospholipid Syndrome and the Lungs. EMJ 2017. [DOI: 10.33590/emj/10314430] [Reference Citation Analysis]
|
| 500 |
Valero Expósito M, Sobrino Grande C, Villalobos Sánchez L, García Villanueva M. Parestesias y cefalea en mujer de 39 años. Medicine - Programa de Formación Médica Continuada Acreditado 2017;12:1614.e1-1614.e4. [DOI: 10.1016/j.med.2017.02.009] [Reference Citation Analysis]
|
| 501 |
Sobrino Grande C, Villalobos Sánchez L, Valero Expósito M, García Villanueva M. Síndrome antifosfolípido. Medicine - Programa de Formación Médica Continuada Acreditado 2017;12:1551-1559. [DOI: 10.1016/j.med.2017.02.001] [Reference Citation Analysis]
|
| 502 |
Rumsey DG, Myones B, Massicotte P. Diagnosis and treatment of antiphospholipid syndrome in childhood: A review. Blood Cells Mol Dis 2017;67:34-40. [PMID: 28283251 DOI: 10.1016/j.bcmd.2017.02.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 503 |
Islam MA, Alam F, Gan SH, Cavestro C, Wong KK. Coexistence of antiphospholipid antibodies and cephalalgia. Cephalalgia 2018;38:568-80. [DOI: 10.1177/0333102417694881] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 504 |
Zaratzian C, Gouriet F, Tissot-dupont H, Casalta J, Million M, Bardin N, Grisoli D, Habib G, Raoult D. Antiphospholipid antibodies proposed in the diagnosis of infective endocarditis. Eur J Clin Microbiol Infect Dis 2017;36:1159-62. [DOI: 10.1007/s10096-017-2903-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 505 |
Gkogkolou P, Ehrchen J, Goerge T. Severe antiphospholipid antibody syndrome - response to plasmapheresis and rituximab. J Dermatolog Treat 2017;28:564-6. [PMID: 28084106 DOI: 10.1080/09546634.2017.1282599] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 506 |
Demetrio Pablo R, Muñoz P, López-Hoyos M, Calvo V, Riancho L, Martínez-Taboada VM. Thrombocytopenia as a thrombotic risk factor in patients with antiphospholipid antibodies without disease criteria. Med Clin (Barc) 2017;148:394-400. [PMID: 28153433 DOI: 10.1016/j.medcli.2016.11.026] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 507 |
Shi H, Teng J, Sun Y, Wu X, Hu Q, Liu H, Cheng X, Yin Y, Ye J, Chen PP, Yang C. Clinical characteristics and laboratory findings of 252 Chinese patients with anti-phospholipid syndrome: comparison with Euro-Phospholipid cohort. Clin Rheumatol 2017;36:599-608. [DOI: 10.1007/s10067-017-3549-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 508 |
Taraborelli M, Erkan D. Pregnancy-Related Challenges in Systemic Autoimmune Diseases. J Infus Nurs 2015;38:360-8. [PMID: 26339942 DOI: 10.1097/NAN.0000000000000124] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 509 |
Regina P, Pnina R, Natur A, Yair L. Anti-phospholipid syndrome associated with schizophrenia description of five patients and review of the literature. Immunol Res 2017;65:438-46. [DOI: 10.1007/s12026-017-8895-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 510 |
Anvari E, Ferreira Provenzano L, Nevares A, Herlitz L, Smith H. Lupus Nephritis (Including Antiphospholipid Antibody Syndrome), Adult. Glomerulonephritis 2017. [DOI: 10.1007/978-3-319-27334-1_14-1] [Reference Citation Analysis]
|
| 511 |
Ohhashi M, Takahashi H, Baba Y, Suzuki H, Horie K, Usui R, Ohkuchi A, Watanabe T, Matsubara S. Pregnancy-related thromboembolism and contributing risk factors: From 10 years of experience at a Japanese tertiary obstetrics institute. Hypertens Res Pregnancy 2017;5:59-64. [DOI: 10.14390/jsshp.hrp2017-012] [Reference Citation Analysis]
|
| 512 |
Noureldine MHA, Uthman I. Nonclassification Criteria Manifestations of the Antiphospholipid Syndrome. Handbook of Systemic Autoimmune Diseases 2017. [DOI: 10.1016/b978-0-444-63655-3.00009-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 513 |
Cervera R, Rodríguez-pintó I, Espinosa G, Reverter JC. Thrombotic Manifestations of the Antiphospholipid Syndrome. Handbook of Systemic Autoimmune Diseases 2017. [DOI: 10.1016/b978-0-444-63655-3.00006-5] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 514 |
Mekinian A, Kayem G, Cohen J, Carbillon L, Abisror N, Josselin-mahr L, Bornes M, Fain O. Le syndrome des antiphospholipides obstétrical : quelle est la place d’un traitement complémentaire à la combinaison aspirine et héparine ? Gynécologie Obstétrique Fertilité & Sénologie 2017;45:37-42. [DOI: 10.1016/j.gofs.2016.12.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 515 |
Rodriguez-pintó I, Espinosa G, Cervera R. Cardiac Involvement in the Antiphospholipid Syndrome. Handbook of Systemic Autoimmune Diseases 2017. [DOI: 10.1016/b978-0-12-803997-7.00012-0] [Reference Citation Analysis]
|
| 516 |
Carpenter JR, Branch DW. Collagen Vascular Diseases in Pregnancy. Obstetrics: Normal and Problem Pregnancies 2017. [DOI: 10.1016/b978-0-323-32108-2.00046-9] [Reference Citation Analysis]
|
| 517 |
Erkan D, Salmon JE, Lockshin MD. Anti-phospholipid Syndrome. Kelley and Firestein's Textbook of Rheumatology 2017. [DOI: 10.1016/b978-0-323-31696-5.00082-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 518 |
Soybilgic A, Aguiar CL, Massicotte MP, Kenet G, Yeh EA, Andreoli L, Avcin T, Myones BL. 15th International Congress on Antiphospholipid Antibodies Task Force on Pediatric Antiphospholipid Syndrome Report. Antiphospholipid Syndrome 2017. [DOI: 10.1007/978-3-319-55442-6_16] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 519 |
Zuily S, Barbhaiya M, Costenbader KH, Erkan D. 15th International Congress on Antiphospholipid Antibodies Task Force on Antiphospholipid Syndrome Classification Report. Antiphospholipid Syndrome 2017. [DOI: 10.1007/978-3-319-55442-6_15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 520 |
Larner AJ. Differential Diagnosis of TGA. Transient Global Amnesia 2017. [DOI: 10.1007/978-3-319-54476-2_3] [Reference Citation Analysis]
|
| 521 |
Ugolini-lopes MR, Criado PR, Parsi K, Kucukkaya RD, Amigo M, Tektonidou MG, Andrade D. Treatment of Non-criteria Manifestations in Antiphospholipid Syndrome. Antiphospholipid Syndrome 2017. [DOI: 10.1007/978-3-319-55442-6_13] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 522 |
Yelnik CM, Appenzeller S, Sanna G, Kozora E, Bertolaccini ML. Neuropsychiatric Manifestations of Antiphospholipid Syndrome. Antiphospholipid Syndrome 2017. [DOI: 10.1007/978-3-319-55442-6_10] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 523 |
Fasano S, Isenberg DA. Thrombocytopenia in the Antiphospholipid Syndrome. Handbook of Systemic Autoimmune Diseases 2017. [DOI: 10.1016/b978-0-444-63655-3.00008-9] [Reference Citation Analysis]
|
| 524 |
Dzhenina OV, Bogachev VY, Kirsanova TV. False-Positive Lupus Anticoagulant in the Patients Receiving Rivaroxabane. Flebol 2017;11:102. [DOI: 10.17116/flebo2017112102-107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 525 |
Ruiz-irastorza G, Khamashta M. Treatment of Thrombosis in Antiphospholipid Syndrome. Handbook of Systemic Autoimmune Diseases 2017. [DOI: 10.1016/b978-0-444-63655-3.00016-8] [Reference Citation Analysis]
|
| 526 |
Larner AJ. Investigation and Management of TGA. Transient Global Amnesia 2017. [DOI: 10.1007/978-3-319-54476-2_4] [Reference Citation Analysis]
|
| 527 |
Generali E, Folci M, Selmi C, Riboldi P. Immune-Mediated Heart Disease. Adv Exp Med Biol 2017;1003:145-71. [PMID: 28667558 DOI: 10.1007/978-3-319-57613-8_8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 528 |
Rodríguez-pintó I, Espinosa G, Cervera R. Digestive Involvement in the Antiphospholipid Syndrome. The Digestive Involvement in Systemic Autoimmune Diseases 2017. [DOI: 10.1016/b978-0-444-63707-9.00012-x] [Reference Citation Analysis]
|
| 529 |
Serrano RM, Pons-estel GJ, Espinosa G, Cervera R. Prognosis in Antiphospholipid Syndrome. Handbook of Systemic Autoimmune Diseases 2017. [DOI: 10.1016/b978-0-444-63655-3.00019-3] [Reference Citation Analysis]
|
| 530 |
Rauch J, Blank M, de Groot PG, Dupnik KM, Kriegel MA, Levine JS, Shoenfeld Y, Willis R. Origin of Antiphospholipid Antibodies. Antiphospholipid Syndrome 2017. [DOI: 10.1007/978-3-319-55442-6_3] [Reference Citation Analysis]
|
| 531 |
Toplak N, Avčin T. Paediatric Antiphospholipid Syndrome. Handbook of Systemic Autoimmune Diseases 2017. [DOI: 10.1016/b978-0-444-63655-3.00010-7] [Reference Citation Analysis]
|
| 532 |
Kazzaz NM, McCune WJ, Knight JS. Treatment of catastrophic antiphospholipid syndrome. Curr Opin Rheumatol 2016;28:218-27. [PMID: 26927441 DOI: 10.1097/BOR.0000000000000269] [Cited by in Crossref: 60] [Cited by in F6Publishing: 60] [Article Influence: 8.6] [Reference Citation Analysis]
|
| 533 |
Duronio A, Bajjoka I, Hsaiky L, Parasuraman R. Proposed Relationship Between Intravenous Immunoglobulin and Thrombosis in Renal Transplant Recipients. Ann Pharmacother 2007;41:354-8. [DOI: 10.1345/aph.1h434] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 534 |
Watson HG, Crowther M. Antiphospholipid Syndrome. Practical Hemostasis and Thrombosis 2016. [DOI: 10.1002/9781118344729.ch19] [Reference Citation Analysis]
|
| 535 |
Webster A, Pavord S. Obstetrics, Contraception, and Estrogen Replacement. Practical Hemostasis and Thrombosis 2016. [DOI: 10.1002/9781118344729.ch26] [Reference Citation Analysis]
|
| 536 |
Rosa JL. Atherosclerotic vascular disease in systemic lupus erythematosus and related disorders. Lupus 2006;15:35-8. [DOI: 10.1177/0961203306071676] [Reference Citation Analysis]
|
| 537 |
Tang N, Sun Z, Yin S. Characteristics of Chinese patients with antiphospholipid syndrome and the ability of lupus anticoagulant assays to identify them. Clin Chem Lab Med 2016;54:1787-91. [PMID: 27096780 DOI: 10.1515/cclm-2016-0129] [Reference Citation Analysis]
|
| 538 |
Manea P. New therapeutic strategies for recurrent deep vein thrombosis complicated to pulmonary embolism inside secondary antiphospholipid syndrome. Cardiologia Croatica 2016;11:518-518. [DOI: 10.15836/ccar2016.518] [Reference Citation Analysis]
|
| 539 |
Kozora E, Uluğ AM, Erkan D, Vo A, Filley CM, Ramon G, Burleson A, Zimmerman R, Lockshin MD. Functional Magnetic Resonance Imaging of Working Memory and Executive Dysfunction in Systemic Lupus Erythematosus and Antiphospholipid Antibody-Positive Patients: fMRI in SLE and aPL-Positive Patients. Arthritis Care & Research 2016;68:1655-63. [DOI: 10.1002/acr.22873] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 540 |
Pons-Estel GJ, Andreoli L, Scanzi F, Cervera R, Tincani A. The antiphospholipid syndrome in patients with systemic lupus erythematosus. J Autoimmun 2017;76:10-20. [PMID: 27776934 DOI: 10.1016/j.jaut.2016.10.004] [Cited by in Crossref: 83] [Cited by in F6Publishing: 88] [Article Influence: 11.9] [Reference Citation Analysis]
|
| 541 |
Chaturvedi S, McCrae KR. The antiphospholipid syndrome: still an enigma. Hematology Am Soc Hematol Educ Program 2015;2015:53-60. [PMID: 26637701 DOI: 10.1182/asheducation-2015.1.53] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 542 |
Petrosyan V, Carr RW, Milton T, Revington PJ. Hypercoagulopathy and dento-alveolar surgery: a case of exodontia in a patient with hughes' syndrome. Dent Update 2016;43:786-789. [DOI: 10.12968/denu.2016.43.8.786] [Reference Citation Analysis]
|
| 543 |
Sharp CA, Akram Q, Hughes M, Muir L, Herrick AL. Differential diagnosis of critical digital ischemia in systemic sclerosis: Report of five cases and review of the literature. Seminars in Arthritis and Rheumatism 2016;46:209-16. [DOI: 10.1016/j.semarthrit.2016.05.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 544 |
Rodríguez-Pintó I, Moitinho M, Santacreu I, Shoenfeld Y, Erkan D, Espinosa G, Cervera R; CAPS Registry Project Group (European Forum on Antiphospholipid Antibodies). Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry. Autoimmun Rev 2016;15:1120-4. [PMID: 27639837 DOI: 10.1016/j.autrev.2016.09.010] [Cited by in Crossref: 159] [Cited by in F6Publishing: 163] [Article Influence: 22.7] [Reference Citation Analysis]
|
| 545 |
Yelnik CM, Kozora E, Appenzeller S. Cognitive disorders and antiphospholipid antibodies. Autoimmun Rev 2016;15:1193-8. [PMID: 27639839 DOI: 10.1016/j.autrev.2016.09.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 546 |
Fredi M, Gregorini G, Zatti S, Lojacono A, Tincani A. Identifying and managing lupus nephritis during pregnancy. Expert Opinion on Orphan Drugs 2016;4:1021-31. [DOI: 10.1080/21678707.2016.1228452] [Reference Citation Analysis]
|
| 547 |
Franck M, Staub HL, Petracco JB, Norman GL, Lassen AJ, Schiavo N, Borges RBK, von Mühlen CA. Autoantibodies to the Atheroma Component Beta2-Glycoprotein I and Risk of Symptomatic Peripheral Artery Disease. Angiology 2007;58:295-302. [DOI: 10.1177/0003319707302493] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 548 |
Boura P, Tselios K, Skendros P, Kountouras J. Antiphospholipid Syndrome in Greece: Clinical and Immunological Study and Review of the Literature. Angiology 2004;55:421-30. [DOI: 10.1177/000331970405500409] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 549 |
White CW, Thomason AR, Boyd K. Role of Novel Oral Anticoagulants in the Treatment of Antiphospholipid Syndrome. Hosp Pharm 2016;51:759-67. [PMID: 27803506 DOI: 10.1310/hpj5109-759] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 550 |
Urolagin SS, Swaroop D, Agrawal C, Dholakia P, Karalwad MB. Management of phenytoin-induced gingival enlargement in a patient with antiphospholipid antibody syndrome: A rare case report. J Indian Soc Periodontol 2016;20:561-4. [PMID: 29242694 DOI: 10.4103/0972-124X.201693] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 551 |
Urbanus RT. Rivaroxaban to treat thrombotic antiphospholipid syndrome. The Lancet Haematology 2016;3:e403-4. [DOI: 10.1016/s2352-3026(16)30107-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 552 |
Bertolaccini ML, Khamashta MA. Laboratory diagnosis and management challenges in the antiphospholipid syndrome. Lupus 2006;15:172-8. [DOI: 10.1191/0961203306lu2293rr] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 553 |
van Leuven SI, Kastelein JJ, D’cruz DP, Hughes GR, Stroes ES. Atherogenesis in rheumatology. Lupus 2006;15:117-21. [DOI: 10.1191/0961203306lu2273rr] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 554 |
Tincani A, Bompane D, Danieli E, Doria A. Pregnancy, lupus and antiphospholipid syndrome (Hughes syndrome). Lupus 2006;15:156-60. [DOI: 10.1191/0961203306lu2279rr] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 555 |
Burt J. Aortic Valve Thrombosis in Antiphospholipid Syndrome Causing Coronary Artery Embolic Disease. J Cardiovasc Med Cardiol 2016. [DOI: 10.17352/2455-2976.000028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 556 |
Wijeyaratne CN, Galappaththi S, Palipane E, Jayawardane D, Dodampahala SH, Tudawe MN, Gooneratne LV, de Silva R, Ratnayake D, Seneviratne SL. Pregnancy outcomes of antiphospholipid syndrome: In a low resource South Asian setting. Obstet Med 2016;9:83-9. [PMID: 27512499 DOI: 10.1177/1753495X16629300] [Reference Citation Analysis]
|
| 557 |
Kim KJ, Baek IW, Park KS, Kim WU, Cho CS. Association between antiphospholipid antibodies and arterial thrombosis in patients with rheumatoid arthritis. Lupus 2017;26:88-94. [PMID: 27510601 DOI: 10.1177/0961203316658557] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 558 |
Scholz P, Auler M, Brachvogel B, Benzing T, Mallman P, Streichert T, Klatt AR. Detection of multiple annexin autoantibodies in a patient with recurrent miscarriages, fulminant stroke and seronegative antiphospholipid syndrome. Biochem Med (Zagreb) 2016;26:272-8. [PMID: 27346975 DOI: 10.11613/BM.2016.032] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 559 |
Andreoli L, Bertsias GK, Agmon-Levin N, Brown S, Cervera R, Costedoat-Chalumeau N, Doria A, Fischer-Betz R, Forger F, Moraes-Fontes MF, Khamashta M, King J, Lojacono A, Marchiori F, Meroni PL, Mosca M, Motta M, Ostensen M, Pamfil C, Raio L, Schneider M, Svenungsson E, Tektonidou M, Yavuz S, Boumpas D, Tincani A. EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis 2017;76:476-85. [PMID: 27457513 DOI: 10.1136/annrheumdis-2016-209770] [Cited by in Crossref: 414] [Cited by in F6Publishing: 428] [Article Influence: 59.1] [Reference Citation Analysis]
|
| 560 |
Grenn RC, Yalavarthi S, Gandhi AA, Kazzaz NM, Núñez-Álvarez C, Hernández-Ramírez D, Cabral AR, McCune WJ, Bockenstedt PL, Knight JS. Endothelial progenitor dysfunction associates with a type I interferon signature in primary antiphospholipid syndrome. Ann Rheum Dis 2017;76:450-7. [PMID: 27432357 DOI: 10.1136/annrheumdis-2016-209442] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 561 |
Noureldine MHA, Harifi G, Berjawi A, Haydar AA, Nader M, Elnawar R, Sweid A, Al Saleh J, Khamashta MA, Uthman I. Hughes syndrome and epilepsy: when to test for antiphospholipid antibodies? Lupus 2016;25:1397-411. [DOI: 10.1177/0961203316651747] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 562 |
Martínez-Flores JA, Serrano M, Morales JM, Serrano A. Antiphospholipid Syndrome and Kidney Involvement: New Insights. Antibodies (Basel) 2016;5:E17. [PMID: 31557998 DOI: 10.3390/antib5030017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 563 |
Yamamoto Y, Aoki S. Systemic lupus erythematosus: strategies to improve pregnancy outcomes. Int J Womens Health 2016;8:265-72. [PMID: 27468250 DOI: 10.2147/IJWH.S90157] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 564 |
Specker C. [Antiphospholipid syndrome]. Z Rheumatol 2016;75:570-4. [PMID: 27383180 DOI: 10.1007/s00393-016-0153-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 565 |
El-Shereef RR, El-Abedin Z, Abdel Aziz R, Talat I, Saleh M, Abdel-Samia H, Sameh A, Sharha M. Catastrophic Antiphospholipid Syndrome. Case Rep Rheumatol 2016;2016:4161439. [PMID: 27375916 DOI: 10.1155/2016/4161439] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 566 |
Levy Y, Almog O, Gorshtein A, Shoenfeld Y. The environment and antiphospholipid syndrome. Lupus 2006;15:784-90. [DOI: 10.1177/0961203306071004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 567 |
Bordin G, Boldorini R, Meroni PL. The two hit hypothesis in the antiphospholipid syndrome: acute ischaemic heart involvement after valvular replacement despite anticoagulation in a patient with secondary APS. Lupus 2003;12:851-3. [DOI: 10.1191/0961203303lu445cr] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 568 |
Ruiz-irastorza G, Egurbide M, Martinez-berriotxoa A, Ugalde J, Aguirre C. Antiphospholipid antibodies predict early damage in patients with systemic lupus erythematosus. Lupus 2004;13:900-5. [DOI: 10.1191/0961203304lu2030oa] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 569 |
Tincani A, Biasini-rebaioli C, Cattaneo R, Riboldi P. Nonorgan specific autoantibodies and heart damage. Lupus 2005;14:656-9. [DOI: 10.1191/0961203305lu2194oa] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 570 |
Blank M, Aron-maor A, Shoenfeld Y. From rheumatic fever to Libman-Sacks endocarditis: is there any possible pathogenetic link? Lupus 2005;14:697-701. [DOI: 10.1191/0961203305lu2203oa] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 571 |
Meroni PL, Tincani A, Sepp N, Raschi E, Testoni C, Corsini E, Cavazzana I, Pellegrini S, Salmaggi A. Endothelium and the brain in CNS lupus. Lupus 2003;12:919-28. [DOI: 10.1191/0961203303lu503oa] [Cited by in Crossref: 81] [Cited by in F6Publishing: 84] [Article Influence: 11.6] [Reference Citation Analysis]
|
| 572 |
Bouaziz JD, Barete S, Le Pelletier F, Amoura Z, Piette JC, Francès C. Cutaneous lesions of the digits in systemic lupus erythematosus: 50 cases. Lupus 2007;16:163-7. [DOI: 10.1177/0961203306075792] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 573 |
Tarr T, Lakos G, Bhattoa HP, Shoenfeld Y, Szegedi G, Kiss E. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients. Lupus 2007;16:39-45. [DOI: 10.1177/0961203306074767] [Cited by in Crossref: 59] [Cited by in F6Publishing: 65] [Article Influence: 8.4] [Reference Citation Analysis]
|
| 574 |
Triolo G, Ferrante A, Accardo-palumbo A, Ciccia F, Cadelo M, Castelli A, Perino A, Licata G. IVIG in APS pregnancy. Lupus 2004;13:731-5. [DOI: 10.1191/0961203304lu2011oa] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 575 |
Motta M, Tincani A, Lojacono A, Faden D, Gorla R, Airò P, Neri F, Gasparoni A, Ciardelli L, de Silvestri A, Marconi M, Chirico G. Neonatal outcome in patients with rheumatic disease. Lupus 2004;13:718-23. [DOI: 10.1191/0961203403lu2002oa] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 576 |
Sangle SR, D’cruz DP. Renal artery stenosis: a new facet of the antiphospholipid (Hughes) syndrome. Lupus 2003;12:803-4. [DOI: 10.1191/0961203303lu493ed] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 577 |
Boehlen F, Bader M, de Moerloose P. Letter to the Editor. Lupus 2004;13:70-1. [DOI: 10.1191/0961203304lu481xx] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 578 |
Andrejevic S, Bonaci-nikolic B, Sefik-bukilica M, Petrovic R. Clinical and serological follow-up of 71 patients with anti-mitochondrial type 5 antibodies. Lupus 2007;16:788-93. [DOI: 10.1177/0961203307081913] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 579 |
Ideguchi H, Ohno S, Ueda A, Ishigatsubo Y. Catastrophic antiphospholipid syndrome associated with malignancies (case report and review of the literature). Lupus 2007;16:59-64. [DOI: 10.1177/0961203306073166] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 580 |
Moroni G, Ponticelli C. Pregnancy in women with systemic lupus erythematosus (SLE). European Journal of Internal Medicine 2016;32:7-12. [DOI: 10.1016/j.ejim.2016.04.005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 581 |
Bhattacharya M, Biswas A, Kannan M, Mishra P, Kumar A, Choudhry VP, Saxena R. Clinicohematologic Spectrum in Patientswith Lupus Anticoagulant. Clin Appl Thromb Hemost 2005;11:191-5. [DOI: 10.1177/107602960501100208] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 582 |
Nakakubo S, Sasaki D, Uetake K, Kobayashi I. Stroke During Norovirus Infection as the Initial Episode of Antiphospholipid Syndrome. Glob Pediatr Health 2016;3:2333794X15622771. [PMID: 27335993 DOI: 10.1177/2333794X15622771] [Reference Citation Analysis]
|
| 583 |
Manna R, Ricci V, Curigliano V, Pomponi M, Adamo F, Costa A, De Socio G, D'onofrio F, Gasbarrini G, Bria P. Psychiatric Manifestations as a Primary Symptom in Antiphospholipid Syndrome. Int J Immunopathol Pharmacol 2006;19:915-7. [DOI: 10.1177/039463200601900421] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 584 |
Zikos TA, Sokolove J, Ahuja N, Berube C. Eculizumab Induces Sustained Remission in a Patient With Refractory Primary Catastrophic Antiphospholipid Syndrome. J Clin Rheumatol 2015;21:311-3. [PMID: 26267719 DOI: 10.1097/RHU.0000000000000290] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 585 |
Parodis I, Arnaud L, Gerhardsson J, Zickert A, Sundelin B, Malmström V, Svenungsson E, Gunnarsson I. Antiphospholipid Antibodies in Lupus Nephritis. PLoS One 2016;11:e0158076. [PMID: 27336701 DOI: 10.1371/journal.pone.0158076] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 586 |
Negrini S, Pappalardo F, Murdaca G, Indiveri F, Puppo F. The antiphospholipid syndrome: from pathophysiology to treatment. Clin Exp Med 2017;17:257-67. [PMID: 27334977 DOI: 10.1007/s10238-016-0430-5] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 8.4] [Reference Citation Analysis]
|
| 587 |
Dhakal P, Gundabolu K, Bhatt VR. An Algorithmic Approach to Management of Venous Thromboembolism. Clin Appl Thromb Hemost 2017;23:511-7. [PMID: 27268941 DOI: 10.1177/1076029616652727] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 588 |
Marcantoni C, Emmanuele C, Scolari F. Renal involvement in primary antiphospholipid syndrome. J Nephrol 2016;29:507-15. [PMID: 27198137 DOI: 10.1007/s40620-016-0317-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 589 |
Islam MA, Alam F, Sasongko TH, Husin A, Abdullah S, Gan SH, Wong KK. Antiplatelet and anticoagulant agents for preventing recurrence of peripheral vascular thrombosis in patients with Antiphospholipid syndrome. Cochrane Database of Systematic Reviews 2016. [DOI: 10.1002/14651858.cd012198] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 590 |
Bala MM, Celinska-lowenhoff M, Padjas A, Szot W, Undas A. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome. Cochrane Database of Systematic Reviews 2016. [DOI: 10.1002/14651858.cd012169] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 591 |
Abdel-Wahab N, Lopez-Olivo MA, Pinto-Patarroyo GP, Suarez-Almazor ME. Systematic review of case reports of antiphospholipid syndrome following infection. Lupus 2016;25:1520-31. [PMID: 27060064 DOI: 10.1177/0961203316640912] [Cited by in Crossref: 72] [Cited by in F6Publishing: 80] [Article Influence: 10.3] [Reference Citation Analysis]
|
| 592 |
Esteve-valverde E, Ferrer-oliveras R, Alijotas-reig J. Obstetric antiphospholipid syndrome. Revista Clínica Española (English Edition) 2016;216:135-45. [DOI: 10.1016/j.rceng.2015.11.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 593 |
Rodriguez-pintó I, Espinosa G, Cervera R. Catastrophic antiphospholipid syndrome: The current management approach. Best Practice & Research Clinical Rheumatology 2016;30:239-49. [DOI: 10.1016/j.berh.2016.07.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 594 |
Esteve-valverde E, Ferrer-oliveras R, Alijotas-reig J. Síndrome antifosfolipídico obstétrico. Revista Clínica Española 2016;216:135-45. [DOI: 10.1016/j.rce.2015.09.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 595 |
Hoayek JG, Moussa HN, Rehman HA, Nasab SH, Blackwell SC, Sibai BM. Catastrophic antiphospholipid syndrome in pregnancy, a diagnosis that should not be missed. The Journal of Maternal-Fetal & Neonatal Medicine 2016;29:3950-5. [DOI: 10.3109/14767058.2016.1160047] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 596 |
Mackman N, Roubey RA. Is leukocyte tissue factor the key to venous thrombosis in antiphospholipid syndrome? J Thromb Haemost 2016;14:1008-10. [PMID: 26879261 DOI: 10.1111/jth.13296] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 597 |
Fujimoto M, Asano Y, Ishii T, Ogawa F, Kawakami T, Kodera M, Abe M, Isei T, Ito T, Inoue Y, Imafuku S, Irisawa R, Ohtsuka M, Ohtsuka M, Kadono T, Kawaguchi M, Kukino R, Kono T, Sakai K, Takahara M, Tanioka M, Nakanishi T, Nakamura Y, Hashimoto A, Hasegawa M, Hayashi M, Fujiwara H, Maekawa T, Matsuo K, Madokoro N, Yamasaki O, Yoshino Y, Le Pavoux A, Tachibana T, Ihn H; Wound/Burn Guidelines Committee. The wound/burn guidelines - 4: Guidelines for the management of skin ulcers associated with connective tissue disease/vasculitis. J Dermatol 2016;43:729-57. [PMID: 26972733 DOI: 10.1111/1346-8138.13275] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 598 |
Rezk M, Dawood R, Badr H. Maternal and fetal outcome in women with antiphospholipid syndrome: a three-year observational study. J Matern Fetal Neonatal Med 2016;29:4015-9. [PMID: 26856354 DOI: 10.3109/14767058.2016.1152254] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 599 |
Yelnik CM, Kozora E, Appenzeller S. Non-stroke Central Neurologic Manifestations in Antiphospholipid Syndrome. Curr Rheumatol Rep 2016;18. [DOI: 10.1007/s11926-016-0568-x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 600 |
Noureldine MHA, Khamashta MA, Merashli M, Sabbouh T, Hughes GRV, Uthman I. Musculoskeletal manifestations of the antiphospholipid syndrome. Lupus 2016;25:451-62. [DOI: 10.1177/0961203316636467] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 601 |
Yokoyama K, Mori M, Yoshida A. Mycophenolate mofetil therapy for two cases of antiphospholipid antibody-associated chorea. Modern Rheumatology 2018;28:709-11. [DOI: 10.3109/14397595.2015.1134035] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 602 |
Islam MA, Wong KK, Sasongko TH, Gan SH, Wong JS. Familial primary antiphospholipid syndrome: A report of co-occurrence in three Malaysian family members. Eur J Rheumatol 2016;3:139-41. [PMID: 27733946 DOI: 10.5152/eurjrheum.2015.0068] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 603 |
Murphy M, Harris N. Antiphospholipid Antibody Syndrome: Clinical Manifestations and Laboratory Diagnosis. Manual of Molecular and Clinical Laboratory Immunology 2016. [DOI: 10.1128/9781555818722.ch93] [Reference Citation Analysis]
|
| 604 |
Julian LJ, Filley CM. Rheumatologic and other autoimmune dementias. Non-Alzheimer's and Atypical Dementia 2016. [DOI: 10.1002/9781118797662.ch14] [Reference Citation Analysis]
|
| 605 |
Alba P, Gómez-puerta JA, Goycochea-robles MV, Amigo MC. Organ Damage and Quality of Life in Antiphospholipid Syndrome. Curr Rheumatol Rep 2016;18. [DOI: 10.1007/s11926-015-0556-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 606 |
Pillai VG. DVT and Pregnancy. Principles of Critical Care in Obstetrics 2016. [DOI: 10.1007/978-81-322-2686-4_20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 607 |
Lee HJ, Kang YM, Lee E, Jeong BJ, Jo YJ, Seong JS, Woo YM, Jeong KH. A Case of Azygos Vein Thombosis Associated with Transient Antiphospholipid Syndrome in Urinary Tract Infection with Escherichia coli. J Rheum Dis 2016;23:118. [DOI: 10.4078/jrd.2016.23.2.118] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 608 |
Chighizola CB, Borghi MO, Meroni PL. Antibodies and Diagnostic Tests in Antiphospholipid Syndrome. Systemic Lupus Erythematosus 2016. [DOI: 10.1016/b978-0-12-801917-7.00057-7] [Reference Citation Analysis]
|
| 609 |
Bagheri J, Bagheri A. Concurrence of pleural effusion and inferior vena cava thrombus in antiphospholipid syndrome complicated by intra-cardiac thrombus. Res Cardiovasc Med 2016;5:11. [DOI: 10.5812/cardiovascmed.33696] [Reference Citation Analysis]
|
| 610 |
Singer HS, Mink JW, Gilbert DL, Jankovic J. Chorea, Athetosis, and Ballism. Movement Disorders in Childhood 2016. [DOI: 10.1016/b978-0-12-411573-6.00010-3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 611 |
Gómez-puerta JA, Cervera R. Systemic Lupus Erythematosus and Antiphospholipid Syndrome. Connective Tissue Disease 2016. [DOI: 10.1007/978-3-319-24535-5_14] [Reference Citation Analysis]
|
| 612 |
Volpe BT. Pathogenesis of Tissue Injury in the Brain in Patients with Systemic Lupus Erythematosus. Systemic Lupus Erythematosus 2016. [DOI: 10.1016/b978-0-12-801917-7.00036-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 613 |
Avčin T, O'neil KM. Antiphospholipid Syndrome. Textbook of Pediatric Rheumatology 2016. [DOI: 10.1016/b978-0-323-24145-8.00024-7] [Cited by in Crossref: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 614 |
Kruczek K, Cooper K, Mai H, Nand S. Acquired Coagulation Disorders. Anticoagulation and Hemostasis in Neurosurgery 2016. [DOI: 10.1007/978-3-319-27327-3_8] [Reference Citation Analysis]
|
| 615 |
Ofer-Shiber S, Molad Y. Frequency of vascular and pregnancy morbidity in patients with low vs. moderate-to-high titers of antiphospholipid antibodies. Blood Coagul Fibrinolysis 2015;26:261-6. [PMID: 25526601 DOI: 10.1097/MBC.0000000000000218] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 616 |
Ünlü O, Zuily S, Erkan D. The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus. Eur J Rheumatol 2016;3:75-84. [PMID: 27708976 DOI: 10.5152/eurjrheum.2015.0085] [Cited by in Crossref: 90] [Cited by in F6Publishing: 97] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 617 |
Rao AN, Kazzaz NM, Knight JS. Do neutrophil extracellular traps contribute to the heightened risk of thrombosis in inflammatory diseases? World J Cardiol 2015;7:829-42. [PMID: 26730289 DOI: 10.4330/wjc.v7.i12.829] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 618 |
Aguiar CL, Soybilgic A, Avcin T, Myones BL. Pediatric antiphospholipid syndrome. Curr Rheumatol Rep. 2015;17:27. [PMID: 25854492 DOI: 10.1007/s11926-015-0504-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 619 |
Zhuravlyova L, Kharkiv National Medical University, Alexandrova N, Letik I, Kharkiv National Medical University, Kharkiv National Medical University. The peculiarities of differential diagnosis of systemic lupus erythematosus. Shidnoevr z vnutr simejnoi med 2015;2015:25-34. [DOI: 10.15407/internalmed2015.01.025] [Reference Citation Analysis]
|
| 620 |
Artim-Esen B, Diz-Küçükkaya R, İnanç M. The significance and management of thrombocytopenia in antiphospholipid syndrome. Curr Rheumatol Rep 2015;17:14. [PMID: 25740703 DOI: 10.1007/s11926-014-0494-8] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 621 |
Yelnik C, Lambert M, Hachulla E. Manifestations neurologiques centrales du syndrome des anticorps antiphospholipides. Pratique Neurologique - FMC 2015;6:245-253. [DOI: 10.1016/j.praneu.2015.10.010] [Reference Citation Analysis]
|
| 622 |
Saraiva SDS, Custódio IF, Mazetto BDM, Collela MP, de Paula EV, Appenzeller S, Annichino-bizzachi J, Orsi FA. Recurrent thrombosis in antiphospholipid syndrome may be associated with cardiovascular risk factors and inflammatory response. Thrombosis Research 2015;136:1174-8. [DOI: 10.1016/j.thromres.2015.10.029] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 623 |
Takei K, Sato M, Nakamura M, Shimizu H. Longitudinally extensive transverse myelitis with anti-NMDA receptor antibodies during a systemic lupus erythematosus flare-up. BMJ Case Rep 2015;2015:bcr2015212112. [PMID: 26611483 DOI: 10.1136/bcr-2015-212112] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 624 |
Greco A, Rizzo MI, De Virgilio A, Conte M, Gallo A, Attanasio G, Ruoppolo G, de Vincentiis M. Autoimmune epilepsy. Autoimmun Rev 2016;15:221-5. [PMID: 26626229 DOI: 10.1016/j.autrev.2015.11.007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 52] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 625 |
Pathak R, Khanal R, Aryal MR, Giri S, Karmacharya P, Pathak B, Acharya U, Bhatt VR. Sarcoidosis and Antiphospholipid Syndrome: A Systematic Review of Cases. N Am J Med Sci 2015;7:379-83. [PMID: 26605200 DOI: 10.4103/1947-2714.166213] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 626 |
Marcovecchio ML, Petrosino MI, Chiarelli F. Diabetes and epilepsy in children and adolescents. Curr Diab Rep 2015;15:21. [PMID: 25728403 DOI: 10.1007/s11892-015-0588-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 627 |
Sajjan VV, Lunge S, Swamy MB, Pandit AM. Livedo reticularis: A review of the literature. Indian Dermatol Online J 2015;6:315-21. [PMID: 26500860 DOI: 10.4103/2229-5178.164493] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 628 |
Sahin M, Oguz A, Tuzun D, Boysan SN, Mese B, Sahin H, Gul K. Primary Adrenal Failure due to Antiphospholipid Syndrome. Case Rep Endocrinol 2015;2015:161497. [PMID: 26583075 DOI: 10.1155/2015/161497] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 629 |
Artenjak A, Locatelli I, Brelih H, Simonič DM, Ulcova-Gallova Z, Swadzba J, Musial J, Iwaniec T, Stojanovich L, Conti F, Valesini G, Avčin T, Cohen Tervaert JW, Shoenfeld Y, Blank M, Ambrožič A, Sodin-Semrl S, Božič B, Čučnik S. Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I. Immunol Res 2015;61:35-44. [PMID: 25395339 DOI: 10.1007/s12026-014-8578-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 630 |
Nikolova-Vlahova MK, Nikolov KV, Baleva MP, Savov AS. Antiphospholipid antibodies in patients with upper-extremity deep vein thrombosis. Cent Eur J Immunol 2015;40:307-10. [PMID: 26648774 DOI: 10.5114/ceji.2015.54592] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
|
| 631 |
Mavrogeni SI, Sfikakis PP, Kitas GD, Kolovou G, Tektonidou MG. Cardiac involvement in antiphospholipid syndrome: The diagnostic role of noninvasive cardiac imaging. Semin Arthritis Rheum 2016;45:611-6. [PMID: 26616201 DOI: 10.1016/j.semarthrit.2015.09.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 632 |
Khan S. Antiphospholipid syndrome is an important modifiable risk factor of stroke in the young. Ann Indian Acad Neurol 2015;18:359-60. [PMID: 26425024 DOI: 10.4103/0972-2327.160058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 633 |
Dandroo JM, Mohsin N, Nabi F. Antiphospholipid antibody syndrome presenting as transverse myelitis. Egypt Rheumatol Rehabil 2015;42:204-206. [DOI: 10.4103/1110-161x.168209] [Reference Citation Analysis]
|
| 634 |
Shlebak A. Antiphospholipid syndrome presenting as cerebral venous sinus thrombosis: a case series and a review: Table 1. J Clin Pathol 2016;69:337-43. [DOI: 10.1136/jclinpath-2015-203077] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 635 |
Brock CO, Brohl AS, Običan SG. Incidence, pathophysiology, and clinical manifestations of antiphospholipid syndrome: REVIEW OF ANTIPHOSPHOLIPID SYNDROME. Birth Defect Res C 2015;105:201-8. [DOI: 10.1002/bdrc.21107] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 636 |
Skeik N, Soo-hoo SS, Porten BR, Graber J, Alden P, Cragg A, Alexander JQ, Rizvi A, Manunga JM, Garberich RF, Sullivan T. Arterial Embolisms and Thrombosis in Upper Extremity Ischemia. Vasc Endovascular Surg 2015;49:100-9. [DOI: 10.1177/1538574415596740] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 637 |
Arabidze GG, Shapchenko AV, Muslimova OV, Larina OY, Sorokoletov AM. Clinical case of rheumatoid arthritis with antiphospholipid antibody syndrome. CardioSomatics 2015;6:70-78. [DOI: 10.26442/cs45162] [Reference Citation Analysis]
|
| 638 |
Capilla-Geay E, Poyet R, Brocq FX, Pons F, Kerebel S, Foucault G, Jego C, Cellarier GR. [Acute anterior myocardial infarction as presenting feature of antiphospholipid syndrome related lupus arthritis]. Rev Med Interne 2016;37:371-4. [PMID: 26363818 DOI: 10.1016/j.revmed.2015.08.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 639 |
Reshetnyak TM, Seredavkina NV, Satybaldyeva MA, Nasonov EL, Reshetnyak VI. Liver transplantation in a patient with primary antiphospholipid syndrome and Budd-Chiari syndrome. World J Hepatol 2015;7:2229-36. [PMID: 26380049 DOI: 10.4254/wjh.v7.i19.2229] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 640 |
Del Ross T, Ruffatti A, Cuffaro S, Tonello M, Calligaro A, Favaro M, Facchinetti M, Hoxha A, Punzi L. The clinical relevance of the IgM isotype of antiphospholipid antibodies in the vascular antiphospholipid syndrome. Thromb Res 2015;136:883-6. [PMID: 26410418 DOI: 10.1016/j.thromres.2015.08.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 641 |
Hood DB, Snyder KR, Buckner TR, Hurley BL, Pitts KR, Lopez LR. Differential assay reactivity of immunglobulin A anti-ß2 glycoprotein I antibodies: implications for the clinical interpretation of antiphospholipid antibody testing. Eur J Rheumatol 2015;2:135-8. [PMID: 27708950 DOI: 10.5152/eurjrheum.2015.0012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 642 |
Forastiero R, Martinuzzo M. The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome. Expert Review of Clinical Immunology 2015;11:1255-63. [DOI: 10.1586/1744666x.2015.1080121] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 643 |
Foltyn Zadura A, Memon AA, Stojanovich L, Perricone C, Conti F, Valesini G, Bogdanovic G, Hillarp A, Shoenfeld Y, Sundquist J, Leffler J, Svensson PJ, Trouw LA, Blom AM. Factor H Autoantibodies in Patients with Antiphospholipid Syndrome and Thrombosis. J Rheumatol 2015;42:1786-93. [PMID: 26276971 DOI: 10.3899/jrheum.150185] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 644 |
Patsouras MD, Sikara MP, Grika EP, Moutsopoulos HM, Tzioufas AG, Vlachoyiannopoulos PG. Elevated expression of platelet-derived chemokines in patients with antiphospholipid syndrome. J Autoimmun 2015;65:30-7. [PMID: 26283469 DOI: 10.1016/j.jaut.2015.08.001] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 645 |
Guimarães LE, Baker B, Perricone C, Shoenfeld Y. Vaccines, adjuvants and autoimmunity. Pharmacol Res 2015;100:190-209. [PMID: 26275795 DOI: 10.1016/j.phrs.2015.08.003] [Cited by in Crossref: 107] [Cited by in F6Publishing: 84] [Article Influence: 13.4] [Reference Citation Analysis]
|
| 646 |
Poddighe D, Castelli L, Marseglia GL, Bruni P. A sudden onset of a pseudo-neurological syndrome after HPV-16/18 AS04-adjuvated vaccine: might it be an autoimmune/inflammatory syndrome induced by adjuvants (ASIA) presenting as a somatoform disorder? Immunol Res 2014;60:236-46. [PMID: 25388965 DOI: 10.1007/s12026-014-8575-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 647 |
Delgado MG, Rodríguez S, García R, Sánchez P, Sáiz A, Calleja S. Antiphospholipid Syndrome of Late Onset: A Difficult Diagnosis of a Recurrent Embolic Stroke. Journal of Stroke and Cerebrovascular Diseases 2015;24:e209-11. [DOI: 10.1016/j.jstrokecerebrovasdis.2015.04.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 648 |
Isert M, Miesbach W, Stoever G, Lindhoff-last E, Linnemann B. Screening for lupus anticoagulants in patients treated with vitamin K antagonists. Int Jnl Lab Hem 2015;37:758-65. [DOI: 10.1111/ijlh.12409] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 649 |
Amirthalingam S. Thrombosis in Haematological Disorders: Tailored Management Approaches. EMJ Hematol 2015. [DOI: 10.33590/emjhematol/10312317] [Reference Citation Analysis]
|
| 650 |
Stadler K, Mutzenbach JS, Kalss G, Sellner J, Al-Schameri AR, Trinka E, Killer-Oberpfalzer M. Therapeutic challenges after successful thrombectomy in a patient with an antiphospholipid syndrome associated M1-occlusion: A case report. Interv Neuroradiol 2015;21:598-602. [PMID: 26135672 DOI: 10.1177/1591019915590371] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 651 |
Espinosa G, Cervera R. Current treatment of antiphospholipid syndrome: lights and shadows. Nat Rev Rheumatol 2015;11:586-96. [PMID: 26122952 DOI: 10.1038/nrrheum.2015.88] [Cited by in Crossref: 83] [Cited by in F6Publishing: 85] [Article Influence: 10.4] [Reference Citation Analysis]
|
| 652 |
Hüzmeli C, Candan F, Koçkara AŞ, Alaygut D, Kayataş M. Upper extremity venous thrombosis associated with primary antiphospholipid syndrome and immunoglobulin M nephropathy in diabetes mellitus type II. Eur J Rheumatol 2018;5:145-6. [PMID: 30185366 DOI: 10.5152/eurjrheum.2015.0109] [Reference Citation Analysis]
|
| 653 |
Merashli M, Noureldine MH, Uthman I, Khamashta M. Antiphospholipid syndrome: an update. Eur J Clin Invest 2015;45:653-62. [PMID: 25851448 DOI: 10.1111/eci.12449] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 654 |
Rosenbaum AN, Anavekar NS, Ernste FC, Mankad SV, Le RJ, Manocha KK, Barsness GW. A case of catastrophic antiphospholipid syndrome: first report with advanced cardiac imaging using MRI. Lupus 2015;24:1338-41. [DOI: 10.1177/0961203315587960] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 655 |
Aggarwal A. Role of autoantibody testing. Best Pract Res Clin Rheumatol. 2014;28:907-920. [PMID: 26096093 DOI: 10.1016/j.berh.2015.04.010] [Cited by in Crossref: 34] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 656 |
Blank M, Cruz-tapias P. Antiphospholipid Syndrome and Vaccines. Vaccines and Autoimmunity 2015. [DOI: 10.1002/9781118663721.ch15] [Reference Citation Analysis]
|
| 657 |
Smyk DS, Sakkas LI, Shoenfeld Y, Bogdanos DP. Hepatitis B Vaccination and Autoimmunity. Vaccines and Autoimmunity 2015. [DOI: 10.1002/9781118663721.ch16] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 658 |
Sénant M, Rostane H, Fernani-Oukil F, Hosking F, Bellery F, Courchinoux A, Tartour E, Darnige L, Dragon-Durey MA. Increased Performances of the Biological Diagnosis of the Antiphospholipid Syndrome by the Use of a Multiplex Assay. J Immunol Res 2015;2015:983094. [PMID: 26065010 DOI: 10.1155/2015/983094] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 659 |
Chighizola CB, Ubiali T, Meroni PL. Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management-An Insight into Future Approaches. J Immunol Res 2015;2015:951424. [PMID: 26075289 DOI: 10.1155/2015/951424] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 660 |
Hamdani MA, Saud Al-Arfaj AR, Parvez K, Naseeb F, Ibrahim Ael F, Cal JH. Pulmonary manifestations of systemic lupus erythematosus patients with and without antiphospholipid syndrome. Pak J Med Sci 2015;31:70-5. [PMID: 25878617 DOI: 10.12669/pjms.311.6544] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 661 |
Ulcova-Gallova Z, Bibkova K, Micanova Z, Losan P, Babcova K. Possible Effect of Extended Use of Hormonal Contraception on Increased Levels of Antiphospholipid Antibodies in Infertile Women. Geburtshilfe Frauenheilkd 2015;75:251-4. [PMID: 25914418 DOI: 10.1055/s-0035-1545869] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 662 |
Lampropoulos K, Kotsas D, Iliopoulos T. Heart failure with complete recovery in a patient with systemic lupus erythematosus. Reumatologia 2015;53:49-52. [PMID: 27407226 DOI: 10.5114/reum.2015.50558] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 663 |
Zuily S, Rat AC, Regnault V, Kaminsky P, Mismetti P, Ninet J, Baillet N, Magy-Bertrand N, Pasquali JL, Lambert M, Pasquier E, Lorcerie B, Lecompte T, Guillemin F, Wahl D; TAC(I)T investigators. Impairment of quality of life in patients with antiphospholipid syndrome. Lupus 2015;24:1161-8. [PMID: 25862730 DOI: 10.1177/0961203315580871] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 664 |
Rosa RF, Ugolini-lopes MR, Zeinad-valim AK, D’amico E, Andrade D. Difficult Clinical Situations in the Antiphospholipid Syndrome. Curr Rheumatol Rep 2015;17. [DOI: 10.1007/s11926-015-0502-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 665 |
Wang QY, Ye XH, Ding J, Wu XK. Segmental small bowel necrosis associated with antiphospholipid syndrome: A case report. World J Gastroenterol 2015; 21(13): 4096-4100 [PMID: 25852299 DOI: 10.3748/wjg.v21.i13.4096] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 666 |
Ramos-Casals M, Brito-Zerón P, Kostov B, Sisó-Almirall A, Bosch X, Buss D, Trilla A, Stone JH, Khamashta MA, Shoenfeld Y. Google-driven search for big data in autoimmune geoepidemiology: analysis of 394,827 patients with systemic autoimmune diseases. Autoimmun Rev 2015;14:670-9. [PMID: 25842074 DOI: 10.1016/j.autrev.2015.03.008] [Cited by in Crossref: 92] [Cited by in F6Publishing: 77] [Article Influence: 11.5] [Reference Citation Analysis]
|
| 667 |
Specker C. Antiphospholipid-Syndrom. Z Rheumatol 2015;74:191-198. [DOI: 10.1007/s00393-014-1459-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 668 |
Rawlings CR, Fremlin GA, Nash J, Harding K. A rheumatology perspective on cutaneous vasculitis: assessment and investigation for the non-rheumatologist. Int Wound J 2016;13:17-21. [PMID: 25818263 DOI: 10.1111/iwj.12437] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 669 |
Rai R, Swetha T. Association of anti-phospholipid antibodies with connective tissue diseases. Indian Dermatol Online J 2015;6:89-91. [PMID: 25821728 DOI: 10.4103/2229-5178.153009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 670 |
Wang CY, Chyuan IT, Wang YL, Kuo MY, Chang CW, Wu KJ, Hsu PN, Nagasawa T, Wara-aswapati N, Chen YW. β2-Glycoprotein I-Dependent Anti-Cardiolipin Antibodies Associated With Periodontitis in Patients With Systemic Lupus Erythematosus. J Periodontol 2015;86:995-1004. [PMID: 25817824 DOI: 10.1902/jop.2015.140664] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 671 |
Amengual O, Fujita D, Ota E, Carmona L, Oku K, Sugiura-Ogasawara M, Murashima A, Atsumi T. Primary prophylaxis to prevent obstetric complications in asymptomatic women with antiphospholipid antibodies: a systematic review. Lupus 2015;24:1135-42. [PMID: 25813871 DOI: 10.1177/0961203315578765] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 672 |
Hawro T, Bogucki A, Krupińska-Kun M, Maurer M, Woźniacka A. Intractable headaches, ischemic stroke, and seizures are linked to the presence of anti-β2GPI antibodies in patients with systemic lupus erythematosus. PLoS One 2015;10:e0119911. [PMID: 25781014 DOI: 10.1371/journal.pone.0119911] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 673 |
Amigo MC, Goycochea-Robles MV, Espinosa-Cuervo G, Medina G, Barragán-Garfias JA, Vargas A, Jara LJ. Development and initial validation of a damage index (DIAPS) in patients with thrombotic antiphospholipid syndrome (APS). Lupus 2015;24:927-34. [PMID: 25767071 DOI: 10.1177/0961203315576858] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 674 |
Thayaparan AS, Lowe SA. Cutaneous pseudovasculitis, antiphospholipid syndrome and obstetric misadventure. Lupus 2015;24:1107-10. [PMID: 25748061 DOI: 10.1177/0961203315575588] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 675 |
Tun NT, Krishnamurthy M, Snyder R. Catastrophic antiphospholipid syndrome and heparin-induced thrombocytopenia-related diseases or chance association? Blood Coagulation & Fibrinolysis 2015;26:214-9. [DOI: 10.1097/mbc.0000000000000210] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 676 |
Denas G, Jose SP, Bracco A, Zoppellaro G, Pengo V. Antiphospholipid syndrome and the heart: A case series and literature review. Autoimmunity Reviews 2015;14:214-22. [DOI: 10.1016/j.autrev.2014.11.003] [Cited by in Crossref: 57] [Cited by in F6Publishing: 61] [Article Influence: 7.1] [Reference Citation Analysis]
|
| 677 |
Chaturvedi S, McCrae KR. Recent advances in the antiphospholipid antibody syndrome. Curr Opin Hematol 2014;21:371-9. [PMID: 25023470 DOI: 10.1097/MOH.0000000000000067] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 678 |
Sada PR, Cohen H, Isenberg D. The Pathophysiology of Antiphospholipid Syndrome. TOUNJ 2015;8:2-9. [DOI: 10.2174/1874303x01508010002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 679 |
Katikaneni M, Gangam M, Berney SM, Umer S. Antiphospholipid Syndrome (APS) - An Update on Clinical Features and Treatment Options. TOUNJ 2015;8:27-38. [DOI: 10.2174/1874303x01508020027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 680 |
Willis R, Gonzalez EB. Antiphospholipid Antibodies and APS Nephropathy. TOUNJ 2015;8:10-17. [DOI: 10.2174/1874303x01508020010] [Reference Citation Analysis]
|
| 681 |
Weitz IC. Complement the hemostatic system: an intimate relationship. Thromb Res 2014;133 Suppl 2:S117-21. [PMID: 24862131 DOI: 10.1016/S0049-3848(14)50020-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 682 |
Lee YH, Yang HM, Tahk SJ, Hong YS, Park JS, Seo KW, Choi YW, Noh CK. Recurrent stent thrombosis in a patient with antiphospholipid syndrome and dual anti-platelet therapy non-responsiveness. Korean Circ J 2015;45:71-6. [PMID: 25653707 DOI: 10.4070/kcj.2015.45.1.71] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 683 |
Rege S, Mackworth-young C. Antiphospholipid antibodies as biomarkers in psychiatry: review of psychiatric manifestations in antiphospholipid syndrome. Translational Developmental Psychiatry 2015;3:25452. [DOI: 10.3402/tdp.v3.25452] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 684 |
Lally L, Sammaritano LR. Vasculitis in Antiphospholipid Syndrome. Rheumatic Disease Clinics of North America 2015;41:109-23. [DOI: 10.1016/j.rdc.2014.09.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 685 |
Abreu MM, Danowski A, Wahl DG, Amigo MC, Tektonidou M, Pacheco MS, Fleming N, Domingues V, Sciascia S, Lyra JO. The relevance of “non-criteria” clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical Features. Autoimmun Rev. 2015;14:401-414. [PMID: 25641203 DOI: 10.1016/j.autrev.2015.01.002] [Cited by in Crossref: 153] [Cited by in F6Publishing: 160] [Article Influence: 19.1] [Reference Citation Analysis]
|
| 686 |
Pazzola G, Zuily S, Erkan D. The Challenge of Bleeding in Antiphospholipid Antibody-Positive Patients. Curr Rheumatol Rep 2015;17. [DOI: 10.1007/s11926-014-0481-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 687 |
Zuily S, Wahl D. Pulmonary Hypertension in Antiphospholipid Syndrome. Curr Rheumatol Rep 2015;17. [DOI: 10.1007/s11926-014-0478-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 688 |
Gu KM, Shin JW, Park IW. A case of antiphospholipid syndrome refractory to secondary anticoagulating prophylaxis after deep vein thrombosis-pulmonary embolism. Tuberc Respir Dis (Seoul) 2014;77:274-8. [PMID: 25580146 DOI: 10.4046/trd.2014.77.6.274] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 689 |
Barcellini W, Artusi C. Non-Thrombotic Hematologic Manifestations in APS. Antiphospholipid Antibody Syndrome 2015. [DOI: 10.1007/978-3-319-11044-8_10] [Reference Citation Analysis]
|
| 690 |
Rodríguez-pintó I, Espinosa G, Cervera R. The. Antiphospholipid Antibody Syndrome 2015. [DOI: 10.1007/978-3-319-11044-8_20] [Reference Citation Analysis]
|
| 691 |
Smukowska-gorynia A, Mularek-kubzdela T, Araszkiewicz A. Recurrent acute myocardial infarction as an initial manifestation of antiphospholipid syndrome: treatment and management. Blood Coagulation & Fibrinolysis 2015;26:91-4. [DOI: 10.1097/mbc.0000000000000141] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 692 |
Yilmaz S, Topcu F, Selimoglu Sen H, Yildirim Y, Yilmaz Z, Kara AV, Akgul Ozmen C. Primary Antiphospholipid Syndrome Associated with Pneumonia: A Case Report of a 16-Year-Old Male Patient. Case Reports in Pulmonology 2015;2015:1-4. [DOI: 10.1155/2015/249612] [Reference Citation Analysis]
|
| 693 |
Khamashta MA, Amigo M. Antiphospholipid syndrome. Rheumatology. Elsevier; 2015. pp. 1144-52. [DOI: 10.1016/b978-0-323-09138-1.00139-x] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 694 |
Nouh A, Speiser J, Biller J. Acquired neurocutaneous disorders. Handb Clin Neurol 2015;132:29-73. [PMID: 26564070 DOI: 10.1016/B978-0-444-62702-5.00003-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 695 |
Rahman A, Raimondo MG. Secondary Antiphospholipid Syndrome. Antiphospholipid Antibody Syndrome 2015. [DOI: 10.1007/978-3-319-11044-8_19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 696 |
Blank M, Israeli E, Cervera R. The Infectious Origin of the Anti-Phospholipid Syndrome. Infection and Autoimmunity 2015. [DOI: 10.1016/b978-0-444-63269-2.00045-3] [Reference Citation Analysis]
|
| 697 |
Coghlan JG, Schreiber B, D'cruz DP. The heart in rheumatic disease. Rheumatology 2015. [DOI: 10.1016/b978-0-323-09138-1.00035-8] [Reference Citation Analysis]
|
| 698 |
Alijotas-Reig J, Ferrer-Oliveras R, Ruffatti A, Tincani A, Lefkou E, Bertero MT, Coloma-Bazan E, de Carolis S, Espinosa G, Rovere-Querini P, Kuzenko A, Valverde EE, Robles A, Cervera R, Canti V, Fredi M, Gil-Aguado A, Lundelin K, Llurba E, Melnychuk T, Nalli C, Picardo E, Silvestro E, del Ross T, Farran-Codina I; (EUROAPS Study Group Collaborators). The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases. Autoimmun Rev 2015;14:387-95. [PMID: 25555817 DOI: 10.1016/j.autrev.2014.12.010] [Cited by in Crossref: 94] [Cited by in F6Publishing: 97] [Article Influence: 10.4] [Reference Citation Analysis]
|
| 699 |
Elebrashy I, Yousief E, Saif A. Primary anti-phospholipid antibody syndrome causing recurrent venous thrombosis and thrombocytopenia in a patient with Addison's disease. JRSM Open 2014;5:2054270414562985. [PMID: 25548656 DOI: 10.1177/2054270414562985] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 700 |
Poulton K, Ripoll VM, Pericleous C, Meroni PL, Gerosa M, Ioannou Y, Rahman A, Giles IP. Purified IgG from patients with obstetric but not IgG from non-obstetric antiphospholipid syndrome inhibit trophoblast invasion. Am J Reprod Immunol 2015;73:390-401. [PMID: 25469631 DOI: 10.1111/aji.12341] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 701 |
Kern RZ. Progress in Clinical Neurosciences: Migraine-Stroke: A Causal Relationship, but Which Direction? Can j neurol sci 2004;31:451-9. [DOI: 10.1017/s0317167100003620] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 702 |
Rodríguez-Sanz A, Martínez-Sánchez P, Prefasi D, Fuentes B, Pascual-Salcedo D, Blanco-Bañares MJ, Díez-Tejedor E. Antiphospholipid antibodies correlate with stroke severity and outcome in patients with antiphospholipid syndrome. Autoimmunity 2015;48:275-81. [PMID: 25434364 DOI: 10.3109/08916934.2014.988329] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 703 |
Ambrosino P, Lupoli R, Di Minno A, Iervolino S, Peluso R, Di Minno MN. Markers of cardiovascular risk in patients with antiphospholipid syndrome: a meta-analysis of literature studies. Ann Med 2014;46:693-702. [PMID: 25307359 DOI: 10.3109/07853890.2014.959559] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 704 |
Trichard S, Zamour C, Nicol A, Durel CA. Une ischémie mésentérique révélatrice d’un syndrome des antiphospholipides. Ann Fr Med Urgence 2014;4:403-406. [DOI: 10.1007/s13341-014-0479-2] [Reference Citation Analysis]
|
| 705 |
Zhu D, Fu J, Zhang Y, Li S, Zhang G, Guan Y, Dong Q. Neurological antiphospholipid syndrome: Clinical, neuroimaging, and pathological characteristics. Journal of the Neurological Sciences 2014;346:138-44. [DOI: 10.1016/j.jns.2014.08.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 706 |
Agmon-Levin N, Shoenfeld Y. The spectrum between antiphospholipid syndrome and systemic lupus erythematosus. Clin Rheumatol 2014;33:293-5. [PMID: 24435353 DOI: 10.1007/s10067-014-2486-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 707 |
Uthman I, Noureldine MHA, Berjawi A, Skaf M, Haydar AA, Merashli M, Hughes GRV. Hughes syndrome and Multiple sclerosis. Lupus 2015;24:115-21. [DOI: 10.1177/0961203314555539] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 708 |
Strakhan M, Hurtado-Sbordoni M, Galeas N, Bakirhan K, Alexis K, Elrafei T. 36-year-old female with catastrophic antiphospholipid syndrome treated with eculizumab: a case report and review of literature. Case Rep Hematol 2014;2014:704371. [PMID: 25389502 DOI: 10.1155/2014/704371] [Cited by in Crossref: 18] [Cited by in F6Publishing: 31] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 709 |
Bolleke E, Seferi S, Rroji M, Idrizi A, Barbullushi M, Thereska N. Exhausting multiple hemodialysis access failures. Med Arch 2014;68:361-3. [PMID: 25568574 DOI: 10.5455/medarh.2014.68.361-363] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 710 |
Chighizola CB, Gerosa M, Trespidi L, Di Giacomo A, Rossi F, Acaia B, Meroni PL. Update on the current recommendations and outcomes in pregnant women with antiphospholipid syndrome. Expert Review of Clinical Immunology 2014;10:1505-17. [DOI: 10.1586/1744666x.2014.968129] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 711 |
Ripoll VM, Lambrianides A, Pierangeli SS, Poulton K, Ioannou Y, Heywood WE, Mills K, Latchman DS, Isenberg DA, Rahman A, Giles IP. Changes in regulation of human monocyte proteins in response to IgG from patients with antiphospholipid syndrome. Blood 2014;124:3808-16. [PMID: 25301710 DOI: 10.1182/blood-2014-05-577569] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 712 |
Ahluwalia J, Sreedharanunni S, Kumar N, Masih J, Bose SK, Varma N, Varma S, Singh S. Thrombotic Primary Antiphospholipid Syndrome: the profile of antibody positivity in patients from North India. Int J Rheum Dis 2016;19:903-12. [DOI: 10.1111/1756-185x.12479] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 713 |
Salaun E, Bartoli MA, Soler R, Khibri H, Ebbo M, Bernit E, Flavian A, Harlé JR, Magnan PE, Sarlon-bartoli G. Severe Symptomatic Stenosis of Visceral and Renal Arteries Leading Primary Antiphospholipid Syndrome Diagnosis. Annals of Vascular Surgery 2014;28:1796.e9-1796.e13. [DOI: 10.1016/j.avsg.2014.04.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 714 |
Gordon O, Almagor Y, Fridler D, Mandel A, Qutteineh H, Yanir A, Reif S, Revel Vilk S. De novo neonatal antiphospholipid syndrome: A case report and review of the literature. Seminars in Arthritis and Rheumatism 2014;44:241-5. [DOI: 10.1016/j.semarthrit.2014.04.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 715 |
Pericleous C, Ripoll VM, Giles I, Ioannou Y. Laboratory tests for the antiphospholipid syndrome. Methods Mol Biol 2014;1134:221-35. [PMID: 24497366 DOI: 10.1007/978-1-4939-0326-9_17] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 716 |
Giannakopoulos B, Mirarabshahi P, Qi M, Weatherall C, Qi JC, Tanaka K, Millar E, Vonthethoff L, Gatto D, Spielman D, Krilis SA. Deletion of the antiphospholipid syndrome autoantigen β2 -glycoprotein I potentiates the lupus autoimmune phenotype in a Toll-like receptor 7-mediated murine model. Arthritis Rheumatol 2014;66:2270-80. [PMID: 24692206 DOI: 10.1002/art.38646] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 717 |
Georgopoulou S, Efraimidou S, Maclennan SJ, Ibrahim F, Cox T. Antiphospholipid (Hughes) syndrome: description of population and health-related quality of life (HRQoL) using the SF-36. Lupus 2015;24:174-9. [DOI: 10.1177/0961203314551809] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 718 |
Plavsic A, Miskovic R, Raskovic S, Bogic M, Bonaci Nikolic B. Systemic Lupus Erythematosus and Antiphospholipid Syndrome. Open Access Maced J Med Sci 2014;2:544-549. [DOI: 10.3889/oamjms.2014.098] [Reference Citation Analysis]
|
| 719 |
Hucker WJ, Chatzizisis YS, Steigner ML, Winters GL, Kirshenbaum JM. Myocardial catastrophe: a case of sudden, severe myocardial dysfunction. Circulation 2014;130:854-62. [PMID: 25210096 DOI: 10.1161/CIRCULATIONAHA.113.007417] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 720 |
Mekinian A, Costedoat-Chalumeau N, Masseau A, Tincani A, De Caroli S, Alijotas-Reig J, Ruffatti A, Ambrozic A, Botta A, Le Guern V, Fritsch-Stork R, Nicaise-Roland P, Carbonne B, Carbillon L, Fain O. Obstetrical APS: is there a place for hydroxychloroquine to improve the pregnancy outcome? Autoimmun Rev 2015;14:23-9. [PMID: 25179813 DOI: 10.1016/j.autrev.2014.08.040] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 721 |
Fernández-Madrid F, Maroun MC. Autoantibodies in breast cancer. Adv Clin Chem 2014;64:221-40. [PMID: 24938020 DOI: 10.1016/b978-0-12-800263-6.00005-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 722 |
Crowl A, Schullo-Feulner A, Moon JY. Warfarin monitoring in antiphospholipid syndrome and lupus anticoagulant. Ann Pharmacother 2014;48:1479-83. [PMID: 25104566 DOI: 10.1177/1060028014546361] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 723 |
de Jesús GR, Rodrigues G, de Jesús NR, Levy RA. Pregnancy morbidity in antiphospholipid syndrome: what is the impact of treatment? Curr Rheumatol Rep 2014;16:403. [PMID: 24390757 DOI: 10.1007/s11926-013-0403-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 724 |
Amaya-Amaya J, Montoya-Sánchez L, Rojas-Villarraga A. Cardiovascular involvement in autoimmune diseases. Biomed Res Int 2014;2014:367359. [PMID: 25177690 DOI: 10.1155/2014/367359] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 725 |
Lim W. Antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program. 2013;2013:675-680. [PMID: 24319251 DOI: 10.1182/asheducation-2013.1.675] [Cited by in Crossref: 53] [Cited by in F6Publishing: 60] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 726 |
Peixoto MV, de Carvalho JF, Rodrigues CE. Clinical, laboratory, and therapeutic analyses of 21 patients with neonatal thrombosis and antiphospholipid antibodies: a literature review. J Immunol Res 2014;2014:672603. [PMID: 25133197 DOI: 10.1155/2014/672603] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 727 |
Küçükşahin O, Ateş A, Okoh AK, Kulahcioglu E, Turgay M, Kınıklı G. Treatment resistant severe digital ischemia associated with antiphospholipid syndrome in a male patient with systemic sclerosis. Case Rep Rheumatol 2014;2014:291382. [PMID: 25110600 DOI: 10.1155/2014/291382] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 728 |
Ong MS, Kohane IS, Cai T, Gorman MP, Mandl KD. Population-level evidence for an autoimmune etiology of epilepsy. JAMA Neurol 2014;71:569-74. [PMID: 24687183 DOI: 10.1001/jamaneurol.2014.188] [Cited by in Crossref: 111] [Cited by in F6Publishing: 120] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 729 |
Zandman-Goddard G, Pierangeli SS, Gertel S, Blank M. Tolerogenic dendritic cells specific for β2-glycoprotein-I Domain-I, attenuate experimental antiphospholipid syndrome. J Autoimmun 2014;54:72-80. [PMID: 24972993 DOI: 10.1016/j.jaut.2014.06.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 730 |
Mittal T, Rathi M. Rheumatological diseases and kidneys: a nephrologist's perspective. Int J Rheum Dis 2014;17:834-44. [PMID: 24952962 DOI: 10.1111/1756-185X.12424] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 731 |
Ateka-Barrutia O, Khamashta MA. The challenge of pregnancy for patients with SLE. Lupus 2013;22:1295-308. [PMID: 24098002 DOI: 10.1177/0961203313504637] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 732 |
De Maeseneire Ch, Duray MC, Rutgers MP, Gille M. Neurological presentations of the antiphospholipid syndrome: three illustrative cases. Acta Neurol Belg 2014;114:117-23. [PMID: 24464766 DOI: 10.1007/s13760-013-0275-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 733 |
Boc A, Vene N, Štalc M, Košmelj K, Mavri A. Unprovoked proximal venous thrombosis is associated with an increased risk of asymptomatic pulmonary embolism. Thrombosis Research 2014;133:1011-5. [DOI: 10.1016/j.thromres.2014.02.033] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 734 |
Teh CL, Leong TS. Antiphospholipid syndrome in Sarawak: real world experience in a developing country. Clin Rheumatol 2015;34:175-8. [PMID: 24831689 DOI: 10.1007/s10067-014-2671-6] [Reference Citation Analysis]
|
| 735 |
Alonso A. Laughing and crying without apparent reason. More Case Studies in Stroke 2014. [DOI: 10.1017/cbo9781139424578.007] [Reference Citation Analysis]
|
| 736 |
D'Ippolito S, Meroni PL, Koike T, Veglia M, Scambia G, Di Simone N. Obstetric antiphospholipid syndrome: a recent classification for an old defined disorder. Autoimmun Rev 2014;13:901-8. [PMID: 24820522 DOI: 10.1016/j.autrev.2014.05.004] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 737 |
Vikerfors A, Svenungsson E, Ågren A, Mobarrez F, Bremme K, Holmström M, Eelde A, Bruzelius M, Elgue G, Wallén H, Antovic A. Studies of fibrin formation and fibrinolytic function in patients with the antiphospholipid syndrome. Thrombosis Research 2014;133:936-44. [DOI: 10.1016/j.thromres.2014.02.023] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 738 |
Armstrong EM, Bellone JM, Hornsby LB, Treadway S, Phillippe HM. Acquired Thrombophilia. J Pharm Pract 2014;27:234-42. [PMID: 24742931 DOI: 10.1177/0897190014530424] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 739 |
Matta BN, Uthman I, Taher AT, Khamashta MA. The current standing of diagnosis of antiphospholipid syndrome associated with systemic lupus erythematosus. Expert Rev Clin Immunol 2013;9:659-68. [PMID: 23899236 DOI: 10.1586/1744666X.2013.811183] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 740 |
Ruiz-García R, Serrano M, Martínez-Flores JÁ, Mora S, Morillas L, Martín-Mola MÁ, Morales JM, Paz-Artal E, Serrano A. Isolated IgA anti- β2 glycoprotein I antibodies in patients with clinical criteria for antiphospholipid syndrome. J Immunol Res 2014;2014:704395. [PMID: 24741618 DOI: 10.1155/2014/704395] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 741 |
Sciascia S, Cuadrado MJ, Khamashta M, Roccatello D. Renal involvement in antiphospholipid syndrome. Nat Rev Nephrol. 2014;10:279-289. [PMID: 24642799 DOI: 10.1038/nrneph.2014.38] [Cited by in Crossref: 62] [Cited by in F6Publishing: 66] [Article Influence: 6.9] [Reference Citation Analysis]
|
| 742 |
Carecchio M, Cantello R, Comi C. Revisiting the molecular mechanism of neurological manifestations in antiphospholipid syndrome: beyond vascular damage. J Immunol Res 2014;2014:239398. [PMID: 24741580 DOI: 10.1155/2014/239398] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 743 |
Anand P, Mann SK, Fischbein NJ, Lansberg MG. Bilateral internal carotid artery occlusion associated with the antiphospholipid antibody syndrome. Case Rep Neurol 2014;6:50-4. [PMID: 24707268 DOI: 10.1159/000360473] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 744 |
Feced Olmos CM, Alegre Sancho JJ, Ivorra Cortés J, Zaragozá García JM. Humeral Artery Thrombosis Simulating an Elbow Monoarthritis in a Woman With Primary Antiphospholipid Syndrome (Hughes Syndrome). Reumatología Clínica (English Edition) 2014;10:135-136. [DOI: 10.1016/j.reumae.2013.12.012] [Reference Citation Analysis]
|
| 745 |
Feced Olmos CM, Alegre Sancho JJ, Ivorra Cortés J, Zaragozá García JM. Trombosis de la arteria humeral simulando una monoartritis de codo en una paciente con síndrome antifosfolipídico primario (síndrome de Hughes). Reumatología Clínica 2014;10:135-6. [DOI: 10.1016/j.reuma.2013.03.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 746 |
Yokokawa T, Sugimoto K, Iwaya S, Suzuki S, Sakamoto N, Nakazato K, Suzuki H, Saitoh SI, Takeishi Y. A case of acute myocardial infarction during perioperative period of non-cardiac surgery in a patient with antiphospholipid syndrome and a history of coronary artery bypass surgery. J Cardiol Cases 2014;9:189-91. [PMID: 30534322 DOI: 10.1016/j.jccase.2014.01.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 747 |
Cervera R, Espinosa G. Diagnosing catastrophic antiphospholipid syndrome: the necessity for clinical awareness. International Journal of Clinical Rheumatology 2014;9:1-3. [DOI: 10.2217/ijr.13.70] [Reference Citation Analysis]
|
| 748 |
Freeman H, Patel J, Fernandez D, Sharples P, Ramanan AV. Fitting and flailing: recognition of paediatric antiphospholipid syndrome. Arch Dis Child Educ Pract Ed 2014;99:28-36. [PMID: 24091699 DOI: 10.1136/archdischild-2012-302404] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 749 |
Cervera R, Serrano R, Pons-estel GJ, Ceberio-hualde L, Shoenfeld Y, de Ramón E, Buonaiuto V, Jacobsen S, Zeher MM, Tarr T, Tincani A, Taglietti M, Theodossiades G, Nomikou E, Galeazzi M, Bellisai F, Meroni PL, Derksen RHWM, de Groot PGD, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris J, Quéré I, Hachulla E, Vasconcelos C, Fernández-nebro A, Haro M, Amoura Z, Miyara M, Tektonidou M, Espinosa G, Bertolaccini ML, Khamashta MA. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis 2015;74:1011-8. [DOI: 10.1136/annrheumdis-2013-204838] [Cited by in Crossref: 374] [Cited by in F6Publishing: 392] [Article Influence: 41.6] [Reference Citation Analysis]
|
| 750 |
Gómez-Puerta JA, Cervera R. Diagnosis and classification of the antiphospholipid syndrome. J Autoimmun. 2014;48-49:20-25. [PMID: 24461539 DOI: 10.1016/j.jaut.2014.01.006] [Cited by in Crossref: 181] [Cited by in F6Publishing: 191] [Article Influence: 20.1] [Reference Citation Analysis]
|
| 751 |
Stojanovich L, Djokovic A. Tomography and blood vessels in Hughes syndrome. Lupus 2014;23:337-41. [DOI: 10.1177/0961203313520061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 752 |
Haselboeck J, Ringl H, Mueller C, Pabinger I, Winkler S. Post-surgical hemorrhagic infarction of the adrenal gland as the first clinical manifestation of antiphospholipid syndrome after 43 years of antibody-positivity. Modern Rheumatology 2014;23:1237-41. [DOI: 10.3109/s10165-012-0741-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 753 |
Freire PV, Watanabe E, dos Santos NR, Bueno C, Bonfá E, de Carvalho JF. Distinct antibody profile: a clue to primary antiphospholipid syndrome evolving into systemic lupus erythematosus? Clin Rheumatol 2014;33:349-53. [PMID: 24420722 DOI: 10.1007/s10067-013-2472-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 754 |
Puente D, Pombo G, Forastiero R. Current management of antiphospholipid syndrome-related thrombosis. Expert Review of Cardiovascular Therapy 2014;7:1551-8. [DOI: 10.1586/erc.09.112] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 755 |
Burgos PI, Alarcón GS. Thrombosis in systemic lupus erythematosus: risk and protection. Expert Review of Cardiovascular Therapy 2014;7:1541-9. [DOI: 10.1586/erc.09.137] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 756 |
Arinuma Y, Kikuchi H, Aramaki K, Kyogoku M, Hirohata S. Histopathological analysis of cerebral hemorrhage in systemic lupus erythematosus complicated with antiphospholipid syndrome. Modern Rheumatology 2014;21:509-13. [DOI: 10.3109/s10165-011-0420-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 757 |
Sasaki H, Ito K, Furusaki A, Amasaki Y, Abe T. Chorea as the First Manifestation of Systemic Lupus Erythematosus Associated with Anti-phospholipid Syndrome. J Jpn Soc Intern Med 2014;103:744-746. [DOI: 10.2169/naika.103.744] [Reference Citation Analysis]
|
| 758 |
Culwell KR, Navarro GM. Contraception for Women with Rheumatologic Disease. Contraception for the Medically Challenging Patient 2014. [DOI: 10.1007/978-1-4939-1233-9_17] [Reference Citation Analysis]
|
| 759 |
Kozora E. Neurocognitive Function, Autoimmune Disorders and. Encyclopedia of the Neurological Sciences 2014. [DOI: 10.1016/b978-0-12-385157-4.00441-3] [Reference Citation Analysis]
|
| 760 |
Culwell KR, Navarro GM. Contraception for Women with Rheumatologic Disease. Contraception for the Medically Challenging Patient 2014. [DOI: 10.1007/978-1-4939-2341-0_17] [Reference Citation Analysis]
|
| 761 |
Sussman J, Davies-jones G. Neurologic Manifestations of Hematologic Disorders. Aminoff's Neurology and General Medicine 2014. [DOI: 10.1016/b978-0-12-407710-2.00025-4] [Reference Citation Analysis]
|
| 762 |
Mubarak M, Nasri H. What nephrolopathologists need to know about antiphospholipid syndrome-associated nephropathy: Is it time for formulating a classification for renal morphologic lesions? J Nephropathol 2014;3:4-8. [PMID: 24644536 DOI: 10.12860/jnp.2014.02] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
|
| 763 |
Fritzler MJ. Autoantibody Assays. The Autoimmune Diseases 2014. [DOI: 10.1016/b978-0-12-384929-8.00077-0] [Reference Citation Analysis]
|
| 764 |
Grover-páez F, García-benavides L, Cardona-muñóz EG, Ramos-becerra CG, García-corral JR, Medina-garcía CE, Alanis-sánchez GA, Totsuka-sutto SE. Successful Management of a Complicated Ulcer Caused by Autoimmune Vasculitis, with Sildenafil Citrate in a Patient with Primary Antiphospholipid Syndrome and Transient Steroid-Induced Diabetes Mellitus: A Case Report and Literature Review. JDM 2014;04:189-193. [DOI: 10.4236/jdm.2014.43027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 765 |
Levine AB, Lockshin MD. Antiphospholipid Syndrome. Contraception and Pregnancy in Patients with Rheumatic Disease 2014. [DOI: 10.1007/978-1-4939-0673-4_6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 766 |
Galli M. Treatment of the antiphospholipid syndrome. Auto Immun Highlights 2014;5:1-7. [PMID: 26000150 DOI: 10.1007/s13317-013-0056-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 767 |
Pons-estel GJ, Cervera R. Renal Involvement in Antiphospholipid Syndrome. Curr Rheumatol Rep 2014;16. [DOI: 10.1007/s11926-013-0397-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 768 |
Amin H, Greer DM. Cryptogenic Stroke—The Appropriate Diagnostic Evaluation. Curr Treat Options Cardio Med 2014;16. [DOI: 10.1007/s11936-013-0280-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 769 |
Camous J, Decrombecque T, Louvain-quintard V, Doubine S, Dartevelle P, Stéphan F. Outcomes of patients with antiphospholipid syndrome after pulmonary endarterectomy. European Journal of Cardio-Thoracic Surgery 2014;46:116-20. [DOI: 10.1093/ejcts/ezt572] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 770 |
Yang JY, Chan AK. Pediatric thrombophilia. Pediatr Clin North Am 2013;60:1443-62. [PMID: 24237981 DOI: 10.1016/j.pcl.2013.09.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 771 |
Gupta S, Zivadinov R, Ramasamy D, Ambrus JL Jr. Reversible cerebral vasoconstriction syndrome (RCVS) in antiphospholipid antibody syndrome (APLA): the role of centrally acting vasodilators. Case series and review of literature. Clin Rheumatol 2014;33:1829-33. [PMID: 24277114 DOI: 10.1007/s10067-013-2434-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 772 |
Matyja-Bednarczyk A, Swadźba J, Iwaniec T, Sanak M, Dziedzina S, Ćmiel A, Musiał J. Risk factors for arterial thrombosis in antiphospholipid syndrome. Thromb Res 2014;133:173-6. [PMID: 24321419 DOI: 10.1016/j.thromres.2013.11.012] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 773 |
Kolyada A, Porter A, Beglova N. Inhibition of thrombotic properties of persistent autoimmune anti-β2GPI antibodies in the mouse model of antiphospholipid syndrome. Blood 2014;123:1090-7. [PMID: 24277078 DOI: 10.1182/blood-2013-08-520882] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 774 |
Behera KK, Kapoor N, Seshadri MS, Rajaratnam S. Acute adrenal insufficiency due to primary antiphospholipid antibody syndrome. Indian J Endocrinol Metab 2013;17:S240-2. [PMID: 24251172 DOI: 10.4103/2230-8210.119584] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 775 |
Zamproni LN, Rubert MCS, Zétola VF, Mader-joaquim MJ, Lange MC. Cognitive impairment and antiphospholipid syndrome: is paradoxical embolism the rule? Neurological Research 2013;35:890-4. [DOI: 10.1179/1743132813y.0000000237] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 776 |
Erre GL, Bosincu L, Faedda R, Fenu P, Masala A, Sanna M, Taras L, Longu MG, Piras M, Soro G, Satta AE, Passiu G. Antiphospholipid syndrome nephropathy (APSN) in patients with lupus nephritis: a retrospective clinical and renal pathology study. Rheumatol Int 2014;34:535-41. [DOI: 10.1007/s00296-013-2900-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 777 |
Gómez-Puerta JA, Peris P, Reverter JC, Espinosa G, Martinez-Ferrer A, Monegal A, Monteagudo J, Tàssies D, Guañabens N. High prevalence of prothrombotic abnormalities in multifocal osteonecrosis: description of a series and review of the literature. Medicine (Baltimore) 2013;92:295-304. [PMID: 24145698 DOI: 10.1097/MD.0000000000000007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 778 |
Singh NK, Behera DR, Agrawal A, Singh MN, Kumar V, Godhra M, Gupta A, Yadav DP, Singh U, Pandey LK, Matah M. Hospital based prospective longitudinal clinical and immunologic study of 179 patients of primary anti-phospholipid syndrome. Int J Rheum Dis 2013;16:547-55. [DOI: 10.1111/1756-185x.12150] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 779 |
Bashal F. Hematological disorders in patients with systemic lupus erythematosus. Open Rheumatol J 2013;7:87-95. [PMID: 24198852 DOI: 10.2174/1874312901307010087] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 780 |
Park IC, Baek YH, Han SY, Lee SW, Chung WT, Lee SW, Kang SH, Cho DS. Simultaneous intrahepatic and subgaleal hemorrhage in antiphospholipid syndrome following anticoagulation therapy. World J Gastroenterol 2013; 19(38): 6494-6499 [PMID: 24151371 DOI: 10.3748/wjg.v19.i38.6494] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 781 |
Dekeyser M, Zuily S, Champigneulle J, Eschwège V, Frimat L, Perret-Guillaume C, Wahl D. [Antiphospholipid syndrome in nephrology. Kidney damage and practical aspects of the management]. Nephrol Ther 2014;10:1-9. [PMID: 24113198 DOI: 10.1016/j.nephro.2013.07.368] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 782 |
Guleria VS, Chauhan P, Shankar S, Nair V. All that seems sepsis is not sepsis. Indian J Crit Care Med 2013;17:185-7. [PMID: 24082618 DOI: 10.4103/0972-5229.117077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 783 |
Kunimoto BT. Catastrophic wounds. J Cutan Med Surg 2013;17 Suppl 1:S33-9. [PMID: 24144254 DOI: 10.2310/7750.2013.WOUND2] [Reference Citation Analysis]
|
| 784 |
Soo Hoo GW. Overview and assessment of risk factors for pulmonary embolism. Expert Rev Respir Med 2013;7:171-91. [PMID: 23547993 DOI: 10.1586/ers.13.7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 785 |
Careaga M, Hansen RL, Hertz-Piccotto I, Van de Water J, Ashwood P. Increased anti-phospholipid antibodies in autism spectrum disorders. Mediators Inflamm. 2013;2013:935608. [PMID: 24174712 DOI: 10.1155/2013/935608] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 786 |
Lanéelle D, Urbanski G, Beucher A-, Lavigne C. Thromboses inhabituelles et syndrome catastrophique des antiphospholipides. Réanimation 2013;22:501-509. [DOI: 10.1007/s13546-013-0716-5] [Reference Citation Analysis]
|
| 787 |
Garritsen HS, Probst-Kepper M, Legath N, Eberl W, Samaniego S, Woudenberg J, Schuitemaker JH, Kroll H, Gurney DA, Moore GW, Zehnder JL. High sensitivity and specificity of a new functional flow cytometry assay for clinically significant heparin-induced thrombocytopenia antibodies. Int J Lab Hematol 2014;36:135-43. [PMID: 23981347 DOI: 10.1111/ijlh.12136] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 788 |
Korkmaz S, Uslu AU, Sahin S, Senel S, Sencan M. Is there a link between mean platelet volume and thrombotic events in antiphospholipid syndrome? Platelets 2014;25:343-7. [PMID: 23971949 DOI: 10.3109/09537104.2013.824563] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 789 |
García de Lucas MD, Olalla J, Martín-Salido E, Espinosa G. [Antiphospholipid syndrome: analysis of 27 patients]. Med Clin (Barc) 2013;141:182-3. [PMID: 23597956 DOI: 10.1016/j.medcli.2013.01.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 790 |
Ramon I, Mathian A, Bachelot A, Hervier B, Haroche J, Boutin-Le Thi Huong D, Costedoat-Chalumeau N, Wechsler B, Karmali R, Velkeniers B, Touraine P, Coussieu C, Bennani A, Renard-Penna R, Grenier PA, Wahl D, Piette JC, Amoura Z. Primary adrenal insufficiency due to bilateral adrenal hemorrhage-adrenal infarction in the antiphospholipid syndrome: long-term outcome of 16 patients. J Clin Endocrinol Metab 2013;98:3179-89. [PMID: 23783099 DOI: 10.1210/jc.2012-4300] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 791 |
Sangle SR, Tanikawa A, Schreiber K, Zakalka M, D'Cruz DP. The prevalence of abnormal pulse wave velocity, pulse contour analysis and ankle-brachial index in patients with livedo reticularis: a controlled study. Rheumatology (Oxford) 2013;52:1992-8. [PMID: 23893524 DOI: 10.1093/rheumatology/ket227] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 792 |
Rambaldi MP, Mecacci F, Guaschino S, Paidas MJ. Inherited and acquired thrombophilias. Reprod Sci 2014;21:167-82. [PMID: 23899550 DOI: 10.1177/1933719113497282] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 793 |
Punnialingam S, Khamashta MA. Duration of anticoagulation treatment for thrombosis in APS: is it ever safe to stop? Curr Rheumatol Rep 2013;15:318. [PMID: 23494857 DOI: 10.1007/s11926-013-0318-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 794 |
Koolaee RM, Moran AM, Shahane A. Diffuse alveolar hemorrhage and Libman-Sacks endocarditis as a manifestation of possible primary antiphospholipid syndrome. J Clin Rheumatol 2013;19:79-83. [PMID: 23340096 DOI: 10.1097/RHU.0b013e318278c577] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 795 |
Marchetti T, Cohen M, de Moerloose P. Obstetrical antiphospholipid syndrome: from the pathogenesis to the clinical and therapeutic implications. Clin Dev Immunol 2013;2013:159124. [PMID: 23983765 DOI: 10.1155/2013/159124] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 796 |
Clark CA, Davidovits J, Spitzer KA, Laskin CA. The lupus anticoagulant: results from 2257 patients attending a high-risk pregnancy clinic. Blood 2013;122:341-7. [DOI: 10.1182/blood-2013-02-485839] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 797 |
Nandagudi A, Jury EC, Alonzi D, Butters TD, Hughes S, Isenberg DA. Heart failure in a woman with SLE, anti-phospholipid syndrome and Fabry's disease. Lupus 2013;22:1070-6. [PMID: 23864039 DOI: 10.1177/0961203313497116] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 798 |
Abdul Haium AA, Sheppard M, Rubens M, Daubeney P. Catastrophic antiphospholipid syndrome in childhood: presentation with an inferior caval vein mass. BMJ Case Rep 2013;2013:bcr2013010043. [PMID: 23861282 DOI: 10.1136/bcr-2013-010043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 799 |
Zuily S, Regnault V, Guillemin F, Kaminsky P, Rat A, Lecompte T, Wahl D. Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study. Thrombosis Research 2013;132:e1-7. [DOI: 10.1016/j.thromres.2013.04.012] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 800 |
Barnea ER, Rambaldi M, Paidas MJ, Mecacci F. Reproduction and autoimmune disease: important translational implications from embryo–maternal interaction. Immunotherapy 2013;5:769-80. [DOI: 10.2217/imt.13.59] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 801 |
Gualtierotti R, Biggioggero M, Meroni PL. Cutting-edge issues in coronary disease and the primary antiphospholipid syndrome. Clin Rev Allergy Immunol 2013;44:51-6. [PMID: 21403998 DOI: 10.1007/s12016-011-8268-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 802 |
Kim K, Baek I, Yoon C, Kim W, Cho C. Thrombotic risk in patients with immune thrombocytopenia and its association with antiphospholipid antibodies. Br J Haematol 2013;161:706-714. [DOI: 10.1111/bjh.12318] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 803 |
Beh SC, Greenberg BM, Frohman T, Frohman EM. Transverse myelitis. Neurol Clin 2013;31:79-138. [PMID: 23186897 DOI: 10.1016/j.ncl.2012.09.008] [Cited by in Crossref: 108] [Cited by in F6Publishing: 118] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 804 |
Padilla-Fernández B, García-Casado D, Martín-Izquierdo M, Manzano-Rodríguez C, García-García J, Lorenzo-Gómez MF. Bilateral renal infarction in a lupus patient: an unusual pathology. Clin Med Insights Case Rep 2013;6:87-91. [PMID: 23761987 DOI: 10.4137/CCRep.S11633] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 805 |
McLeod JM, Brantigan CO, Alix K, Kruse DL, Stone PA. Transmetatarsal amputation in the setting of antiphospholipid antibody syndrome. J Foot Ankle Surg 2013;52:383-8. [PMID: 23621979 DOI: 10.1053/j.jfas.2013.02.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 806 |
Cervera R, Espinosa G. The anti-phospholipid syndrome: 30 years in the forefront (1983-2013). Rheumatology (Oxford) 2013;52:1347-8. [PMID: 23620552 DOI: 10.1093/rheumatology/ket151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 807 |
Baizabal-Carvallo JF, Bonnet C, Jankovic J. Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome. J Neural Transm (Vienna) 2013;120:1579-89. [PMID: 23580159 DOI: 10.1007/s00702-013-1023-z] [Cited by in Crossref: 60] [Cited by in F6Publishing: 64] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 808 |
Ahluwalia J, Singh S, Naseem S, Suri D, Rawat A, Gupta A, Masih J, Bose S. Antiphospholipid antibodies in children with systemic lupus erythematosus: a long-term clinical and laboratory follow-up status study from northwest India. Rheumatol Int 2014;34:669-73. [PMID: 23563494 DOI: 10.1007/s00296-013-2736-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 809 |
Bontadi A, Ruffatti A, Falcinelli E, Giannini S, Marturano A, Tonello M, Hoxha A, Pengo V, Punzi L, Momi S, Gresele P. Platelet and endothelial activation in catastrophic and quiescent antiphospholipid syndrome. Thromb Haemost 2013;109:901-8. [PMID: 23572134 DOI: 10.1160/TH12-03-0212] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 810 |
Mubarak M. Catastrophic antiphospholipid syndrome presenting with sudden renal failure: The lesson lies in vascular lesions. J Nephropathol 2013;2:135-8. [DOI: 10.5812/nephropathol.9217] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 811 |
Davis AE. Antiphospholipid Syndrome (APS). Evidence-Based Nursing Care for Stroke and Neurovascular Conditions 2013. [DOI: 10.1002/9781118704950.ch12] [Reference Citation Analysis]
|
| 812 |
Hollan I, Meroni PL, Ahearn JM, Cohen Tervaert JW, Curran S, Goodyear CS, Hestad KA, Kahaleh B, Riggio M, Shields K, Wasko MC. Cardiovascular disease in autoimmune rheumatic diseases. Autoimmun Rev 2013;12:1004-15. [PMID: 23541482 DOI: 10.1016/j.autrev.2013.03.013] [Cited by in Crossref: 175] [Cited by in F6Publishing: 183] [Article Influence: 17.5] [Reference Citation Analysis]
|
| 813 |
Zuily S, Huttin O, Mohamed S, Marie P, Selton-suty C, Wahl D. Valvular Heart Disease in Antiphospholipid Syndrome. Curr Rheumatol Rep 2013;15. [DOI: 10.1007/s11926-013-0320-8] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 814 |
Subrt I, Ulcova-Gallova Z, Cerna M, Hejnalova M, Slovanova J, Bibkova K, Micanova Z. Recurrent pregnancy loss, plasminogen activator inhibitor-1 (-675) 4G/5G polymorphism and antiphospholipid antibodies in Czech women. Am J Reprod Immunol 2013;70:54-8. [PMID: 23445116 DOI: 10.1111/aji.12099] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 815 |
Martín-suñé N, Ríos-blanco JJ, Noval-martín S, Alvarez-pellicer J, Barbado-hernández FJ, Arnalich-fernández F. Intracranial hypertension and antiphospholipid antibodies. International Journal of Clinical Rheumatology 2013;8:9-11. [DOI: 10.2217/ijr.12.70] [Reference Citation Analysis]
|
| 816 |
Lambrianides A, Turner-Stokes T, Pericleous C, Ehsanullah J, Papadimitraki E, Poulton K, Ioannou Y, Lawrie A, Mackie I, Chen P, Latchman D, Isenberg D, Rahman A, Giles I. Interactions of human monoclonal and polyclonal antiphospholipid antibodies with serine proteases involved in hemostasis. Arthritis Rheum 2011;63:3512-21. [PMID: 21739425 DOI: 10.1002/art.30525] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 817 |
Kahn KA. Headache due to Systemic Disease. Neurological Disorders due to Systemic Disease 2013. [DOI: 10.1002/9781118414019.ch2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 818 |
Murakami J, Shimizu Y. Hepatic manifestations in hematological disorders. Int J Hepatol 2013;2013:484903. [PMID: 23606974 DOI: 10.1155/2013/484903] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 819 |
Borie R, Crestani B. Atteintes pleuro-pulmonaires associées au lupus érythémateux. Lupus érythémateux 2013. [DOI: 10.1016/b978-2-294-71447-4.50035-0] [Reference Citation Analysis]
|
| 820 |
Mestres CA, Marcacci C, Espinosa G, Pomar JL, Colli A, Cervera R. Heart Valve Surgery and the Antiphospholipid Syndrome. Inflammatory Response in Cardiovascular Surgery 2013. [DOI: 10.1007/978-1-4471-4429-8_38] [Reference Citation Analysis]
|
| 821 |
Navarra SV, Torralba TP. The Musculoskeletal System and Bone Metabolism. Dubois' Lupus Erythematosus and Related Syndromes 2013. [DOI: 10.1016/b978-1-4377-1893-5.00025-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] |
